BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ;  Canadian Critical Care Trials Group. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7:e47559. [PMID: 23133515 DOI: 10.1371/journal.pone.0047559] [Cited by in Crossref: 671] [Cited by in F6Publishing: 684] [Article Influence: 67.1] [Reference Citation Analysis]
Number Citing Articles
1 Saito T, Kotani T, Suzuka T, Matsuda S, Takeuchi T, Sato T. Adipose-derived stem/stromal cells with heparin-enhanced anti-inflammatory and antifibrotic effects mitigate induced pulmonary fibrosis in mice. Biochem Biophys Res Commun 2022;629:135-41. [PMID: 36116376 DOI: 10.1016/j.bbrc.2022.08.096] [Reference Citation Analysis]
2 Stenger E, Giver CR, Langston A, Kota D, Das PK, Chinnadurai R, Galipeau J, Waller EK, Qayed M. Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease. Front Immunol 2022;13:959658. [DOI: 10.3389/fimmu.2022.959658] [Reference Citation Analysis]
3 Maene A, Deniz G, Bouland C, Lagneaux L, Philippart P, Buxant F. Suburethral implantation of autologous regenerative cells for female stress urinary incontinence management: Results of a pilot study. Eur J Obstet Gynecol Reprod Biol 2022;278:38-44. [PMID: 36113285 DOI: 10.1016/j.ejogrb.2022.08.028] [Reference Citation Analysis]
4 Guillamat-prats R. Role of Mesenchymal Stem/Stromal Cells in Coagulation. IJMS 2022;23:10393. [DOI: 10.3390/ijms231810393] [Reference Citation Analysis]
5 Shibl NG, Fikry EM, Mansour HA, Alsemeh AE, Abdel-Ghany RH, El-Sayed SS. Ameliorative effect of bone marrow-derived mesenchymal stem cells on burn-induced hepatic and metabolic derangements in rats. Life Sci 2022;307:120891. [PMID: 36007609 DOI: 10.1016/j.lfs.2022.120891] [Reference Citation Analysis]
6 Mohamed SA, Duffy A, McInerney V, Krawczyk J, Hayat A, Naughton S, Finnerty A, Holohan M, Liew A, Tubassam M, Walsh SR, O'Brien T, Howard L. Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with "no-option" critical limb ischemia; observations on feasibility of the autologous approach from a clinical trial. Cytotherapy 2022:S1465-3249(22)00731-9. [PMID: 35999133 DOI: 10.1016/j.jcyt.2022.07.002] [Reference Citation Analysis]
7 Sone H, Kajiya M, Takeda K, Sasaki S, Horikoshi S, Motoike S, Morimoto S, Yoshii H, Yoshino M, Iwata T, Ouhara K, Matsuda S, Mizuno N. Clumps of mesenchymal stem cells/extracellular matrix complexes directly reconstruct the functional periodontal tissue in a rat periodontal defect model. J Tissue Eng Regen Med 2022. [PMID: 35951352 DOI: 10.1002/term.3343] [Reference Citation Analysis]
8 Fakiha K. Adipose stromal vascular fraction: a promising treatment for severe burn injury. Hum Cell 2022. [PMID: 35906507 DOI: 10.1007/s13577-022-00743-z] [Reference Citation Analysis]
9 Munk A, Duvald CS, Pedersen M, Lohmann S, Keller AK, Møller BK, Ringgaard S, Buus NH, Jespersen B, Eijken M. Dosing Limitation for Intra-Renal Arterial Infusion of Mesenchymal Stromal Cells. IJMS 2022;23:8268. [DOI: 10.3390/ijms23158268] [Reference Citation Analysis]
10 Miller CL, O JM, Allan JS, Madsen JC. Novel approaches for long-term lung transplant survival. Front Immunol 2022;13:931251. [DOI: 10.3389/fimmu.2022.931251] [Reference Citation Analysis]
11 Lipat AJ, Cottle C, Pirlot BM, Mitchell J, Pando B, Helmly B, Kosko J, Rajan D, Hematti P, Chinnadurai R. Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells. Stem Cells Transl Med 2022:szac050. [PMID: 35881077 DOI: 10.1093/stcltm/szac050] [Reference Citation Analysis]
12 Zhu L, Wang S, Qu J, Hui Z, Kan C, Hou N, Sun X. The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus. Cell Reprogram 2022. [PMID: 35877064 DOI: 10.1089/cell.2022.0039] [Reference Citation Analysis]
13 Wang X, Wang K, Yu M, Velluto D, Hong X, Wang B, Chiu A, Melero-Martin JM, Tomei AA, Ma M. Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression. Sci Adv 2022;8:eabn0071. [PMID: 35867788 DOI: 10.1126/sciadv.abn0071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Athiel Y, Nasone J, Arakelian L, Faivre L, Dugas A, Jouannic JM, Larghero J, Guilbaud L. Biodistribution of allogenic umbilical cord-derived mesenchymal stromal cells after fetal repair of myelomeningocele in an ovine model. Stem Cell Res Ther 2022;13:300. [PMID: 35841029 DOI: 10.1186/s13287-022-02991-0] [Reference Citation Analysis]
15 Vives J, Hernández J, Mirabel C, Puigdomenech-Poch M, Romeo-Guitart D, Marmolejo-Martínez-Artesero S, Cabrera-Pérez R, Jaramillo J, Kumru H, García-López J, Vidal-Samsó J, Navarro X, Coll-Bonet R. Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance. Cells 2022;11:2153. [PMID: 35883596 DOI: 10.3390/cells11142153] [Reference Citation Analysis]
16 He W, Shi C, Yin J, Huang F, Yan W, Deng J, Zhang B, Wang B, Wang H. Spinal cord decellularized matrix scaffold loaded with engineered basic fibroblast growth factor-overexpressed human umbilical cord mesenchymal stromal cells promoted the recovery of spinal cord injury. J Biomed Mater Res B Appl Biomater 2022. [PMID: 35799479 DOI: 10.1002/jbm.b.35131] [Reference Citation Analysis]
17 Zhang D, Ding C, Duan T, Zhou Q. Applications of Hydrogels in Premature Ovarian Failure and Intrauterine Adhesion. Front Mater 2022;9:942957. [DOI: 10.3389/fmats.2022.942957] [Reference Citation Analysis]
18 Sun P, Pan B. Topical Application of Conditioned Medium from Hypoxically Cultured Amnion-Derived Mesenchymal Stem Cells Promotes Wound Healing in Diabetic Mice. Plast Reconstr Surg 2022;150:232e-3e. [PMID: 35594414 DOI: 10.1097/PRS.0000000000009214] [Reference Citation Analysis]
19 Ghai S, Saini S, Ansari S, Verma V, Chopra S, Sharma V, Devi P, Malakar D. Allogenic umbilical cord blood-mesenchymal stem cells are more effective than antibiotics in alleviating subclinical mastitis in dairy cows. Theriogenology 2022;187:141-51. [DOI: 10.1016/j.theriogenology.2022.05.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Carp DM, Liang Y. Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source. Cells 2022;11:2077. [DOI: 10.3390/cells11132077] [Reference Citation Analysis]
21 Kaffash Farkhad N, Sedaghat A, Reihani H, Adhami Moghadam A, Bagheri Moghadam A, Khadem Ghaebi N, Khodadoust MA, Ganjali R, Tafreshian AR, Tavakol-Afshari J. Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial. Stem Cell Res Ther 2022;13:283. [PMID: 35765103 DOI: 10.1186/s13287-022-02920-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, Hedayati Asl AA, Abbasi Kakroodi F, Jaroughi N, Mohseni Meybodi MA, Setoodeh A, Abbasi F, Hosseini SE, Moeini Nia F, Salman Yazdi R, Navabi R, Hajizadeh-Saffar E, Baharvand H. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial. Stem Cell Res Ther 2022;13:264. [PMID: 35725652 DOI: 10.1186/s13287-022-02941-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kay AG, Fox JM, Hewitson JP, Stone AP, Robertson S, James S, Wang X, Kapasa E, Yang XB, Genever PG. CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations. Front Immunol 2022;13:903796. [DOI: 10.3389/fimmu.2022.903796] [Reference Citation Analysis]
24 Williams P, Klersy C, Karki C, Bennett D, Rodríguez AM, Ciccocioppo R. Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn's Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons. Adv Ther 2022;39:2761-77. [PMID: 35426592 DOI: 10.1007/s12325-022-02113-5] [Reference Citation Analysis]
25 Sivan SS, Bonstein I, Marmor YN, Pelled G, Gazit Z, Amit M. Encapsulation of Human-Bone-Marrow-Derived Mesenchymal Stem Cells in Small Alginate Beads Using One-Step Emulsification by Internal Gelation: In Vitro, and In Vivo Evaluation in Degenerate Intervertebral Disc Model. Pharmaceutics 2022;14:1179. [DOI: 10.3390/pharmaceutics14061179] [Reference Citation Analysis]
26 Li Y, Ricardo SD, Samuel CS. Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease. IJMS 2022;23:6035. [DOI: 10.3390/ijms23116035] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhang Y, Gu J, Wang X, Li L, Fu L, Wang D, Wang X, Han X. Opportunities and challenges: mesenchymal stem cells in the treatment of multiple sclerosis. Int J Neurosci 2022;:1-14. [PMID: 35579409 DOI: 10.1080/00207454.2022.2042690] [Reference Citation Analysis]
28 Jones OY, Mccurdy D. Cell Based Treatment of Autoimmune Diseases in Children. Front Pediatr 2022;10:855260. [DOI: 10.3389/fped.2022.855260] [Reference Citation Analysis]
29 Shoukrie SI, Venugopal S, Dhanoa RK, Selvaraj R, Selvamani TY, Zahra A, Malla J, Hamouda RK, Hamid PF. Safety and Efficacy of Injecting Mesenchymal Stem Cells Into a Human Knee Joint To Treat Osteoarthritis: A Systematic Review. Cureus. [DOI: 10.7759/cureus.24823] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Madani S, Amanzadi M, Aghayan HR, Setudeh A, Rezaei N, Rouhifard M, Larijani B. Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis. Syst Rev 2022;11. [DOI: 10.1186/s13643-022-01950-3] [Reference Citation Analysis]
31 Freitag J, Wickham J, Shah K, Tenen A. Real-world evidence of mesenchymal stem cell therapy in knee osteoarthritis: a large prospective two-year case series. Regen Med 2022. [PMID: 35411799 DOI: 10.2217/rme-2022-0002] [Reference Citation Analysis]
32 Coulon SJ, Schuman JS, Du Y, Bahrani Fard MR, Ethier CR, Stamer WD. A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork. Progress in Retinal and Eye Research 2022. [DOI: 10.1016/j.preteyeres.2022.101063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Xian Bo S, Chen W, Chang L, Hao Ran Y, Hui Hui G, Ya Kun Z, Wu Kun X, Hai Tao F, Wen Dan C. The Research Progress of Exosomes in Osteoarthritis, With Particular Emphasis on the Therapeutic Effect. Front Pharmacol 2022;13:731756. [PMID: 35308214 DOI: 10.3389/fphar.2022.731756] [Reference Citation Analysis]
34 Ringdén O, Moll G, Gustafsson B, Sadeghi B. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome. Front Immunol 2022;13:839844. [DOI: 10.3389/fimmu.2022.839844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
35 Shang Z, Wang R, Li D, Chen J, Zhang B, Wang M, Wang X, Wanyan P. Spinal Cord Injury: A Systematic Review and Network Meta-Analysis of Therapeutic Strategies Based on 15 Types of Stem Cells in Animal Models. Front Pharmacol 2022;13:819861. [DOI: 10.3389/fphar.2022.819861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Pandey V, Madi S, Gupta P. The promising role of autologous and allogeneic mesenchymal stromal cells in managing knee osteoarthritis. What is beyond Mesenchymal stromal cells? Journal of Clinical Orthopaedics and Trauma 2022;26:101804. [DOI: 10.1016/j.jcot.2022.101804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhang Y, Dong N, Hong H, Qi J, Zhang S, Wang J. Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke. Int J Mol Sci 2022;23:2550. [PMID: 35269692 DOI: 10.3390/ijms23052550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Koehler N, Buhler L, Egger B, Gonelle-gispert C. Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function. Front Endocrinol 2022;13:822191. [DOI: 10.3389/fendo.2022.822191] [Reference Citation Analysis]
39 Karakaş N, Üçüncüoğlu S, Uludağ D, Karaoğlan BS, Shah K, Öztürk G. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives. Cells 2022;11:465. [DOI: 10.3390/cells11030465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Giri J, Moll G. MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel. Curr Stem Cell Rep. [DOI: 10.1007/s40778-022-00207-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
41 Scheiber AL, Clark CA, Kaito T, Iwamoto M, Horwitz EM, Kawasawa YI, Otsuru S. Culture Condition of Bone Marrow Stromal Cells Affects Quantity and Quality of the Extracellular Vesicles. Int J Mol Sci 2022;23:1017. [PMID: 35162938 DOI: 10.3390/ijms23031017] [Reference Citation Analysis]
42 Pittenger MF, Eghtesad S, Sanchez PG, Liu X, Wu Z, Chen L, Griffith BP. MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts. Int J Mol Sci 2022;23:694. [PMID: 35054878 DOI: 10.3390/ijms23020694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Thapaswini Y, Nikitha, Phanindra S, Ramavarapu A, Kudala V, Cherukuri S. Evaluation of the toxicity of human dental pulp-derived mesenchymal stem cells on animal models: An animal study. J Pharm Bioall Sci 2022;14:683. [DOI: 10.4103/jpbs.jpbs_84_22] [Reference Citation Analysis]
44 Niroomand A, Hirdman G, Olm F, Lindstedt S. Current Status and Future Perspectives on Machine Perfusion: A Treatment Platform to Restore and Regenerate Injured Lungs Using Cell and Cytokine Adsorption Therapy. Cells 2021;11:91. [PMID: 35011653 DOI: 10.3390/cells11010091] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Madani S, Setudeh A, Aghayan HR, Alavi-Moghadam S, Rouhifard M, Rezaei N, Rostami P, Mohsenipour R, Amirkashani D, Bandarian F, Arjmand B, Larijani B. Placenta derived Mesenchymal Stem Cells transplantation in Type 1 diabetes: preliminary report of phase 1 clinical trial. J Diabetes Metab Disord 2021;20:1179-89. [PMID: 34900770 DOI: 10.1007/s40200-021-00837-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Paprocka J, Kaminiów K, Kozak S, Sztuba K, Emich-Widera E. Stem Cell Therapies for Cerebral Palsy and Autism Spectrum Disorder-A Systematic Review. Brain Sci 2021;11:1606. [PMID: 34942908 DOI: 10.3390/brainsci11121606] [Reference Citation Analysis]
47 Yu H, Commander CW, Stavas JM. Stem Cell-Based Therapies: What Interventional Radiologists Need to Know. Semin Intervent Radiol 2021;38:523-34. [PMID: 34853498 DOI: 10.1055/s-0041-1736657] [Reference Citation Analysis]
48 Götherström C, David AL, Walther-Jallow L, Åström E, Westgren M. Mesenchymal Stem Cell Therapy for Osteogenesis Imperfecta. Clin Obstet Gynecol 2021;64:898-903. [PMID: 34510048 DOI: 10.1097/GRF.0000000000000656] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Kiritsi D, Dieter K, Niebergall-Roth E, Fluhr S, Daniele C, Esterlechner J, Sadeghi S, Ballikaya S, Erdinger L, Schauer F, Gewert S, Laimer M, Bauer JW, Hovnanian A, Zambruno G, El Hachem M, Bourrat E, Papanikolaou M, Petrof G, Kitzmüller S, Ebens CL, Frank MH, Frank NY, Ganss C, Martinez AE, McGrath JA, Tolar J, Kluth MA. Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa. JCI Insight 2021;6:e151922. [PMID: 34665781 DOI: 10.1172/jci.insight.151922] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 Lara-Barba E, Araya MJ, Hill CN, Bustamante-Barrientos FA, Ortloff A, García C, Galvez-Jiron F, Pradenas C, Luque-Campos N, Maita G, Elizondo-Vega R, Djouad F, Vega-Letter AM, Luz-Crawford P. Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal Stem/Stromal Cells for Osteoarticular Disease Treatment. Front Immunol 2021;12:768771. [PMID: 34790203 DOI: 10.3389/fimmu.2021.768771] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
51 Wang MY, Zhou TY, Zhang ZD, Liu HY, Zheng ZY, Xie HQ. Current therapeutic strategies for respiratory diseases using mesenchymal stem cells. MedComm (2020) 2021;2:351-80. [PMID: 34766151 DOI: 10.1002/mco2.74] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Krief B, Algor SW, Nakdimon I, Elhikis A, Benhamou M, Kadmon AS, Keren S, Ohana O, Feldman I, Cnaan RB, Leibovitch I, Loewenstein A, Barak A, Barzelay A. Retinal Lineage Therapeutic Specific Effect of Human Orbital and Abdominal Adipose-Derived Mesenchymal Stem Cells. Stem Cells Int 2021;2021:7022247. [PMID: 34712333 DOI: 10.1155/2021/7022247] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Gala D, Gurusamy V, Patel K, Damodar S, Swaminath G, Ullal G. Stem Cell Therapy for Post-Traumatic Stress Disorder: A Novel Therapeutic Approach. Diseases 2021;9:77. [PMID: 34842629 DOI: 10.3390/diseases9040077] [Reference Citation Analysis]
54 Pant T, Juric M, Bosnjak ZJ, Dhanasekaran A. Recent Insight on the Non-coding RNAs in Mesenchymal Stem Cell-Derived Exosomes: Regulatory and Therapeutic Role in Regenerative Medicine and Tissue Engineering. Front Cardiovasc Med 2021;8:737512. [PMID: 34660740 DOI: 10.3389/fcvm.2021.737512] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
55 Kong W, Lyu C, Liao H, Du Y. Collagen crosslinking: effect on structure, mechanics and fibrosis progression. Biomed Mater 2021;16. [PMID: 34587604 DOI: 10.1088/1748-605X/ac2b79] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Wang Y, Yi H, Song Y. The safety of MSC therapy over the past 15 years: a meta-analysis. Stem Cell Res Ther 2021;12:545. [PMID: 34663461 DOI: 10.1186/s13287-021-02609-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
57 Matsumoto T, Sato Y, Kobayashi T, Suzuki K, Kimura A, Soma T, Ito E, Kikuchi T, Kobayashi S, Harato K, Niki Y, Matsumoto M, Nakamura M, Miyamoto T. Adipose-Derived Stem Cell Sheets Improve Early Biomechanical Graft Strength in Rabbits After Anterior Cruciate Ligament Reconstruction. Am J Sports Med 2021;49:3508-18. [PMID: 34643475 DOI: 10.1177/03635465211041582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Sugimoto Y, Yamazaki Y, Moriyama K, Sugimoto T, Kumazawa K, Baba K, Sone Y, Takeda A. Differentiation and proliferation potencies of human bone tissue-derived mesenchymal stromal cells (hBT-MSCs) after long-term cryopreservation -Comparison among cells stored for 1, 5, 10, 15, and 20 years. Regen Ther 2021;18:363-71. [PMID: 34632009 DOI: 10.1016/j.reth.2020.01.006] [Reference Citation Analysis]
59 Calcat-I-Cervera S, Sanz-Nogués C, O'Brien T. When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease. Front Med (Lausanne) 2021;8:728496. [PMID: 34616756 DOI: 10.3389/fmed.2021.728496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Renesme L, Cobey KD, Le M, Lalu MM, Thebaud B. Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol. BMJ Open 2021;11:e054740. [PMID: 34620674 DOI: 10.1136/bmjopen-2021-054740] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Krampera M, Le Blanc K. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell 2021;28:1708-25. [PMID: 34624232 DOI: 10.1016/j.stem.2021.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
62 Shaw TD, Krasnodembskaya AD, Schroeder GN, Zumla A, Maeurer M, O'Kane CM. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases. Clin Microbiol Rev 2021;:e0006421. [PMID: 34612662 DOI: 10.1128/CMR.00064-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
63 Lee S, Chae DS, Song BW, Lim S, Kim SW, Kim IK, Hwang KC. ADSC-Based Cell Therapies for Musculoskeletal Disorders: A Review of Recent Clinical Trials. Int J Mol Sci 2021;22:10586. [PMID: 34638927 DOI: 10.3390/ijms221910586] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Beghini DG, Horita SI, Henriques-Pons A. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future. Cells 2021;10:2588. [PMID: 34685567 DOI: 10.3390/cells10102588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Padda J, Khalid K, Zubair U, Al Hennawi H, Yadav J, Almanie AH, Mehta KA, Tasnim F, Cooper AC, Jean-Charles G. Stem Cell Therapy and Its Significance in Pain Management. Cureus 2021;13:e17258. [PMID: 34540482 DOI: 10.7759/cureus.17258] [Reference Citation Analysis]
66 Gupta PK, Dutta S, Kala S, Nekkanti M, Desai SC, Mahapatra SS, Dhar A, Raju R, M R, Behera A, P S, Raviraja NS, Viswanathan P, Chandrashekar M, Thej C, K V P, Abraham J, Boggarapu H, Udaykumar K. Phase IV postmarketing surveillance study shows continued efficacy and safety of stempeucel® in patients with critical limb ischemia due to Buerger's disease. Stem Cells Transl Med 2021. [PMID: 34519179 DOI: 10.1002/sctm.21-0197] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
67 Sato Y, Kuragaichi T, Saga S, Nakayama H, Obata T, Watanabe M, Fujikura K, Watanabe M, Hata KI, Ohgushi H. Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction. Circ Rep 2021;3:550-4. [PMID: 34568634 DOI: 10.1253/circrep.CR-21-0091] [Reference Citation Analysis]
68 Xin WQ, Wei W, Pan YL, Cui BL, Yang XY, Bähr M, Doeppner TR. Modulating poststroke inflammatory mechanisms: Novel aspects of mesenchymal stem cells, extracellular vesicles and microglia. World J Stem Cells 2021; 13(8): 1030-1048 [PMID: 34567423 DOI: 10.4252/wjsc.v13.i8.1030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
69 Muñoz-Domínguez N, Roura S, Prat-Vidal C, Vives J. Wharton's Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View. Pharmaceutics 2021;13:1336. [PMID: 34575412 DOI: 10.3390/pharmaceutics13091336] [Reference Citation Analysis]
70 Benavides FP, Pinto GBA, Heckler MCT, Hurtado DMR, Teixeira LR, Monobe MMS, Machado GF, de Melo GD, Rodríguez-Sánchez DN, Alvarenga FDCLE, Amorim RM. Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs. Cell Transplant 2021;30:9636897211034464. [PMID: 34427495 DOI: 10.1177/09636897211034464] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Yiğenoğlu TN, Başcı S, Şahin D, Ulaş T, Dal MS, Korkmaz S, Hacıbekiroğlu T, Namdaroğlu S, Erkurt MA, Turgut B, Altuntaş F. Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients. Transfus Apher Sci 2021;:103237. [PMID: 34419356 DOI: 10.1016/j.transci.2021.103237] [Reference Citation Analysis]
72 Paton MCB, Wall DA, Elwood N, Chiang KY, Cowie G, Novak I, Finch-Edmondson M. Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies. Cytotherapy 2021:S1465-3249(21)00715-5. [PMID: 34384698 DOI: 10.1016/j.jcyt.2021.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
73 Rangel ÉB, Rodrigues CO, Guimarães-Souza NK. Stem Cell Applications in Regenerative Medicine for Kidney Diseases. Stem Cells Int 2021;2021:9817324. [PMID: 34394359 DOI: 10.1155/2021/9817324] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Xie Y, Chen F, Jia L, Chen R, Zhang VW, Zhong X, Wang D. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats. J Cell Mol Med 2021;25:8558-66. [PMID: 34322990 DOI: 10.1111/jcmm.16817] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
75 Kirkham AM, Bailey AJM, Tieu A, Maganti HB, Montroy J, Shorr R, Campbell TM, Fergusson DA, Lalu MM, Elmoazzen H, Allan DS. MSC-Derived Extracellular Vesicles in Preclinical Animal Models of Bone Injury: A Systematic Review and Meta-Analysis. Stem Cell Rev Rep 2021. [PMID: 34313927 DOI: 10.1007/s12015-021-10208-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Wagoner ZW, Zhao W. Therapeutic implications of transplanted-cell death. Nat Biomed Eng 2021;5:379-84. [PMID: 34002064 DOI: 10.1038/s41551-021-00729-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Lohmann S, Eijken M, Møldrup U, Møller BK, Hunter J, Moers C, Leuvenink H, Ploeg RJ, Clahsen-van Groningen MC, Hoogduijn M, Baan CC, Keller AK, Jespersen B. Ex Vivo Administration of Mesenchymal Stromal Cells in Kidney Grafts Against Ischemia-reperfusion Injury-Effective Delivery Without Kidney Function Improvement Posttransplant. Transplantation 2021;105:517-28. [PMID: 32956281 DOI: 10.1097/TP.0000000000003429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
78 Wang LM, Jung S, Serban M, Chatterjee A, Lee S, Jeyaseelan K, El Naqa I, Seuntjens J, Ybarra N. Comparison of quantitative and qualitative scoring approaches for radiation-induced pulmonary fibrosis as applied to a preliminary investigation into the efficacy of mesenchymal stem cell delivery methods in a rat model. BJR Open 2021;2:20210006. [PMID: 34381940 DOI: 10.1259/bjro.20210006] [Reference Citation Analysis]
79 Khoury MA, Chamari K, Tabben M, Alkhelaifi K, Ricardo T, Damián C, D'hooghe P. Expanded adipose derived mesenchymal stromal cells are effective in treating chronic insertional patellar tendinopathy: clinical and MRI evaluations of a pilot study. J Exp Orthop 2021;8:49. [PMID: 34213678 DOI: 10.1186/s40634-021-00358-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Kirwin T, Gomes A, Amin R, Sufi A, Goswami S, Wang B. Mechanisms underlying the therapeutic potential of mesenchymal stem cells in atherosclerosis. Regen Med 2021;16:669-82. [PMID: 34189963 DOI: 10.2217/rme-2021-0024] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
81 Tseng WC, Lee PY, Tsai MT, Chang FP, Chen NJ, Chien CT, Hung SC, Tarng DC. Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy. Stem Cell Res Ther 2021;12:367. [PMID: 34183058 DOI: 10.1186/s13287-021-02374-x] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
82 Chen W, Zhang Y, Yang S, Sun J, Qiu H, Hu X, Niu X, Xiao Z, Zhao Y, Zhou Y, Dai J, Chu T. NeuroRegen Scaffolds Combined with Autologous Bone Marrow Mononuclear Cells for the Repair of Acute Complete Spinal Cord Injury: A 3-Year Clinical Study. Cell Transplant 2020;29:963689720950637. [PMID: 32862715 DOI: 10.1177/0963689720950637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
83 Brown HL, Clayton A, Stephens P. The role of bacterial extracellular vesicles in chronic wound infections: Current knowledge and future challenges. Wound Repair Regen 2021. [PMID: 34132443 DOI: 10.1111/wrr.12949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Imbarak N, Abdel-Aziz HI, Farghaly LM, Hosny S. Effect of mesenchymal stem cells versus aloe vera on healing of deep second-degree burn. Stem Cell Investig 2021;8:12. [PMID: 34268441 DOI: 10.21037/sci-2020-030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Puzzitiello RN, Dubin J, Menendez ME, Moverman MA, Pagani NR, Drager J, Salzler MJ. Public Opinion and Expectations of Stem Cell Therapies in Orthopaedics. Arthroscopy 2021:S0749-8063(21)00571-5. [PMID: 34126222 DOI: 10.1016/j.arthro.2021.05.058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Willekens B, Wens I, Wouters K, Cras P, Cools N. Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials. Autoimmun Rev 2021;20:102873. [PMID: 34119672 DOI: 10.1016/j.autrev.2021.102873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Kim M, Knoepfler PS. Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19. Regen Med 2021;16:525-33. [PMID: 34114493 DOI: 10.2217/rme-2021-0025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
88 Lu J, Shen SM, Ling Q, Wang B, Li LR, Zhang W, Qu DD, Bi Y, Zhu DL. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study. Stem Cell Res Ther 2021;12:340. [PMID: 34112266 DOI: 10.1186/s13287-021-02417-3] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
89 Wong SC, Medrano LC, Hoftman AD, Jones OY, McCurdy DK. Uncharted waters: mesenchymal stem cell treatment for pediatric refractory rheumatic diseases; a single center case series. Pediatr Rheumatol Online J 2021;19:87. [PMID: 34112214 DOI: 10.1186/s12969-021-00575-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Heidari N, Borg TM, Olgiati S, Slevin M, Danovi A, Fish B, Wilson A, Noorani A. Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two Years. Stem Cells Int 2021;2021:9921015. [PMID: 34211557 DOI: 10.1155/2021/9921015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Warnecke A, Prenzler N, Harre J, Köhl U, Gärtner L, Lenarz T, Laner-Plamberger S, Wietzorrek G, Staecker H, Lassacher T, Hollerweger J, Gimona M, Rohde E. First-in-human intracochlear application of human stromal cell-derived extracellular vesicles. J Extracell Vesicles 2021;10:e12094. [PMID: 34136108 DOI: 10.1002/jev2.12094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
92 Varkouhi AK, Monteiro APT, Tsoporis JN, Mei SHJ, Stewart DJ, Dos Santos CC. Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness. Stem Cell Rev Rep 2020;16:812-27. [PMID: 32671645 DOI: 10.1007/s12015-020-10000-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
93 Wiggers TG, Winters M, Van den Boom NA, Haisma HJ, Moen MH. Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials. Br J Sports Med 2021:bjsports-2020-103671. [PMID: 34039582 DOI: 10.1136/bjsports-2020-103671] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
94 Lwin SM, Snowden JA, Griffiths CEM. The promise and challenges of cell therapy for psoriasis. Br J Dermatol 2021. [PMID: 34036569 DOI: 10.1111/bjd.20517] [Reference Citation Analysis]
95 Cai Q, Yin F, Hao L, Jiang W. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19. Stem Cells Dev 2021;30:459-72. [PMID: 33715385 DOI: 10.1089/scd.2020.0198] [Reference Citation Analysis]
96 Akçay A, Atay D, Yilanci M, Kongur M, Eyüboğlu F, Öztürk G, Ovali E. The Use of Umbilical Cord-derived Mesenchymal Stem Cells Seeded Fibrin Matrix in the Treatment of Stage IV Acute Graft-Versus-Host Disease Skin Lesions in Pediatric Hematopoietic Stem Cell Transplant Patients. J Pediatr Hematol Oncol 2021;43:e312-9. [PMID: 33031163 DOI: 10.1097/MPH.0000000000001964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Bogensperger C, Hofmann J, Messner F, Resch T, Meszaros A, Cardini B, Weissenbacher A, Oberhuber R, Troppmair J, Öfner D, Schneeberger S, Hautz T. Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs. Int J Mol Sci 2021;22:5233. [PMID: 34063399 DOI: 10.3390/ijms22105233] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
98 Ng J, Guo F, Marneth AE, Ghanta S, Kwon MY, Keegan J, Liu X, Wright KT, Kamaz B, Cahill LA, Mullally A, Perrella MA, Lederer JA. Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis. Blood Adv 2020;4:4965-79. [PMID: 33049055 DOI: 10.1182/bloodadvances.2020002556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
99 Giri J, Galipeau J. Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. Blood Adv 2020;4:1987-97. [PMID: 32384543 DOI: 10.1182/bloodadvances.2020001711] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 21.0] [Reference Citation Analysis]
100 García-Muñoz E, Vives J. Towards the standardization of methods of tissue processing for the isolation of mesenchymal stromal cells for clinical use. Cytotechnology 2021;:1-10. [PMID: 33994662 DOI: 10.1007/s10616-021-00474-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Bailey AJM, Li H, Kirkham AM, Tieu A, Maganti HB, Shorr R, Fergusson DA, Lalu MM, Elomazzen H, Allan DS. MSC-Derived Extracellular Vesicles to Heal Diabetic Wounds: a Systematic Review and Meta-Analysis of Preclinical Animal Studies. Stem Cell Rev Rep 2021. [PMID: 33893619 DOI: 10.1007/s12015-021-10164-4] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
102 Van Nguyen TT, Vu NB, Van Pham P. Mesenchymal Stem Cell Transplantation for Ischemic Diseases: Mechanisms and Challenges. Tissue Eng Regen Med 2021;18:587-611. [PMID: 33884577 DOI: 10.1007/s13770-021-00334-3] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
103 Bolli R, Solankhi M, Tang XL, Kahlon A. Cell Therapy in Patients with Heart Failure: A Comprehensive Review and Emerging Concepts. Cardiovasc Res 2021:cvab135. [PMID: 33871588 DOI: 10.1093/cvr/cvab135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
104 Bertera S, Knoll MF, Knoll C, Hara H, Kimbrel EA, Kouris NA, Lanza R, Philips BE, Garciafigueroa Y, Giannoukakis N, Cooper DKC, Trucco M, Bottino R. Human Hemangioblast-Derived Mesenchymal Stem Cells Promote Islet Engraftment in a Minimal Islet Mass Transplantation Model in Mice. Front Med (Lausanne) 2021;8:660877. [PMID: 33937296 DOI: 10.3389/fmed.2021.660877] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Yeo-Teh NSL, Tang BL. Moral obligations in conducting stem cell-based therapy trials for autism spectrum disorder. J Med Ethics 2021:medethics-2020-107106. [PMID: 33858947 DOI: 10.1136/medethics-2020-107106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Imanishi Y, Hata M, Matsukawa R, Aoyagi A, Omi M, Mizutani M, Naruse K, Ozawa S, Honda M, Matsubara T, Takebe J. Efficacy of extracellular vesicles from dental pulp stem cells for bone regeneration in rat calvarial bone defects. Inflamm Regen 2021;41:12. [PMID: 33853679 DOI: 10.1186/s41232-021-00163-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
107 Rühle A, Grosu AL, Nicolay NH. The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond? Front Oncol 2021;11:616831. [PMID: 33912447 DOI: 10.3389/fonc.2021.616831] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Kim GB, Shon OJ, Seo MS, Choi Y, Park WT, Lee GW. Mesenchymal Stem Cell-Derived Exosomes and Their Therapeutic Potential for Osteoarthritis. Biology (Basel) 2021;10:285. [PMID: 33915850 DOI: 10.3390/biology10040285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
109 Davis C, Savitz SI, Satani N. Mesenchymal Stem Cell Derived Extracellular Vesicles for Repairing the Neurovascular Unit after Ischemic Stroke. Cells 2021;10:767. [PMID: 33807314 DOI: 10.3390/cells10040767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
110 Fernández-Francos S, Eiro N, Costa LA, Escudero-Cernuda S, Fernández-Sánchez ML, Vizoso FJ. Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine. Int J Mol Sci 2021;22:3576. [PMID: 33808241 DOI: 10.3390/ijms22073576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
111 Nabil A, Uto K, Zahran F, Soliman R, Hassan AA, Elshemy MM, Ali IS, Ebara M, Shiha G. The Potential Safe Antifibrotic Effect of Stem Cell Conditioned Medium and Nilotinib Combined Therapy by Selective Elimination of Rat Activated HSCs. Biomed Res Int 2021;2021:6678913. [PMID: 33855079 DOI: 10.1155/2021/6678913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Schiess M, Suescun J, Doursout MF, Adams C, Green C, Saltarrelli JG, Savitz S, Ellmore TM. Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease. Mov Disord 2021;36:1825-34. [PMID: 33772873 DOI: 10.1002/mds.28582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
113 Guiotto M, Raffoul W, Hart AM, Riehle MO, di Summa PG. Human Platelet Lysate Acts Synergistically With Laminin to Improve the Neurotrophic Effect of Human Adipose-Derived Stem Cells on Primary Neurons in vitro. Front Bioeng Biotechnol 2021;9:658176. [PMID: 33816456 DOI: 10.3389/fbioe.2021.658176] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
114 Sanap A, Joshi K, Shah T, Tillu G, Bhonde R. Pre-conditioning of Mesenchymal Stem Cells with Piper longum L. augments osteogenic differentiation. J Ethnopharmacol 2021;273:113999. [PMID: 33705921 DOI: 10.1016/j.jep.2021.113999] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
115 Tavares MMR, Barbosa LER. Adipose tissue-derived stem cells: a new approach to the treatment of Crohn's disease-associated perianal fistulae. Journal of Coloproctology 2021;38:240-5. [DOI: 10.1016/j.jcol.2018.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
116 Lohmann S, Pool MBF, Rozenberg KM, Keller AK, Moers C, Møldrup U, Møller BK, Lignell SJM, Krag S, Sierra-Parraga JM, Lo Faro ML, Hunter J, Hoogduijn MJ, Baan CC, Leuvenink HGD, Ploeg RJ, Eijken M, Jespersen B. Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: A porcine renal autotransplantation study. Am J Transplant 2021;21:2348-59. [PMID: 33382194 DOI: 10.1111/ajt.16473] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
117 Holan V, Palacka K, Hermankova B. Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials. Cells 2021;10:588. [PMID: 33799995 DOI: 10.3390/cells10030588] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
118 Maehara M, Toyoda E, Takahashi T, Watanabe M, Sato M. Potential of Exosomes for Diagnosis and Treatment of Joint Disease: Towards a Point-of-Care Therapy for Osteoarthritis of the Knee. Int J Mol Sci 2021;22:2666. [PMID: 33800860 DOI: 10.3390/ijms22052666] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
119 Pagotto LEC, de Santana Santos T, Pastore GP. The efficacy of mesenchymal stem cells in regenerating structures associated with the temporomandibular joint: A systematic review. Arch Oral Biol 2021;125:105104. [PMID: 33706151 DOI: 10.1016/j.archoralbio.2021.105104] [Reference Citation Analysis]
120 Cabalzar-Wondberg D, Turina M, Biedermann L, Rogler G, Schreiner P. Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn's disease: A case series. Colorectal Dis 2021;23:1444-50. [PMID: 33595166 DOI: 10.1111/codi.15587] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
121 Masterson CH, Tabuchi A, Hogan G, Fitzpatrick G, Kerrigan SW, Jerkic M, Kuebler WM, Laffey JG, Curley GF. Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection. Sci Rep 2021;11:5265. [PMID: 33664277 DOI: 10.1038/s41598-021-83894-7] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
122 Mebarki M, Abadie C, Larghero J, Cras A. Human umbilical cord-derived mesenchymal stem/stromal cells: a promising candidate for the development of advanced therapy medicinal products. Stem Cell Res Ther 2021;12:152. [PMID: 33637125 DOI: 10.1186/s13287-021-02222-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
123 Huang S, Song J, He C, Cai X, Yuan K, Mei L, Feng Y. Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome. Gene Ther 2021. [PMID: 33633356 DOI: 10.1038/s41434-021-00240-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
124 Hochheuser C, Kunze NY, Tytgat GAM, Voermans C, Timmerman I. The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery. J Pers Med 2021;11:161. [PMID: 33668854 DOI: 10.3390/jpm11030161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Casiraghi F, Perico N, Podestà MA, Todeschini M, Zambelli M, Colledan M, Camagni S, Fagiuoli S, Pinna AD, Cescon M, Bertuzzo V, Maroni L, Introna M, Capelli C, Golay JT, Buzzi M, Mister M, Ordonez PYR, Breno M, Mele C, Villa A, Remuzzi G; MSC-LIVER Study Group. Third-party bone marrow-derived mesenchymal stromal cell infusion before liver transplantation: A randomized controlled trial. Am J Transplant 2021;21:2795-809. [PMID: 33370477 DOI: 10.1111/ajt.16468] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
126 Kiyose R, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Magota H, Oka S, Ukai R, Takemura M, Yokoyama T, Kocsis JD, Honmou O. Intravenous Infusion of Mesenchymal Stem Cells Enhances Therapeutic Efficacy of Reperfusion Therapy in Cerebral Ischemia. World Neurosurg 2021;149:e160-9. [PMID: 33618048 DOI: 10.1016/j.wneu.2021.02.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
127 Dinc G, Gonen ZB, Soltani J, Doganay M. Sepsis and Septic Shock; Current Treatment Dilemma and Role of Stem Cell Therapy in Pediatrics. Arch Pediatr Infect Dis 2021;9. [DOI: 10.5812/pedinfect.105301] [Reference Citation Analysis]
128 Abreu SC, Lopes-Pacheco M, Weiss DJ, Rocco PRM. Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives. Front Cell Dev Biol 2021;9:600711. [PMID: 33659247 DOI: 10.3389/fcell.2021.600711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
129 Zha K, Yang Y, Tian G, Sun Z, Yang Z, Li X, Sui X, Liu S, Zhao J, Guo Q. Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies. Stem Cells Transl Med 2021;10:1008-20. [PMID: 33586908 DOI: 10.1002/sctm.20-0290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
130 He C, Yang Y, Zheng K, Chen Y, Liu S, Li Y, Han Q, Zhao RC, Wang L, Zhang F. Mesenchymal stem cell-based treatment in autoimmune liver diseases: underlying roles, advantages and challenges. Ther Adv Chronic Dis 2021;12:2040622321993442. [PMID: 33633826 DOI: 10.1177/2040622321993442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
131 Thébaud B, Lalu M, Renesme L, van Katwyk S, Presseau J, Thavorn K, Cobey KD, Hutton B, Moher D, Soll RF, Fergusson D. Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research). Stem Cells Transl Med 2021;10:968-75. [PMID: 33570257 DOI: 10.1002/sctm.20-0508] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
132 Samara A, Herlenius E. Is There an Effect of Fetal Mesenchymal Stem Cells in the Mother-Fetus Dyad in COVID-19 Pregnancies and Vertical Transmission? Front Physiol 2020;11:624625. [PMID: 33679426 DOI: 10.3389/fphys.2020.624625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
133 Podestà MA, Remuzzi G, Casiraghi F. Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation. Front Immunol 2020;11:618243. [PMID: 33643298 DOI: 10.3389/fimmu.2020.618243] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
134 Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, Malaise M, Ino J, Beguin Y. Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clin Orthop Relat Res 2020;478:1307-15. [PMID: 31899739 DOI: 10.1097/CORR.0000000000001107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
135 Alishahi M, Anbiyaiee A, Farzaneh M, Khoshnam SE. Human Mesenchymal Stem Cells for Spinal Cord Injury. Curr Stem Cell Res Ther 2020;15:340-8. [PMID: 32178619 DOI: 10.2174/1574888X15666200316164051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
136 Sanchez-Castro EE, Pajuelo-Reyes C, Tejedo R, Soria-Juan B, Tapia-Limonchi R, Andreu E, Hitos AB, Martin F, Cahuana GM, Guerra-Duarte C, de Assis TCS, Bedoya FJ, Soria B, Chávez-Olórtegui C, Tejedo JR. Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming. Front Immunol 2020;11:609961. [PMID: 33633730 DOI: 10.3389/fimmu.2020.609961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 O'Rourke B, Nguyen S, Tilles AW, Bynum JA, Cap AP, Parekkadan B, Barcia RN. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. Stem Cells Transl Med 2021;10:883-94. [PMID: 33527780 DOI: 10.1002/sctm.20-0454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
138 Obi ON, Lower EE, Baughman RP. Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Rev Clin Pharmacol 2021;14:179-210. [PMID: 33487042 DOI: 10.1080/17512433.2021.1878024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Khoury M, Tabben M, Rolón AU, Levi L, Chamari K, D'Hooghe P. Promising improvement of chronic lateral elbow tendinopathy by using adipose derived mesenchymal stromal cells: a pilot study. J Exp Orthop 2021;8:6. [PMID: 33501619 DOI: 10.1186/s40634-020-00320-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
140 Goetz MJ, Kremer S, Behnke J, Staude B, Shahzad T, Holzfurtner L, Chao CM, Morty RE, Bellusci S, Ehrhardt H. MSC Based Therapies to Prevent or Treat BPD-A Narrative Review on Advances and Ongoing Challenges. Int J Mol Sci 2021;22:1138. [PMID: 33498887 DOI: 10.3390/ijms22031138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
141 Shin S, Lee J, Kwon Y, Park KS, Jeong JH, Choi SJ, Bang SI, Chang JW, Lee C. Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton's Jelly. Int J Mol Sci 2021;22:E845. [PMID: 33467726 DOI: 10.3390/ijms22020845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
142 Elshaer SL, Park HS, Pearson L, Hill WD, Longo FM, El-Remessy AB. Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model. Int J Mol Sci 2021;22:E829. [PMID: 33467640 DOI: 10.3390/ijms22020829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Nair S, Rocha-Ferreira E, Fleiss B, Nijboer CH, Gressens P, Mallard C, Hagberg H. Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species. J Neurochem 2021;158:59-73. [PMID: 33314066 DOI: 10.1111/jnc.15267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
144 Bicer M, Cottrell GS, Widera D. Impact of 3D cell culture on bone regeneration potential of mesenchymal stromal cells. Stem Cell Res Ther 2021;12:31. [PMID: 33413646 DOI: 10.1186/s13287-020-02094-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
145 Miceli V, Bertani A, Chinnici CM, Bulati M, Pampalone M, Amico G, Carcione C, Schmelzer E, Gerlach JC, Conaldi PG. Conditioned Medium from Human Amnion-Derived Mesenchymal Stromal/Stem Cells Attenuating the Effects of Cold Ischemia-Reperfusion Injury in an In Vitro Model Using Human Alveolar Epithelial Cells. Int J Mol Sci 2021;22:E510. [PMID: 33419219 DOI: 10.3390/ijms22020510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
146 Subhan BS, Kwong J, Kuhn JF, Monas A, Sharma S, Rabbani PS. Amniotic fluid-derived multipotent stromal cells drive diabetic wound healing through modulation of macrophages. J Transl Med 2021;19:16. [PMID: 33407615 DOI: 10.1186/s12967-020-02674-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Sun JM, Kurtzberg J. Stem cell therapies in cerebral palsy and autism spectrum disorder. Dev Med Child Neurol 2021;63:503-10. [PMID: 33398874 DOI: 10.1111/dmcn.14789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
148 Tzur E, Ben-David D, Gur Barzilai M, Rozen N, Meretzki S. Safety and Efficacy Results of BonoFill First-in-Human, Phase I/IIa Clinical Trial for the Maxillofacial Indication of Sinus Augmentation and Mandibular Bone Void Filling. J Oral Maxillofac Surg 2021;79:787-798.e2. [PMID: 33434518 DOI: 10.1016/j.joms.2020.12.010] [Reference Citation Analysis]
149 Zorina TD. New Insights on the Role of the Mesenchymal-Hematopoietic Stem Cell Axis in Autologous and Allogeneic Hematopoiesis. Stem Cells Dev 2021;30:2-16. [PMID: 33231142 DOI: 10.1089/scd.2020.0148] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
150 Khan S, Khan RS, Newsome PN. Cellular therapies for the treatment of immune-mediated GI and liver disease. Br Med Bull 2020;136:127-41. [PMID: 33290518 DOI: 10.1093/bmb/ldaa035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
151 Yin P, Gui L, Wang C, Yan J, Liu M, Ji L, Wang Y, Ma B, Gao WQ. Targeted Delivery of CXCL9 and OX40L by Mesenchymal Stem Cells Elicits Potent Antitumor Immunity. Mol Ther 2020;28:2553-63. [PMID: 32827461 DOI: 10.1016/j.ymthe.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
152 Abedi M, Alavi-Moghadam S, Payab M, Goodarzi P, Mohamadi-Jahani F, Sayahpour FA, Larijani B, Arjmand B. Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives. Cell Regen 2020;9:20. [PMID: 33258056 DOI: 10.1186/s13619-020-00058-0] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
153 Robertson NJ, Meehan C, Martinello KA, Avdic-Belltheus A, Boggini T, Mutshiya T, Lingam I, Yang Q, Sokolska M, Charalambous X, Bainbridge A, Hristova M, Kramer BW, Golay X, Weil B, Lowdell MW. Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia. Cytotherapy 2021;23:521-35. [PMID: 33262073 DOI: 10.1016/j.jcyt.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
154 Maseda R, Martínez-Santamaría L, Sacedón R, Butta N, de Arriba MDC, García-Barcenilla S, García M, Illera N, Pérez-Conde I, Carretero M, Jiménez E, Melen G, Borobia AM, Jiménez-Yuste V, Vicente Á, Del Río M, de Lucas R, Escámez MJ. Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report. Front Med (Lausanne) 2020;7:576558. [PMID: 33324660 DOI: 10.3389/fmed.2020.576558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
155 Laterre PF, Sánchez-García M, van der Poll T, de la Rosa O, Cadogan KA, Lombardo E, François B. A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit. BMC Pulm Med 2020;20:309. [PMID: 33238991 DOI: 10.1186/s12890-020-01324-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
156 Dudek DW, Walczuk E, Wajda A, Paradowska-Gorycka A. Mesenchymal stem cells in systemic sclerosis therapy. Reumatologia 2020;58:324-30. [PMID: 33227099 DOI: 10.5114/reum.2020.99995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Sávio-Silva C, Beyerstedt S, Soinski-Sousa PE, Casaro EB, Balby-Rocha MTA, Simplício-Filho A, Alves-Silva J, Rangel ÉB. Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells. Stem Cells Int 2020;2020:8833725. [PMID: 33505469 DOI: 10.1155/2020/8833725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
158 Becerra D, Jeffs S, Wojtkiewicz G, Ott H. Characterization of an elastase-induced emphysema model in immune-deficient rats. Eur J Cardiothorac Surg 2020:ezaa320. [PMID: 33141186 DOI: 10.1093/ejcts/ezaa320] [Reference Citation Analysis]
159 de Almeida Fuzeta M, Bernardes N, Oliveira FD, Costa AC, Fernandes-Platzgummer A, Farinha JP, Rodrigues CAV, Jung S, Tseng RJ, Milligan W, Lee B, Castanho MARB, Gaspar D, Cabral JMS, da Silva CL. Scalable Production of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Under Serum-/Xeno-Free Conditions in a Microcarrier-Based Bioreactor Culture System. Front Cell Dev Biol 2020;8:553444. [PMID: 33224943 DOI: 10.3389/fcell.2020.553444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
160 Portilla F, Guerrero JL, Maestre MV, Leyva L, Mera S, García‐olmo D, Rodríguez A, Mata R, Lora F. Treatment of faecal incontinence with autologous expanded mesenchymal stem cells: results of a pilot study. Colorectal Dis 2021;23:698-709. [DOI: 10.1111/codi.15382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
161 Vawda R, Badner A, Hong J, Mikhail M, Dragas R, Xhima K, Jose A, Fehlings MG. Harnessing the Secretome of Mesenchymal Stromal Cells for Traumatic Spinal Cord Injury: Multicell Comparison and Assessment of In Vivo Efficacy. Stem Cells Dev 2020;29:1429-43. [PMID: 32962528 DOI: 10.1089/scd.2020.0079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
162 Ringdén O, Gustafsson B, Sadeghi B. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease. Front Immunol 2020;11:567210. [PMID: 33193339 DOI: 10.3389/fimmu.2020.567210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
163 Sagar R, Almeida-Porada G, Blakemore K, Chan JKY, Choolani M, Götherström C, Jaulent A, MacKenzie TC, Mattar C, Porada CD, Peranteau WH, Schneider H, Shaw SW, Waddington SN, Westgren M, David AL. Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement. Mol Ther 2020;28:2316-9. [PMID: 33069884 DOI: 10.1016/j.ymthe.2020.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
164 Nasser MI, Qi X, Zhu S, He Y, Zhao M, Guo H, Zhu P. Current situation and future of stem cells in cardiovascular medicine. Biomed Pharmacother 2020;132:110813. [PMID: 33068940 DOI: 10.1016/j.biopha.2020.110813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
165 Vandermeulen M, Erpicum P, Weekers L, Briquet A, Lechanteur C, Detry O, Beguin Y, Jouret F. Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation 2020;104:923-36. [PMID: 31929427 DOI: 10.1097/TP.0000000000003077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
166 Palombella S, Guiotto M, Higgins GC, Applegate LL, Raffoul W, Cherubino M, Hart A, Riehle MO, di Summa PG. Human platelet lysate as a potential clinical-translatable supplement to support the neurotrophic properties of human adipose-derived stem cells. Stem Cell Res Ther 2020;11:432. [PMID: 33023632 DOI: 10.1186/s13287-020-01949-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
167 Noh JE, Oh SH, Park IH, Song J. Intracerebral Transplants of GMP-Grade Human Umbilical Cord-Derived Mesenchymal Stromal Cells Effectively Treat Subacute-Phase Ischemic Stroke in a Rodent Model. Front Cell Neurosci 2020;14:546659. [PMID: 33100972 DOI: 10.3389/fncel.2020.546659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
168 Shang F, Yu Y, Liu S, Ming L, Zhang Y, Zhou Z, Zhao J, Jin Y. Advancing application of mesenchymal stem cell-based bone tissue regeneration. Bioact Mater 2021;6:666-83. [PMID: 33005830 DOI: 10.1016/j.bioactmat.2020.08.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
169 Chen G, Fan XY, Zheng XP, Jin YL, Liu Y, Liu SC. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance via PTEN-mediated crosstalk between the PI3K/Akt and Erk/MAPKs signaling pathways in the skeletal muscles of db/db mice. Stem Cell Res Ther 2020;11:401. [PMID: 32938466 DOI: 10.1186/s13287-020-01865-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
170 Bisserier M, Pradhan N, Hadri L. Current and emerging therapeutic approaches to pulmonary hypertension. Rev Cardiovasc Med 2020;21:163-79. [PMID: 32706206 DOI: 10.31083/j.rcm.2020.02.597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
171 Ramallo M, Carreras-Sánchez I, López-Fernández A, Vélez R, Aguirre M, Feldman S, Vives J. Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord. Histol Histopathol 2021;36:19-30. [PMID: 32914860 DOI: 10.14670/HH-18-249] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
172 Adlerz K, Patel D, Rowley J, Ng K, Ahsan T. Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles. Stem Cell Res 2020;48:101978. [PMID: 32947235 DOI: 10.1016/j.scr.2020.101978] [Cited by in Crossref: 7] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
173 Lopes GM, Grudzinski PB, Beyer Nardi N, Leguisamo NM. Cell Therapy Improves Cardiac Function in Anthracycline-Induced Cardiomyopathy Preclinical Models: A Systematic Review and Meta-Analysis. Stem Cells Dev 2020;29:1247-65. [PMID: 32741268 DOI: 10.1089/scd.2020.0044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Capin L, Abbassi N, Lachat M, Calteau M, Barratier C, Mojallal A, Bourgeois S, Auxenfans C. Encapsulation of Adipose-Derived Mesenchymal Stem Cells in Calcium Alginate Maintains Clonogenicity and Enhances their Secretory Profile. Int J Mol Sci 2020;21:E6316. [PMID: 32878250 DOI: 10.3390/ijms21176316] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
175 Chargari C, Supiot S, Hennequin C, Chapel A, Simon JM. [Treatment of radiation-induced late effects: What's new?]. Cancer Radiother 2020;24:602-11. [PMID: 32855027 DOI: 10.1016/j.canrad.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
176 Kheur S, Sanap A, Kharat A, Gupta AA, Raj AT, Kheur M, Bhonde R. Hypothesizing the therapeutic potential of mesenchymal stem cells in oral submucous fibrosis. Med Hypotheses 2020;144:110204. [PMID: 33254511 DOI: 10.1016/j.mehy.2020.110204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
177 Bruschettini M, Romantsik O, Moreira A, Ley D, Thébaud B. Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants. Cochrane Database Syst Rev 2020;8:CD013202. [PMID: 32813884 DOI: 10.1002/14651858.CD013202.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
178 Hamdan H, Hashmi SK, Lazarus H, Gale RP, Qu W, El Fakih R. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? Blood Rev 2021;46:100742. [PMID: 32854985 DOI: 10.1016/j.blre.2020.100742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
179 Rady D, Abbass MMS, El-Rashidy AA, El Moshy S, Radwan IA, Dörfer CE, Fawzy El-Sayed KM. Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation. Stem Cells Int 2020;2020:8837654. [PMID: 33953753 DOI: 10.1155/2020/8837654] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
180 Kanzaki S, Toyoda M, Umezawa A, Ogawa K. Application of Mesenchymal Stem Cell Therapy and Inner Ear Regeneration for Hearing Loss: A Review. Int J Mol Sci 2020;21:E5764. [PMID: 32796705 DOI: 10.3390/ijms21165764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
181 Chinnadurai R, Forsberg MH, Kink JA, Hematti P, Capitini CM. Use of MSCs and MSC-educated macrophages to mitigate hematopoietic acute radiation syndrome. Curr Stem Cell Rep 2020;6:77-85. [PMID: 32944493 DOI: 10.1007/s40778-020-00176-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
182 Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. J Neurol. [DOI: 10.1007/s00415-020-10138-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
183 Nazari-Shafti TZ, Neuber S, Garcia Duran A, Xu Z, Beltsios E, Seifert M, Falk V, Stamm C. Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease. Stem Cells Transl Med 2020;9:1558-69. [PMID: 32761804 DOI: 10.1002/sctm.19-0432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
184 Heidari N, Noorani A, Slevin M, Cullen A, Stark L, Olgiati S, Zerbi A, Wilson A. Patient-Centered Outcomes of Microfragmented Adipose Tissue Treatments of Knee Osteoarthritis: An Observational, Intention-to-Treat Study at Twelve Months. Stem Cells Int 2020;2020:8881405. [PMID: 32831853 DOI: 10.1155/2020/8881405] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
185 Klöß S, Dehmel S, Braun A, Parnham MJ, Köhl U, Schiffmann S. From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment. Front Immunol 2020;11:1423. [PMID: 32733473 DOI: 10.3389/fimmu.2020.01423] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
186 Holkar K, Vaidya A, Pethe P, Kale V, Ingavle G. Biomaterials and extracellular vesicles in cell-free therapy for bone repair and regeneration: Future line of treatment in regenerative medicine. Materialia 2020;12:100736. [DOI: 10.1016/j.mtla.2020.100736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
187 Charles-de-Sá L, Gontijo-de-Amorim NF, Rigotti G, Sbarbati A, Bernardi P, Benati D, Bizon Vieira Carias R, Maeda Takiya C, Borojevic R. Photoaged Skin Therapy with Adipose-Derived Stem Cells. Plast Reconstr Surg 2020;145:1037e-49e. [PMID: 32459770 DOI: 10.1097/PRS.0000000000006867] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
188 Yang HY, Fierro F, So M, Yoon DJ, Nguyen AV, Gallegos A, Bagood MD, Rojo-Castro T, Alex A, Stewart H, Chigbrow M, Dasu MR, Peavy TR, Soulika AM, Nolta JA, Isseroff RR. Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice. Stem Cells Transl Med 2020;9:1353-64. [PMID: 32720751 DOI: 10.1002/sctm.19-0380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
189 Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas. J Crohns Colitis. 2020;14:64-70. [PMID: 31197361 DOI: 10.1093/ecco-jcc/jjz116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 37] [Article Influence: 7.5] [Reference Citation Analysis]
190 Götherström C, Walther-Jallow L. Stem Cell Therapy as a Treatment for Osteogenesis Imperfecta. Curr Osteoporos Rep 2020;18:337-43. [PMID: 32710427 DOI: 10.1007/s11914-020-00594-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
191 Rühle A, Lopez Perez R, Zou B, Grosu AL, Huber PE, Nicolay NH. The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage. Stem Cell Rev Rep 2019;15:356-73. [PMID: 30937640 DOI: 10.1007/s12015-019-09886-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
192 Levy O, Kuai R, Siren EMJ, Bhere D, Milton Y, Nissar N, De Biasio M, Heinelt M, Reeve B, Abdi R, Alturki M, Fallatah M, Almalik A, Alhasan AH, Shah K, Karp JM. Shattering barriers toward clinically meaningful MSC therapies. Sci Adv 2020;6:eaba6884. [PMID: 32832666 DOI: 10.1126/sciadv.aba6884] [Cited by in Crossref: 58] [Cited by in F6Publishing: 153] [Article Influence: 29.0] [Reference Citation Analysis]
193 Mangin G, Kubis N. Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story. Stem Cell Rev Rep 2019;15:176-93. [PMID: 30443706 DOI: 10.1007/s12015-018-9864-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
194 Sánchez-Guijo F, García-Arranz M, López-Parra M, Monedero P, Mata-Martínez C, Santos A, Sagredo V, Álvarez-Avello JM, Guerrero JE, Pérez-Calvo C, Sánchez-Hernández MV, Del-Pozo JL, Andreu EJ, Fernández-Santos ME, Soria-Juan B, Hernández-Blasco LM, Andreu E, Sempere JM, Zapata AG, Moraleda JM, Soria B, Fernández-Avilés F, García-Olmo D, Prósper F. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine 2020;25:100454. [PMID: 32838232 DOI: 10.1016/j.eclinm.2020.100454] [Cited by in Crossref: 48] [Cited by in F6Publishing: 79] [Article Influence: 24.0] [Reference Citation Analysis]
195 García-fernández C, López-fernández A, Borrós S, Lecina M, Vives J. Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells. Biochemical Engineering Journal 2020;159:107601. [DOI: 10.1016/j.bej.2020.107601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
196 Lim JY, Ryu DB, Kim TW, Lee SE, Park G, Yoon HK, Min CK. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model. Stem Cell Res Ther 2020;11:254. [PMID: 32586381 DOI: 10.1186/s13287-020-01768-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
197 Fan D, Zeng M, Xia Q, Wu S, Ye S, Rao J, Lin D, Zhang H, Ma H, Han Z, Guo X, Liu Z. Efficacy and safety of umbilical cord mesenchymal stem cells in treatment of cesarean section skin scars: a randomized clinical trial. Stem Cell Res Ther 2020;11:244. [PMID: 32586366 DOI: 10.1186/s13287-020-01695-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
198 Cheung TS, Bertolino GM, Giacomini C, Bornhäuser M, Dazzi F, Galleu A. Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers. Front Immunol 2020;11:1338. [PMID: 32670295 DOI: 10.3389/fimmu.2020.01338] [Cited by in Crossref: 16] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
199 Boberg E, von Bahr L, Afram G, Lindström C, Ljungman P, Heldring N, Petzelbauer P, Garming Legert K, Kadri N, Le Blanc K. Treatment of chronic GvHD with mesenchymal stromal cells induces durable responses: A phase II study. Stem Cells Transl Med 2020;9:1190-202. [PMID: 32573983 DOI: 10.1002/sctm.20-0099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
200 Owen A, Newsome PN. Mesenchymal Stromal Cells, a New Player in Reducing Complications From Liver Transplantation? Front Immunol 2020;11:1306. [PMID: 32636850 DOI: 10.3389/fimmu.2020.01306] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
201 Gur S, Hellstrom WJ. Harnessing Stem Cell Potential for the Treatment of Erectile Function in Men with Diabetes Mellitus: From Preclinical/Clinical Perspectives to Penile Tissue Engineering. CSCR 2020;15:308-20. [DOI: 10.2174/1574888x14666190828142045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
202 Ledesma-Martínez E, Mendoza-Núñez VM, Santiago-Osorio E. Mesenchymal Stem Cells for Periodontal Tissue Regeneration in Elderly Patients. J Gerontol A Biol Sci Med Sci 2019;74:1351-8. [PMID: 30289440 DOI: 10.1093/gerona/gly227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
203 Sanap A, Bhonde R, Joshi K. Conditioned medium of adipose derived Mesenchymal Stem Cells reverse insulin resistance through downregulation of stress induced serine kinases. Eur J Pharmacol 2020;881:173215. [PMID: 32473166 DOI: 10.1016/j.ejphar.2020.173215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
204 Rogers CJ, Harman RJ, Bunnell BA, Schreiber MA, Xiang C, Wang FS, Santidrian AF, Minev BR. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. J Transl Med. 2020;18:203. [PMID: 32423449 DOI: 10.1186/s12967-020-02380-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 52] [Article Influence: 19.0] [Reference Citation Analysis]
205 Srifa W, Kosaric N, Amorin A, Jadi O, Park Y, Mantri S, Camarena J, Gurtner GC, Porteus M. Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice. Nat Commun 2020;11:2470. [PMID: 32424320 DOI: 10.1038/s41467-020-16065-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
206 Freitag J, Wickham J, Shah K, Tenen A. Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application. Future Sci OA 2020;6:FSO584. [PMID: 32670609 DOI: 10.2144/fsoa-2020-0048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Rossi F, Braun M, Brock J, Sen-Lum J, Ellens S, Lander E, Stoddard D, Cross C, Vance A, Stewart D, Thebaud B, Illes J. Closing gaps, opening doors: an experimental collaboration in stem cell intervention. Mol Biol Rep 2020;47:4105-8. [PMID: 32372173 DOI: 10.1007/s11033-020-05469-5] [Reference Citation Analysis]
208 Gökçinar-Yagci B, Karaosmanoglu B, Taskiran EZ, Çelebi-Saltik B. Transcriptome and proteome profiles of human umbilical cord vein CD146+ stem cells. Mol Biol Rep 2020;47:3833-56. [PMID: 32361895 DOI: 10.1007/s11033-020-05474-8] [Reference Citation Analysis]
209 Khoury M, Rocco PRM, Phinney DG, Krampera M, Martin I, Viswanathan S, Nolta JA, LeBlanc K, Galipeau J, Weiss DJ. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential. Cytotherapy 2020;22:602-5. [PMID: 32933835 DOI: 10.1016/j.jcyt.2020.04.089] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
210 Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, Vader P. Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev 2020;159:332-43. [PMID: 32305351 DOI: 10.1016/j.addr.2020.04.004] [Cited by in Crossref: 228] [Cited by in F6Publishing: 243] [Article Influence: 114.0] [Reference Citation Analysis]
211 Wang SG, Hsu NC, Wang SM, Wang FN. Successful Treatment of Plaque Psoriasis with Allogeneic Gingival Mesenchymal Stem Cells: A Case Study. Case Rep Dermatol Med. 2020;2020:4617520. [PMID: 32280547 DOI: 10.1155/2020/4617520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
212 López-Fernández A, Barro V, Ortiz-Hernández M, Manzanares MC, Vivas D, Vives J, Vélez R, Ginebra MP, Aguirre M. Effect of Allogeneic Cell-Based Tissue-Engineered Treatments in a Sheep Osteonecrosis Model. Tissue Eng Part A 2020;26:993-1004. [PMID: 32122263 DOI: 10.1089/ten.TEA.2019.0339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
213 Swart JF, de Roock S, Nievelstein RAJ, Slaper-Cortenbach ICM, Boelens JJ, Wulffraat NM. Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients. Rheumatology (Oxford) 2019;58:1812-7. [PMID: 31070229 DOI: 10.1093/rheumatology/kez157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
214 Wang SM, Lee CU, Lim HK. Stem cell therapies for Alzheimer's disease: is it time? Curr Opin Psychiatry 2019;32:105-16. [PMID: 30557266 DOI: 10.1097/YCO.0000000000000478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
215 Behnke J, Kremer S, Shahzad T, Chao CM, Böttcher-Friebertshäuser E, Morty RE, Bellusci S, Ehrhardt H. MSC Based Therapies-New Perspectives for the Injured Lung. J Clin Med 2020;9:E682. [PMID: 32138309 DOI: 10.3390/jcm9030682] [Cited by in Crossref: 51] [Cited by in F6Publishing: 67] [Article Influence: 25.5] [Reference Citation Analysis]
216 Rajabi H, Aslani S, Abhari A, Sanajou D. Expression Profiles of MicroRNAs in Stem Cells Differentiation. Curr Pharm Biotechnol 2020;21:906-18. [PMID: 32072899 DOI: 10.2174/1389201021666200219092520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
217 Peralta OA, Carrasco C, Vieytes C, Tamayo MJ, Muñoz I, Sepulveda S, Tadich T, Duchens M, Melendez P, Mella A, Torres CG. Safety and efficacy of a mesenchymal stem cell intramammary therapy in dairy cows with experimentally induced Staphylococcus aureus clinical mastitis. Sci Rep 2020;10:2843. [PMID: 32071371 DOI: 10.1038/s41598-020-59724-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
218 Moll G, Hoogduijn MJ, Ankrum JA. Editorial: Safety, Efficacy and Mechanisms of Action of Mesenchymal Stem Cell Therapies. Front Immunol 2020;11:243. [PMID: 32133010 DOI: 10.3389/fimmu.2020.00243] [Cited by in Crossref: 20] [Cited by in F6Publishing: 37] [Article Influence: 10.0] [Reference Citation Analysis]
219 Suzdaltseva Y, Zhidkih S, Kiselev SL, Stupin V. Locally Delivered Umbilical Cord Mesenchymal Stromal Cells Reduce Chronic Inflammation in Long-Term Nonhealing Wounds: A Randomized Study. Stem Cells Int 2020;2020:5308609. [PMID: 32148521 DOI: 10.1155/2020/5308609] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
220 López-Beas J, Guadix JA, Clares B, Soriano-Ruiz JL, Zugaza JL, Gálvez-Martín P. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: From laboratory to patient. Med Res Rev 2020;40:1315-34. [PMID: 32017179 DOI: 10.1002/med.21659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
221 Black L, Zorina T. Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus. Drug Discovery Today 2020;25:380-91. [DOI: 10.1016/j.drudis.2019.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
222 Uchimura R, Ueda T, Fukazawa R, Hayakawa J, Ohashi R, Nagi‐miura N, Ohno N, Migita M, Itoh Y. Adipose tissue‐derived stem cells suppress coronary arteritis of Kawasaki disease in vivo. Pediatrics International 2020;62:14-21. [DOI: 10.1111/ped.14062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
223 Alcerro JC, Lavernia CJ. Stem Cells and Platelet-rich Plasma for Knee Osteoarthritis: Prevalence and Cost in South Florida. J Am Acad Orthop Surg 2019;27:779-83. [PMID: 30499895 DOI: 10.5435/JAAOS-D-18-00343] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
224 Thompson M, Mei SHJ, Wolfe D, Champagne J, Fergusson D, Stewart DJ, Sullivan KJ, Doxtator E, Lalu M, English SW, Granton J, Hutton B, Marshall J, Maybee A, Walley KR, Santos CD, Winston B, McIntyre L. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis. EClinicalMedicine. 2020;19:100249. [PMID: 31989101 DOI: 10.1016/j.eclinm.2019.100249] [Cited by in Crossref: 45] [Cited by in F6Publishing: 86] [Article Influence: 22.5] [Reference Citation Analysis]
225 Rüdiger M, Kirpalani H, Steinhorn R, Davis JM, Thebaud B. How to introduce MSC-based therapy for the developing lung safely into clinical care? Pediatr Res 2020;88:365-8. [DOI: 10.1038/s41390-020-0758-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
226 Lopes SM, Roncon S, Bordalo F, Amado F, Ferreira S, Pinho AC, Vieira J, Costa-Pereira A. Stem cells out of the bag: characterization of ex vivo expanded mesenchymal stromal cells for possible clinical use. Future Sci OA 2020;6:FSO449. [PMID: 32140248 DOI: 10.2144/fsoa-2019-0129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Barnhoorn MC, Van Halteren AGS, Van Pel M, Molendijk I, Struijk AC, Jansen PM, Verspaget HW, Dijkstra G, Oosten LEM, Van der Meulen-de Jong AE. Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report. J Crohns Colitis 2019;13:807-11. [PMID: 30561580 DOI: 10.1093/ecco-jcc/jjy220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
228 Munshi A, Mehic J, Creskey M, Gobin J, Gao J, Rigg E, Muradia G, Luebbert CC, Westwood C, Stalker A, Allan DS, Johnston MJW, Cyr T, Rosu-Myles M, Lavoie JR. A comprehensive proteomics profiling identifies NRP1 as a novel identity marker of human bone marrow mesenchymal stromal cell-derived small extracellular vesicles. Stem Cell Res Ther. 2019;10:401. [PMID: 31852509 DOI: 10.1186/s13287-019-1516-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
229 Tsujimura M, Kusamori K, Katsumi H, Sakane T, Yamamoto A, Nishikawa M. Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells. Sci Rep 2019;9:18869. [PMID: 31827180 DOI: 10.1038/s41598-019-55269-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Al-Massri KF, Ahmed LA, El-Abhar HS. Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations. J Tissue Eng Regen Med 2020;14:108-22. [PMID: 31677248 DOI: 10.1002/term.2972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
231 Mautner K, Carr D, Whitley J, Bowers R. Allogeneic Versus Autologous Injectable Mesenchymal Stem Cells for Knee Osteoarthritis: Review and Current Status. Techniques in Orthopaedics 2019;34:244-56. [DOI: 10.1097/bto.0000000000000357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
232 Zhao YH. Essential Role of Chinese Medicines in Mesenchymal Stem Cells Transplantation for Treatment of Ischemic Stroke. Chin J Integr Med 2019;25:723-7. [PMID: 31782008 DOI: 10.1007/s11655-019-2708-4] [Reference Citation Analysis]
233 Malhotra A, Lim R, Mockler JC, Wallace EM. Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia. Stem Cells Transl Med 2020;9:289-94. [PMID: 31774236 DOI: 10.1002/sctm.19-0251] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
234 Godoy JAP, Paiva RMA, Souza AM, Kondo AT, Kutner JM, Okamoto OK. Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease.Front Cell Dev Biol. 2019;7:255. [PMID: 31824942 DOI: 10.3389/fcell.2019.00255] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
235 Sadeghi B, Moretti G, Arnberg F, Samén E, Kohein B, Catar R, Kamhieh-Milz J, Geissler S, Moll G, Holmin S, Ringdén O. Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells. Front Immunol 2019;10:2685. [PMID: 31803191 DOI: 10.3389/fimmu.2019.02685] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
236 Li X, Jiang M, Tan T, Narasimhulu CA, Xiao Y, Hao H, Cui Y, Zhang J, Liu L, Yang C, Li Y, Ma J, Verfaillie CM, Parthasarathy S, Zhu H, Liu Z. N-acetylcysteine prevents oxidized low-density lipoprotein-induced reduction of MG53 and enhances MG53 protective effect on bone marrow stem cells. J Cell Mol Med 2020;24:886-98. [PMID: 31742908 DOI: 10.1111/jcmm.14798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
237 Hao D, He C, Ma B, Lankford L, Reynaga L, Farmer DL, Guo F, Wang A. Hypoxic Preconditioning Enhances Survival and Proangiogenic Capacity of Human First Trimester Chorionic Villus-Derived Mesenchymal Stem Cells for Fetal Tissue Engineering. Stem Cells Int 2019;2019:9695239. [PMID: 31781252 DOI: 10.1155/2019/9695239] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
238 Ikarashi S, Tsuchiya A, Kawata Y, Kojima Y, Watanabe T, Takeuchi S, Igarashi K, Ideta-Otsuka M, Oki K, Takamura M, Terai S. Effects of Human Adipose Tissue-Derived and Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in a Dextran Sulfate Sodium-Induced Mouse Model. Biores Open Access 2019;8:185-99. [PMID: 31720090 DOI: 10.1089/biores.2019.0022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
239 Sun Y, Dos Santos A, Balayan A, Deng SX. Evaluation of Cryopreservation Media for the Preservation of Human Corneal Stromal Stem Cells. Tissue Eng Part C Methods 2020;26:37-43. [PMID: 31686624 DOI: 10.1089/ten.TEC.2019.0195] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
240 Nasiri N, Hosseini S, Alini M, Khademhosseini A, Baghaban Eslaminejad M. Targeted cell delivery for articular cartilage regeneration and osteoarthritis treatment. Drug Discovery Today 2019;24:2212-24. [DOI: 10.1016/j.drudis.2019.07.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
241 Ekblad-Nordberg Å, Walther-Jallow L, Westgren M, Götherström C. Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies. Stem Cells Transl Med 2020;9:148-57. [PMID: 31647195 DOI: 10.1002/sctm.19-0107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
242 Galipeau J, Sensébé L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell 2018;22:824-33. [PMID: 29859173 DOI: 10.1016/j.stem.2018.05.004] [Cited by in Crossref: 580] [Cited by in F6Publishing: 697] [Article Influence: 193.3] [Reference Citation Analysis]
243 Tsokas K, McFarland R, Burke C, Lynch JL, Bollenbach T, Callaway DA 2nd, Siegel J. Reducing Risks and Delays in the Translation of Cell and Gene Therapy Innovations into Regulated Products. NAM Perspect 2019;2019. [PMID: 34532664 DOI: 10.31478/201909d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
244 Yang H, Feng R, Fu Q, Xu S, Hao X, Qiu Y, Feng T, Zeng Z, Chen M, Zhang S. Human induced pluripotent stem cell-derived mesenchymal stem cells promote healing via TNF-α-stimulated gene-6 in inflammatory bowel disease models. Cell Death Dis 2019;10:718. [PMID: 31558705 DOI: 10.1038/s41419-019-1957-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
245 Mitxitorena I, Infante A, Gener B, Rodríguez CI. Suitability and limitations of mesenchymal stem cells to elucidate human bone illness. World J Stem Cells 2019; 11(9): 578-593 [PMID: 31616536 DOI: 10.4252/wjsc.v11.i9.578] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
246 Salonius E, Kontturi L, Laitinen A, Haaparanta AM, Korhonen M, Nystedt J, Kiviranta I, Muhonen V. Chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells in a three-dimensional environment. J Cell Physiol 2020;235:3497-507. [PMID: 31552691 DOI: 10.1002/jcp.29238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
247 Fathi E, Sanaat Z, Farahzadi R. Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts. Blood Res 2019;54:165-74. [PMID: 31730689 DOI: 10.5045/br.2019.54.3.165] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
248 Romantsik O, Bruschettini M, Moreira A, Thébaud B, Ley D. Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants. Cochrane Database Syst Rev 2019;9:CD013201. [PMID: 31549743 DOI: 10.1002/14651858.CD013201.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
249 Pool M, Leuvenink H, Moers C. Reparative and Regenerative Effects of Mesenchymal Stromal Cells-Promising Potential for Kidney Transplantation? Int J Mol Sci. 2019;20:4614. [PMID: 31540361 DOI: 10.3390/ijms20184614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
250 Eleuteri S, Fierabracci A. Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications. Int J Mol Sci. 2019;20. [PMID: 31533317 DOI: 10.3390/ijms20184597] [Cited by in Crossref: 56] [Cited by in F6Publishing: 90] [Article Influence: 18.7] [Reference Citation Analysis]
251 Oliva AA, McClain-Moss L, Pena A, Drouillard A, Hare JM. Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience. Aging Med (Milton) 2019;2:142-6. [PMID: 31667462 DOI: 10.1002/agm2.12079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
252 Shah TG, Predescu D, Predescu S. Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options. Clin Transl Med. 2019;8:25. [PMID: 31512000 DOI: 10.1186/s40169-019-0242-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
253 Tsuchiya A, Takeuchi S, Watanabe T, Yoshida T, Nojiri S, Ogawa M, Terai S. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration. Inflamm Regen. 2019;39:18. [PMID: 31516638 DOI: 10.1186/s41232-019-0107-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
254 Levy ML, Crawford JR, Dib N, Verkh L, Tankovich N, Cramer SC. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke. Stroke. 2019;50:2835-2841. [PMID: 31495331 DOI: 10.1161/strokeaha.119.026318] [Cited by in Crossref: 45] [Cited by in F6Publishing: 66] [Article Influence: 15.0] [Reference Citation Analysis]
255 Lonati C, Bassani GA, Brambilla D, Leonardi P, Carlin A, Maggioni M, Zanella A, Dondossola D, Fonsato V, Grange C, Camussi G, Gatti S. Mesenchymal stem cell-derived extracellular vesicles improve the molecular phenotype of isolated rat lungs during ischemia/reperfusion injury. J Heart Lung Transplant 2019;38:1306-16. [PMID: 31530458 DOI: 10.1016/j.healun.2019.08.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
256 Motoike S, Kajiya M, Komatsu N, Horikoshi S, Ogawa T, Sone H, Matsuda S, Ouhara K, Iwata T, Mizuno N, Fujita T, Ikeya M, Kurihara H. Clumps of Mesenchymal Stem Cell/Extracellular Matrix Complexes Generated with Xeno-Free Conditions Facilitate Bone Regeneration via Direct and Indirect Osteogenesis. Int J Mol Sci 2019;20:E3970. [PMID: 31443173 DOI: 10.3390/ijms20163970] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
257 Allan D, Tieu A, Lalu M, Burger D. Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application. Stem Cells Transl Med 2020;9:39-46. [PMID: 31411820 DOI: 10.1002/sctm.19-0114] [Cited by in Crossref: 30] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
258 Dessels C, Ambele MA, Pepper MS. The effect of medium supplementation and serial passaging on the transcriptome of human adipose-derived stromal cells expanded in vitro. Stem Cell Res Ther 2019;10:253. [PMID: 31412930 DOI: 10.1186/s13287-019-1370-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
259 Rühle A, Huber PE. [Normal tissue: radiosensitivity, toxicity, consequences for planning]. Radiologe 2018;58:746-53. [PMID: 29992402 DOI: 10.1007/s00117-018-0430-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
260 Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019;8:886. [PMID: 31412678 DOI: 10.3390/cells8080886] [Cited by in Crossref: 203] [Cited by in F6Publishing: 293] [Article Influence: 67.7] [Reference Citation Analysis]
261 Czekaj P, Król M, Limanówka Ł, Michalik M, Lorek K, Gramignoli R. Assessment of animal experimental models of toxic liver injury in the context of their potential application as preclinical models for cell therapy. Eur J Pharmacol 2019;861:172597. [PMID: 31408648 DOI: 10.1016/j.ejphar.2019.172597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
262 Zavala G, Sandoval C, Meza D, Contreras R, Gubelin W, Khoury M. Differentiation of adipose-derived stem cells to functional CD105neg CD73low melanocyte precursors guided by defined culture condition. Stem Cell Res Ther 2019;10:249. [PMID: 31399041 DOI: 10.1186/s13287-019-1364-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
263 Chrostek MR, Fellows EG, Crane AT, Grande AW, Low WC. Efficacy of stem cell-based therapies for stroke. Brain Res. 2019;1722:146362. [PMID: 31381876 DOI: 10.1016/j.brainres.2019.146362] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
264 Caplan H, Olson SD, Kumar A, George M, Prabhakara KS, Wenzel P, Bedi S, Toledano-Furman NE, Triolo F, Kamhieh-Milz J, Moll G, Cox CS Jr. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front Immunol 2019;10:1645. [PMID: 31417542 DOI: 10.3389/fimmu.2019.01645] [Cited by in Crossref: 84] [Cited by in F6Publishing: 127] [Article Influence: 28.0] [Reference Citation Analysis]
265 Quesada MP, García-Bernal D, Pastor D, Estirado A, Blanquer M, García-Hernández AM, Moraleda JM, Martínez S. Safety and Biodistribution of Human Bone Marrow-Derived Mesenchymal Stromal Cells Injected Intrathecally in Non-Obese Diabetic Severe Combined Immunodeficiency Mice: Preclinical Study. Tissue Eng Regen Med 2019;16:525-38. [PMID: 31624707 DOI: 10.1007/s13770-019-00202-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
266 Mastrolia I, Foppiani EM, Murgia A, Candini O, Samarelli AV, Grisendi G, Veronesi E, Horwitz EM, Dominici M. Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review. Stem Cells Transl Med. 2019;8:1135-1148. [PMID: 31313507 DOI: 10.1002/sctm.19-0044] [Cited by in Crossref: 65] [Cited by in F6Publishing: 90] [Article Influence: 21.7] [Reference Citation Analysis]
267 Mangin G, Cogo A, Moisan A, Bonnin P, Maïer B, Kubis N; RESSTORE Consortium. Intravenous Administration of Human Adipose Derived-Mesenchymal Stem Cells Is Not Efficient in Diabetic or Hypertensive Mice Subjected to Focal Cerebral Ischemia. Front Neurosci 2019;13:718. [PMID: 31379478 DOI: 10.3389/fnins.2019.00718] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
268 Casiraghi F, Remuzzi G. Mesenchymal stromal cells in kidney transplantation. Curr Opin Nephrol Hypertens. 2019;28:40-46. [PMID: 30300159 DOI: 10.1097/mnh.0000000000000461] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
269 Satué M, Schüler C, Ginner N, Erben RG. Intra-articularly injected mesenchymal stem cells promote cartilage regeneration, but do not permanently engraft in distant organs. Sci Rep 2019;9:10153. [PMID: 31300685 DOI: 10.1038/s41598-019-46554-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
270 Yamahara K, Hamada A, Soma T, Okamoto R, Okada M, Yoshihara S, Yoshihara K, Ikegame K, Tamaki H, Kaida K, Inoue T, Ohsugi Y, Nishikawa H, Hayashi H, Ito YM, Iijima H, Ohnishi S, Hashimoto D, Isoe T, Teshima T, Ogawa H, Sato N, Fujimori Y. Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial. BMJ Open 2019;9:e026403. [PMID: 31289066 DOI: 10.1136/bmjopen-2018-026403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
271 Hoogduijn MJ, Lombardo E. Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review. Stem Cells Transl Med 2019;8:1126-34. [PMID: 31282113 DOI: 10.1002/sctm.19-0073] [Cited by in Crossref: 61] [Cited by in F6Publishing: 73] [Article Influence: 20.3] [Reference Citation Analysis]
272 Williams E, Greenough A. Advances in treating bronchopulmonary dysplasia. Expert Rev Respir Med 2019;13:727-35. [PMID: 31244360 DOI: 10.1080/17476348.2019.1637738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
273 Laroye C, Boufenzer A, Jolly L, Cunat L, Alauzet C, Merlin JL, Yguel C, Bensoussan D, Reppel L, Gibot S. Bone marrow vs Wharton's jelly mesenchymal stem cells in experimental sepsis: a comparative study. Stem Cell Res Ther. 2019;10:192. [PMID: 31248453 DOI: 10.1186/s13287-019-1295-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
274 Chu DT, Nguyen Thi Phuong T, Tien NLB, Tran DK, Minh LB, Thanh VV, Gia Anh P, Pham VH, Thi Nga V. Adipose Tissue Stem Cells for Therapy: An Update on the Progress of Isolation, Culture, Storage, and Clinical Application. J Clin Med 2019;8:E917. [PMID: 31247996 DOI: 10.3390/jcm8070917] [Cited by in Crossref: 44] [Cited by in F6Publishing: 58] [Article Influence: 14.7] [Reference Citation Analysis]
275 Ciccocioppo R, Cantore A, Chaimov D, Orlando G. Regenerative medicine: the red planet for clinicians. Intern Emerg Med 2019;14:911-21. [PMID: 31203564 DOI: 10.1007/s11739-019-02126-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
276 Abushouk AI, Salem AMA, Saad A, Afifi AM, Afify AY, Afify H, Salem HSE, Ghanem E, Abdel-Daim MM. Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate. Front Pharmacol 2019;10:635. [PMID: 31258475 DOI: 10.3389/fphar.2019.00635] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
277 Ciccocioppo R, Baumgart DC, Dos Santos CC, Galipeau J, Klersy C, Orlando G. Perspectives of the International Society for Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi). Cytotherapy 2019;21:824-39. [PMID: 31201092 DOI: 10.1016/j.jcyt.2019.05.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
278 Riordan NH, Hincapié ML, Morales I, Fernández G, Allen N, Leu C, Madrigal M, Paz Rodríguez J, Novarro N. Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels. Stem Cells Transl Med 2019;8:1008-16. [PMID: 31187597 DOI: 10.1002/sctm.19-0010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
279 Podestà MA, Remuzzi G, Casiraghi F. Mesenchymal Stromal Cells for Transplant Tolerance. Front Immunol 2019;10:1287. [PMID: 31231393 DOI: 10.3389/fimmu.2019.01287] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 9.7] [Reference Citation Analysis]
280 Soria-Juan B, Escacena N, Capilla-González V, Aguilera Y, Llanos L, Tejedo JR, Bedoya FJ, Juan V, De la Cuesta A, Ruiz-Salmerón R, Andreu E, Grochowicz L, Prósper F, Sánchez-Guijo F, Lozano FS, Miralles M, Del Río-Solá L, Castellanos G, Moraleda JM, Sackstein R, García-Arranz M, García-Olmo D, Martín F, Hmadcha A, Soria B; Collaborative Working Group “Noma Project Team”. Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus. Front Immunol 2019;10:1151. [PMID: 31231366 DOI: 10.3389/fimmu.2019.01151] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
281 Sequiera GL, Sareen N, Sharma V, Surendran A, Abu-el-rub E, Ravandi A, Dhingra S. High throughput screening reveals no significant changes in protein synthesis, processing, and degradation machinery during passaging of mesenchymal stem cells. Can J Physiol Pharmacol 2019;97:536-43. [DOI: 10.1139/cjpp-2018-0553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
282 Liu D, Li X, Xiao Z, Yin W, Zhao Y, Tan J, Chen B, Jiang X, Dai J. Different functional bio-scaffolds share similar neurological mechanism to promote locomotor recovery of canines with complete spinal cord injury. Biomaterials 2019;214:119230. [PMID: 31174066 DOI: 10.1016/j.biomaterials.2019.119230] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
283 Ukon Y, Makino T, Kodama J, Tsukazaki H, Tateiwa D, Yoshikawa H, Kaito T. Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review. Int J Mol Sci 2019;20:E2557. [PMID: 31137666 DOI: 10.3390/ijms20102557] [Cited by in Crossref: 29] [Cited by in F6Publishing: 44] [Article Influence: 9.7] [Reference Citation Analysis]
284 Geiger S, Ozay EI, Geumann U, Hereth MK, Magnusson T, Shanthalingam S, Hirsch D, Kälin S, Günther C, Osborne BA, Tew GN, Hermann FG, Minter LM. Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD. Mol Ther 2019;27:1436-51. [PMID: 31138510 DOI: 10.1016/j.ymthe.2019.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
285 Turnbull MT, Zubair AC, Meschia JF, Freeman WD. Mesenchymal stem cells for hemorrhagic stroke: status of preclinical and clinical research. NPJ Regen Med 2019;4:10. [PMID: 31098299 DOI: 10.1038/s41536-019-0073-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
286 Macgregor C, Petersen A, Munsie M. From the margins to mainstream: How providers of autologous ‘stem cell treatments’ legitimise their practice in Australia. Health (London) 2021;25:51-68. [DOI: 10.1177/1363459319846927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
287 Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, Hill AF, De Kleijn D, Koh M, Lai RC, Mitsialis SA, Ortiz LA, Rohde E, Asada T, Toh WS, Weiss DJ, Zheng L, Giebel B, Lim SK. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 2019;8:1609206. [PMID: 31069028 DOI: 10.1080/20013078.2019.1609206] [Cited by in Crossref: 146] [Cited by in F6Publishing: 229] [Article Influence: 48.7] [Reference Citation Analysis]
288 Musiał-Wysocka A, Kot M, Majka M. The Pros and Cons of Mesenchymal Stem Cell-Based Therapies. Cell Transplant 2019;28:801-12. [PMID: 31018669 DOI: 10.1177/0963689719837897] [Cited by in Crossref: 76] [Cited by in F6Publishing: 128] [Article Influence: 25.3] [Reference Citation Analysis]
289 Borkowska-Kuczkowska A, Sługocka D, Świątkowska-Flis B, Boruczkowski D. The use of mesenchymal stem cells for the treatment of progressive retinal diseases: a review. Regen Med 2019;14:321-9. [PMID: 30977436 DOI: 10.2217/rme-2019-0022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
290 Chahal J, Gómez-Aristizábal A, Shestopaloff K, Bhatt S, Chaboureau A, Fazio A, Chisholm J, Weston A, Chiovitti J, Keating A, Kapoor M, Ogilvie-Harris DJ, Syed KA, Gandhi R, Mahomed NN, Marshall KW, Sussman MS, Naraghi AM, Viswanathan S. Bone Marrow Mesenchymal Stromal Cell Treatment in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial Inflammation. Stem Cells Transl Med 2019;8:746-57. [PMID: 30964245 DOI: 10.1002/sctm.18-0183] [Cited by in Crossref: 23] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
291 Brennen WN, Schweizer MT, Wang H, Bivalacqua TJ, Partin AW, Lim SJ, Chapman C, Abdallah R, Levy O, Bhowmick NA, Karp JM, De Marzo A, Isaacs JT, Denmeade SR. In Reply. Stem Cells Transl Med 2019;8:739-40. [PMID: 30925030 DOI: 10.1002/sctm.19-0068] [Reference Citation Analysis]
292 Wiese DM, Ruttan CC, Wood CA, Ford BN, Braid LR. Accumulating Transcriptome Drift Precedes Cell Aging in Human Umbilical Cord-Derived Mesenchymal Stromal Cells Serially Cultured to Replicative Senescence. Stem Cells Transl Med. 2019;8:945-958. [PMID: 30924318 DOI: 10.1002/sctm.18-0246] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
293 Ferro F, Spelat R, Shaw G, Duffy N, Islam MN, O'Shea PM, O'Toole D, Howard L, Murphy JM. Survival/Adaptation of Bone Marrow-Derived Mesenchymal Stem Cells After Long-Term Starvation Through Selective Processes. Stem Cells 2019;37:813-27. [PMID: 30835892 DOI: 10.1002/stem.2998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
294 van Bel F, Vaes J, Groenendaal F. Prevention, Reduction and Repair of Brain Injury of the Preterm Infant. Front Physiol 2019;10:181. [PMID: 30949060 DOI: 10.3389/fphys.2019.00181] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
295 Tappenbeck N, Schröder HM, Niebergall-Roth E, Hassinger F, Dehio U, Dieter K, Kraft K, Kerstan A, Esterlechner J, Frank NY, Scharffetter-Kochanek K, Murphy GF, Orgill DP, Beck J, Frank MH, Ganss C, Kluth MA. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials. Cytotherapy 2019;21:546-60. [PMID: 30878384 DOI: 10.1016/j.jcyt.2018.12.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
296 Sagar R, Götherström C, David AL, Westgren M. Fetal stem cell transplantation and gene therapy. Best Pract Res Clin Obstet Gynaecol 2019;58:142-53. [PMID: 30910447 DOI: 10.1016/j.bpobgyn.2019.02.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
297 Sher N, Ofir R. Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18. Cell Transplant 2018;27:140-50. [PMID: 29562777 DOI: 10.1177/0963689717727543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
298 Erpicum P, Weekers L, Detry O, Bonvoisin C, Delbouille M, Grégoire C, Baudoux E, Briquet A, Lechanteur C, Maggipinto G, Somja J, Pottel H, Baron F, Jouret F, Beguin Y. Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International 2019;95:693-707. [DOI: 10.1016/j.kint.2018.08.046] [Cited by in Crossref: 40] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
299 Baker EK, Malhotra A, Lim R, Jacobs SE, Hooper SB, Davis PG, Wallace EM. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study. BMJ Open 2019;9:e026265. [PMID: 30826799 DOI: 10.1136/bmjopen-2018-026265] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
300 Attwood SW, Edel MJ. iPS-Cell Technology and the Problem of Genetic Instability-Can It Ever Be Safe for Clinical Use? J Clin Med 2019;8:E288. [PMID: 30823421 DOI: 10.3390/jcm8030288] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 11.0] [Reference Citation Analysis]
301 Liu Q, Chen MX, Sun L, Wallis CU, Zhou JS, Ao LJ, Li Q, Sham PC. Rational use of mesenchymal stem cells in the treatment of autism spectrum disorders. World J Stem Cells 2019; 11(2): 55-72 [PMID: 30842805 DOI: 10.4252/wjsc.v11.i2.55] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
302 Nuzzi R, Tridico F. Perspectives of Autologous Mesenchymal Stem-Cell Transplantation in Macular Hole Surgery: A Review of Current Findings. J Ophthalmol 2019;2019:3162478. [PMID: 30918717 DOI: 10.1155/2019/3162478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
303 Li D, Yan X, Hu Y, Liu Y, Guo R, Liao M, Shao B, Tang Q, Guo X, Chai R, Zhang Q, Tang M. Two-Photon Image Tracking of Neural Stem Cells via Iridium Complexes Encapsulated in Polymeric Nanospheres. ACS Biomater Sci Eng 2019;5:1561-8. [PMID: 33405629 DOI: 10.1021/acsbiomaterials.8b01231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
304 Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A, Paterson K, Boyd R. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019;14:213-230. [PMID: 30762487 DOI: 10.2217/rme-2018-0161] [Cited by in Crossref: 68] [Cited by in F6Publishing: 106] [Article Influence: 22.7] [Reference Citation Analysis]
305 Ciccocioppo R, Klersy C, Leffler DA, Rogers R, Bennett D, Corazza GR. Systematic review with meta-analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas. JGH Open. 2019;3:249-260. [PMID: 31276044 DOI: 10.1002/jgh3.12141] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
306 Stanco D, Caprara C, Ciardelli G, Mariotta L, Gola M, Minonzio G, Soldati G. Tenogenic differentiation protocol in xenogenic-free media enhances tendon-related marker expression in ASCs. PLoS One 2019;14:e0212192. [PMID: 30753235 DOI: 10.1371/journal.pone.0212192] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
307 Marinaro F, Sánchez-Margallo FM, Álvarez V, López E, Tarazona R, Brun MV, Blázquez R, Casado JG. Meshes in a mess: Mesenchymal stem cell-based therapies for soft tissue reinforcement. Acta Biomater 2019;85:60-74. [PMID: 30500445 DOI: 10.1016/j.actbio.2018.11.042] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
308 Moll G, Ankrum JA, Kamhieh-Milz J, Bieback K, Ringdén O, Volk HD, Geissler S, Reinke P. Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. Trends Mol Med 2019;25:149-63. [PMID: 30711482 DOI: 10.1016/j.molmed.2018.12.006] [Cited by in Crossref: 112] [Cited by in F6Publishing: 168] [Article Influence: 37.3] [Reference Citation Analysis]
309 Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database Syst Rev 2019;1:CD009768. [PMID: 30697701 DOI: 10.1002/14651858.CD009768.pub2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
310 Yin JQ, Zhu J, Ankrum JA. Manufacturing of primed mesenchymal stromal cells for therapy. Nat Biomed Eng 2019;3:90-104. [PMID: 30944433 DOI: 10.1038/s41551-018-0325-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 120] [Article Influence: 27.3] [Reference Citation Analysis]
311 Zhuang Q, Ma R, Yin Y, Lan T, Yu M, Ming Y. Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy. Stem Cells Int. 2019;2019:8387350. [PMID: 30766607 DOI: 10.1155/2019/8387350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
312 Ashraf S, Taylor A, Sharkey J, Barrow M, Murray P, Wilm B, Poptani H, Rosseinsky MJ, Adams DJ, Lévy R. In vivo fate of free and encapsulated iron oxide nanoparticles after injection of labelled stem cells. Nanoscale Adv 2019;1:367-77. [DOI: 10.1039/c8na00098k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
313 Khalifeh Soltani S, Forogh B, Ahmadbeigi N, Hadizadeh Kharazi H, Fallahzadeh K, Kashani L, Karami M, Kheyrollah Y, Vasei M. Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. Cytotherapy 2019;21:54-63. [DOI: 10.1016/j.jcyt.2018.11.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
314 Tsai MJ, Liou DY, Lin YR, Weng CF, Huang MC, Huang WC, Tseng FW, Cheng H. Attenuating Spinal Cord Injury by Conditioned Medium from Bone Marrow Mesenchymal Stem Cells. J Clin Med. 2018;8. [PMID: 30585207 DOI: 10.3390/jcm8010023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
315 Rozier P, Maria A, Goulabchand R, Jorgensen C, Guilpain P, Noël D. Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use? Front Immunol 2018;9:2938. [PMID: 30619298 DOI: 10.3389/fimmu.2018.02938] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
316 Alatab S, Shekarchian S, Najafi I, Moghadasali R, Ahmadbeigi N, Pourmand MR, Bolurieh T, Jaroughi N, Pourmand G, Aghdami N. Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety. Cell J 2019;20:483-95. [PMID: 30123994 DOI: 10.22074/cellj.2019.5591] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
317 Gao LR, Zhang NK, Zhang Y, Chen Y, Wang L, Zhu Y, Tang HH. Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats. Stem Cell Res Ther 2018;9:339. [PMID: 30526660 DOI: 10.1186/s13287-018-1084-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
318 Christodoulou I, Goulielmaki M, Devetzi M, Panagiotidis M, Koliakos G, Zoumpourlis V. Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review. Stem Cell Res Ther 2018;9:336. [PMID: 30526687 DOI: 10.1186/s13287-018-1078-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 42] [Article Influence: 8.5] [Reference Citation Analysis]
319 Alencar AKN, Pimentel-Coelho PM, Montes GC, da Silva MMC, Mendes LVP, Montagnoli TL, Silva AMS, Vasques JF, Rosado-de-Castro PH, Gutfilen B, Cunha VDMN, Fraga AGM, Silva PMRE, Martins MA, Ferreira TPT, Mendes-Otero R, Trachez MM, Sudo RT, Zapata-Sudo G. Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice. Front Pharmacol 2018;9:1395. [PMID: 30574088 DOI: 10.3389/fphar.2018.01395] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
320 Scarfe L, Taylor A, Sharkey J, Harwood R, Barrow M, Comenge J, Beeken L, Astley C, Santeramo I, Hutchinson C, Ressel L, Smythe J, Austin E, Levy R, Rosseinsky MJ, Adams DJ, Poptani H, Park BK, Murray P, Wilm B. Non-invasive imaging reveals conditions that impact distribution and persistence of cells after in vivo administration. Stem Cell Res Ther. 2018;9:332. [PMID: 30486897 DOI: 10.1186/s13287-018-1076-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
321 Zhou Y, Liao J, Fang C, Mo C, Zhou G, Luo Y. One-step Derivation of Functional Mesenchymal Stem Cells from Human Pluripotent Stem Cells. Bio Protoc 2018;8:e3080. [PMID: 34532538 DOI: 10.21769/BioProtoc.3080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 François S, Usunier B, Forgue-Lafitte ME, L'Homme B, Benderitter M, Douay L, Gorin NC, Larsen AK, Chapel A. Mesenchymal Stem Cell Administration Attenuates Colon Cancer Progression by Modulating the Immune Component within the Colorectal Tumor Microenvironment. Stem Cells Transl Med 2019;8:285-300. [PMID: 30451398 DOI: 10.1002/sctm.18-0117] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 7.5] [Reference Citation Analysis]
323 Neph A, Onishi K, Wang JH. Myths and Facts of In-Office Regenerative Procedures for Tendinopathy. Am J Phys Med Rehabil 2019;98:500-11. [PMID: 30433886 DOI: 10.1097/PHM.0000000000001097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
324 Grau-Vorster M, Rodríguez L, Torrents-Zapata S, Vivas D, Codinach M, Blanco M, Oliver-Vila I, García-López J, Vives J. Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow-derived multipotent mesenchymal stromal cell expansion cultures. Cytotherapy 2019;21:32-40. [PMID: 30447901 DOI: 10.1016/j.jcyt.2018.09.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
325 Fu H, Chen Q. Mesenchymal stem cell therapy for heart failure: a meta-analysis. Herz 2020;45:557-63. [PMID: 30341444 DOI: 10.1007/s00059-018-4762-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
326 Päth G, Perakakis N, Mantzoros CS, Seufert J. Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells. Metabolism 2019;90:1-15. [PMID: 30342065 DOI: 10.1016/j.metabol.2018.10.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
327 Fujita Y, Kadota T, Araya J, Ochiya T, Kuwano K. Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases. J Clin Med. 2018;7. [PMID: 30322213 DOI: 10.3390/jcm7100355] [Cited by in Crossref: 66] [Cited by in F6Publishing: 80] [Article Influence: 16.5] [Reference Citation Analysis]
328 Ciccocioppo R, Corazza GR. Mesenchymal stromal cells: an opportunity to treat chronic inflammatory intestinal conditions. Cytotherapy. 2018;20:1223-1226. [PMID: 30292459 DOI: 10.1016/j.jcyt.2018.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
329 Huang H, Qian K, Han X, Li X, Zheng Y, Chen Z, Huang X, Chen H. Intraparenchymal Neural Stem/Progenitor Cell Transplantation for Ischemic Stroke Animals: A Meta-Analysis and Systematic Review. Stem Cells Int 2018;2018:4826407. [PMID: 30369951 DOI: 10.1155/2018/4826407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
330 Walraven M, Hinz B. Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer. Matrix Biology 2018;71-72:205-24. [DOI: 10.1016/j.matbio.2018.02.020] [Cited by in Crossref: 88] [Cited by in F6Publishing: 98] [Article Influence: 22.0] [Reference Citation Analysis]
331 Wang F, Tang H, Zhu J, Zhang JH. Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke. Cell Transplant. 2018;27:1825-1834. [PMID: 30251564 DOI: 10.1177/0963689718795424] [Cited by in Crossref: 21] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
332 Jiang T, Liu J, Ouyang Y, Wu H, Zheng L, Zhao J, Zhang X. Intra-hydrogel culture prevents transformation of mesenchymal stem cells induced by monolayer expansion. Biomater Sci 2018;6:1168-76. [PMID: 29564424 DOI: 10.1039/C8BM00007G] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
333 McFetridge ML, Del Borgo MP, Aguilar MI, Ricardo SD. The use of hydrogels for cell-based treatment of chronic kidney disease. Clin Sci (Lond) 2018;132:1977-94. [PMID: 30220651 DOI: 10.1042/CS20180434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
334 Peltzer J, Aletti M, Frescaline N, Busson E, Lataillade JJ, Martinaud C. Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges. Front Immunol. 2018;9:2013. [PMID: 30271402 DOI: 10.3389/fimmu.2018.02013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
335 Moravcikova E, Meyer EM, Corselli M, Donnenberg VS, Donnenberg AD. Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC). Cytometry A 2018;93:894-904. [PMID: 30211967 DOI: 10.1002/cyto.a.23574] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
336 Wang Y, Chen R, Brandacher G, Lee WA, Kuo Y. The suppression effect of dendritic cells maturation by adipose-derived stem cells through TGF-β1 related pathway. Experimental Cell Research 2018;370:708-17. [DOI: 10.1016/j.yexcr.2018.07.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
337 Wang Z, Sun D. Adipose-Derived Mesenchymal Stem Cells: A New Tool for the Treatment of Renal Fibrosis. Stem Cells Dev 2018;27:1406-11. [PMID: 30032706 DOI: 10.1089/scd.2017.0304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
338 Perlee D, van Vught LA, Scicluna BP, Maag A, Lutter R, Kemper EM, van ‘t Veer C, Punchard MA, González J, Richard MP, Dalemans W, Lombardo E, de Vos AF, van der Poll T. Intravenous Infusion of Human Adipose Mesenchymal Stem Cells Modifies the Host Response to Lipopolysaccharide in Humans: A Randomized, Single-Blind, Parallel Group, Placebo Controlled Trial: Mesenchymal Stem Cells in Human Endotoxemia. Stem Cells 2018;36:1778-88. [DOI: 10.1002/stem.2891] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 9.5] [Reference Citation Analysis]
339 Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA. Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering. Stem Cells Int. 2018;2018:8031718. [PMID: 30210552 DOI: 10.1155/2018/8031718] [Cited by in Crossref: 132] [Cited by in F6Publishing: 161] [Article Influence: 33.0] [Reference Citation Analysis]
340 Seng A, Dunavin N. Mesenchymal stromal cell infusions for acute graft-versus-host disease: Rationale, data, and unanswered questions. Adv Cell Gene Ther 2018;1:e14. [DOI: 10.1002/acg2.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
341 Nuzzi R, Marolo P, Tridico F. From DMEK to Corneal Endothelial Cell Therapy: Technical and Biological Aspects. J Ophthalmol 2018;2018:6482095. [PMID: 30155283 DOI: 10.1155/2018/6482095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
342 Georgiev-Hristov T, Guadalajara H, Herreros MD, Lightner AL, Dozois EJ, García-Arranz M, García-Olmo D. A Step-By-Step Surgical Protocol for the Treatment of Perianal Fistula with Adipose-Derived Mesenchymal Stem Cells. J Gastrointest Surg 2018;22:2003-12. [PMID: 30066070 DOI: 10.1007/s11605-018-3895-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
343 Papagianis PC, Pillow JJ, Moss TJ. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies. Paediatr Respir Rev 2019;30:34-41. [PMID: 30201135 DOI: 10.1016/j.prrv.2018.07.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
344 Česen Mazič M, Girandon L, Kneževič M, Avčin SL, Jazbec J. Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells-Single Center Experience. Front Bioeng Biotechnol 2018;6:93. [PMID: 30087891 DOI: 10.3389/fbioe.2018.00093] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
345 Thébaud B. Stem cell-based therapies in neonatology: a new hope. Arch Dis Child Fetal Neonatal Ed 2018;103:F583-8. [PMID: 29973349 DOI: 10.1136/archdischild-2017-314451] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
346 Bor R, Fábián A, Farkas K, Molnár T, Szepes Z. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease – review of pathomechanism and existing clinical data. Expert Opinion on Biological Therapy 2018;18:737-45. [DOI: 10.1080/14712598.2018.1492543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
347 Netsch P, Elvers-Hornung S, Uhlig S, Klüter H, Huck V, Kirschhöfer F, Brenner-Weiß G, Janetzko K, Solz H, Wuchter P, Bugert P, Bieback K. Human mesenchymal stromal cells inhibit platelet activation and aggregation involving CD73-converted adenosine. Stem Cell Res Ther 2018;9:184. [PMID: 29973267 DOI: 10.1186/s13287-018-0936-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
348 Kuwabara A, Liu J, Kamio Y, Liu A, Lawton MT, Lee JW, Hashimoto T. Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice. Neurosurgery 2017;81:1021-8. [PMID: 28431181 DOI: 10.1093/neuros/nyx172] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
349 Hernández-Monjaraz B, Santiago-Osorio E, Ledesma-Martínez E, Alcauter-Zavala A, Mendoza-Núñez VM. Retrieval of a periodontally compromised tooth by allogeneic grafting of mesenchymal stem cells from dental pulp: A case report. J Int Med Res 2018;46:2983-93. [PMID: 29911458 DOI: 10.1177/0300060518773244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
350 Lin HC, Wang CC, Chou HW, Wu ET, Lu FL, Ko BS, Yao M, Wang PY, Wu MH, Chen YS. Airway Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Reverses Bronchopulmonary Dysplasia Superimposed with Acute Respiratory Distress Syndrome in an Infant. Cell Med 2018;10:2155179018759434. [PMID: 32634184 DOI: 10.1177/2155179018759434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
351 van Rhijn-Brouwer FCC, Gremmels H, Fledderus JO, Verhaar MC. Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy. Cell Transplant 2018;27:765-85. [PMID: 29895169 DOI: 10.1177/0963689717738257] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
352 Catalan-Serra I, Brenna Ø. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Hum Vaccin Immunother 2018;14:2597-611. [PMID: 29624476 DOI: 10.1080/21645515.2018.1461297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
353 Zhang S, Wan H, Wang P, Liu M, Li G, Zhang C, Sun Y. Extracellular matrix protein DMP1 suppresses osteogenic differentiation of Mesenchymal Stem Cells. Biochem Biophys Res Commun 2018;501:968-73. [PMID: 29775615 DOI: 10.1016/j.bbrc.2018.05.092] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
354 Cunningham CJ, Redondo-Castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38:1276-1292. [PMID: 29768965 DOI: 10.1177/0271678x18776802] [Cited by in Crossref: 83] [Cited by in F6Publishing: 113] [Article Influence: 20.8] [Reference Citation Analysis]
355 Zhang L, Yu J, Wei W. Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. Front Immunol 2018;9:1087. [PMID: 29868032 DOI: 10.3389/fimmu.2018.01087] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
356 Bruna F, Plaza A, Arango M, Espinoza I, Conget P. Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight. Stem Cell Res Ther 2018;9:137. [PMID: 29751770 DOI: 10.1186/s13287-018-0878-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
357 Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, Marszalek JR, Maitra A, Yee C, Rezvani K, Shpall E, LeBleu VS, Kalluri R. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018;3. [PMID: 29669940 DOI: 10.1172/jci.insight.99263] [Cited by in Crossref: 222] [Cited by in F6Publishing: 304] [Article Influence: 55.5] [Reference Citation Analysis]
358 Kim Y. Can Umbilical Cord Mesenchymal Stem Cells Treatment Be a Hope for Patients with Refractory Crohn's Disease? Gut Liver 2018;12:5-6. [PMID: 29284220 DOI: 10.5009/gnl17492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
359 Servais S, Baron F, Lechanteur C, Seidel L, Selleslag D, Maertens J, Baudoux E, Zachee P, Van Gelder M, Noens L, Kerre T, Lewalle P, Schroyens W, Ory A, Beguin Y. Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study. Oncotarget 2018;9:20590-604. [PMID: 29755674 DOI: 10.18632/oncotarget.25020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
360 Jiang J, Wang Y, Liu B, Chen X, Zhang S. Challenges and research progress of the use of mesenchymal stem cells in the treatment of ischemic stroke. Brain Dev 2018;40:612-26. [PMID: 29661589 DOI: 10.1016/j.braindev.2018.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
361 Gronbach J, Shahzad T, Radajewski S, Chao CM, Bellusci S, Morty RE, Reicherzer T, Ehrhardt H. The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant. Stem Cells Int 2018;2018:9652897. [PMID: 29765429 DOI: 10.1155/2018/9652897] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
362 de Souza Tesch R, Takamori ER, Menezes K, Carias RBV, Dutra CLM, de Freitas Aguiar M, Torraca TSS, Senegaglia AC, Rebelatto CLK, Daga DR, Brofman PRS, Borojevic R. Temporomandibular joint regeneration: proposal of a novel treatment for condylar resorption after orthognathic surgery using transplantation of autologous nasal septum chondrocytes, and the first human case report. Stem Cell Res Ther 2018;9:94. [PMID: 29625584 DOI: 10.1186/s13287-018-0806-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
363 Sun M, Yang Y, Meng W, Xu Q, Lin F, Chen Y, Zhao J, Xiao K. Advanced biotherapy for the treatment of sulfur mustard poisoning. Chemico-Biological Interactions 2018;286:111-8. [DOI: 10.1016/j.cbi.2018.03.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
364 Nam Y, Rim YA, Lee J, Ju JH. Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration. Stem Cells Int 2018;2018:8490489. [PMID: 29765426 DOI: 10.1155/2018/8490489] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
365 Makhlough A, Shekarchian S, Moghadasali R, Einollahi B, Dastgheib M, Janbabaee G, Hosseini SE, Falah N, Abbasi F, Baharvand H, Aghdami N. Bone marrow-mesenchymal stromal cell infusion in patients with chronic kidney disease: A safety study with 18 months of follow-up. Cytotherapy. 2018;20:660-669. [PMID: 29580865 DOI: 10.1016/j.jcyt.2018.02.368] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
366 Wang D, Zhang H, Liang J, Wang H, Hua B, Feng X, Gilkeson GS, Farge D, Shi S, Sun L. A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus. Stem Cell Reports 2018;10:933-41. [PMID: 29478901 DOI: 10.1016/j.stemcr.2018.01.029] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
367 Savelli S, Trombi L, D'Alessandro D, Moscato S, Pacini S, Giannotti S, Lapi S, Scatena F, Petrini M. Pooled human serum: A new culture supplement for bioreactor-based cell therapies. Preliminary results. Cytotherapy 2018;20:556-63. [PMID: 29429942 DOI: 10.1016/j.jcyt.2017.12.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
368 Sagar R, Walther-Jallow L, David AL, Götherström C, Westgren M. Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy. Curr Stem Cell Rep 2018;4:61-8. [PMID: 29600162 DOI: 10.1007/s40778-018-0118-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
369 Aronsson-Kurttila W, Baygan A, Moretti G, Remberger M, Khoein B, Moll G, Sadeghi B, Ringdén O. Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation. Acta Haematol 2018;139:106-14. [PMID: 29408819 DOI: 10.1159/000485735] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
370 Oeller M, Laner-Plamberger S, Hochmann S, Ketterl N, Feichtner M, Brachtl G, Hochreiter A, Scharler C, Bieler L, Romanelli P, Couillard-Despres S, Russe E, Schallmoser K, Strunk D. Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells. Theranostics 2018;8:1421-34. [PMID: 29507631 DOI: 10.7150/thno.21906] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
371 Mcintyre LA, Stewart DJ, Mei SHJ, Courtman D, Watpool I, Granton J, Marshall J, dos Santos C, Walley KR, Winston BW, Schlosser K, Fergusson DA. Cellular Immunotherapy for Septic Shock. A Phase I Clinical Trial. Am J Respir Crit Care Med 2018;197:337-47. [DOI: 10.1164/rccm.201705-1006oc] [Cited by in Crossref: 69] [Cited by in F6Publishing: 82] [Article Influence: 17.3] [Reference Citation Analysis]
372 Gotts JE, Matthay MA. Cell-based Therapy in Sepsis. A Step Closer. Am J Respir Crit Care Med 2018;197:280-1. [DOI: 10.1164/rccm.201710-2068ed] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
373 Kang JM, Yeon BK, Cho SJ, Suh YH. Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials. J Alzheimers Dis. 2016;54:879-889. [PMID: 27567851 DOI: 10.3233/jad-160406] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 11.3] [Reference Citation Analysis]
374 Rios Rodriguez V, Llop M, Poddubnyy D. Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis? Immunotherapy 2017;9:899-911. [PMID: 29338611 DOI: 10.2217/imt-2017-0034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
375 Redondo-Castro E, Cunningham CJ, Miller J, Brown H, Allan SM, Pinteaux E. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming. Stem Cell Res Ther 2018;9:11. [PMID: 29343288 DOI: 10.1186/s13287-017-0753-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 9.5] [Reference Citation Analysis]
376 Rengasamy M, Gupta PK, Kolkundkar U, Singh G, Balasubramanian S, SundarRaj S, Chullikana A, Majumdar AS. Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells. Indian J Med Res. 2016;144:852-864. [PMID: 28474622 DOI: 10.4103/ijmr.ijmr_1842_15] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
377 Wagner DE, Cardoso WV, Gilpin SE, Majka S, Ott H, Randell SH, Thébaud B, Waddell T, Weiss DJ; ATS Subcommittee on Stem Cells and Cell Therapies. An Official American Thoracic Society Workshop Report 2015. Stem Cells and Cell Therapies in Lung Biology and Diseases. Ann Am Thorac Soc 2016;13:S259-78. [PMID: 27509163 DOI: 10.1513/AnnalsATS.201606-466ST] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
378 Gładysz D, Krzywdzińska A, Hozyasz KK. Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment? Mol Neurobiol 2018;55:6387-435. [PMID: 29307081 DOI: 10.1007/s12035-017-0822-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
379 Le BQ, Nurcombe V, Cool SM, van Blitterswijk CA, de Boer J, LaPointe VLS. The Components of Bone and What They Can Teach Us about Regeneration. Materials (Basel) 2017;11:E14. [PMID: 29271933 DOI: 10.3390/ma11010014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
380 Berglund AK, Fortier LA, Antczak DF, Schnabel LV. Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Res Ther. 2017;8:288. [PMID: 29273086 DOI: 10.1186/s13287-017-0742-8] [Cited by in Crossref: 93] [Cited by in F6Publishing: 109] [Article Influence: 18.6] [Reference Citation Analysis]
381 Archambault J, Moreira A, McDaniel D, Winter L, Sun L, Hornsby P. Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies. PLoS One. 2017;12:e0189895. [PMID: 29261798 DOI: 10.1371/journal.pone.0189895] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
382 Vertès AA. Methods and practices to diversify cell-based products. Regen Med 2017;12:997-1013. [PMID: 29243940 DOI: 10.2217/rme-2017-0093] [Reference Citation Analysis]
383 Sarmah D, Agrawal V, Rane P, Bhute S, Watanabe M, Kalia K, Ghosh Z, Dave KR, Yavagal DR, Bhattacharya P. Mesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies. Clin Pharmacol Ther 2018;103:990-8. [PMID: 29090465 DOI: 10.1002/cpt.927] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
384 Wijnand JGJ, Teraa M, Gremmels H, van Rhijn-Brouwer FCC, de Borst GJ, Verhaar MC; SAIL Study Group. Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia. J Vasc Surg 2018;67:656-61. [PMID: 29242062 DOI: 10.1016/j.jvs.2017.09.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
385 Sang W, Lv B, Li K, Lu Y. Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis. Clin Res Hepatol Gastroenterol 2018;42:193-204. [PMID: 29223366 DOI: 10.1016/j.clinre.2017.11.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
386 Markovic BS, Kanjevac T, Harrell CR, Gazdic M, Fellabaum C, Arsenijevic N, Volarevic V. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases. Stem Cell Rev and Rep 2018;14:153-65. [DOI: 10.1007/s12015-017-9789-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
387 Mohr A, Zwacka R. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts. Cancer Lett. 2018;414:239-249. [PMID: 29175461 DOI: 10.1016/j.canlet.2017.11.025] [Cited by in Crossref: 52] [Cited by in F6Publishing: 63] [Article Influence: 10.4] [Reference Citation Analysis]
388 Tribe HC, McEwan J, Taylor H, Oreffo ROC, Tare RS. Mesenchymal Stem Cells: Potential Role in the Treatment of Osteochondral Lesions of the Ankle. Biotechnol J. 2017;12. [PMID: 29068173 DOI: 10.1002/biot.201700070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
389 Braid LR, Wood CA, Wiese DM, Ford BN. Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes. Cytotherapy. 2018;20:232-244. [PMID: 29167063 DOI: 10.1016/j.jcyt.2017.09.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
390 Pierro M, Thébaud B, Soll R. Mesenchymal stem cells for the prevention and treatment of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev 2017;11:CD011932. [PMID: 29125893 DOI: 10.1002/14651858.CD011932.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
391 Liu YY, Chiang CH, Hung SC, Chian CF, Tsai CL, Chen WC, Zhang H. Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury. PLoS One 2017;12:e0187637. [PMID: 29117205 DOI: 10.1371/journal.pone.0187637] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
392 Drucker NA, McCulloh CJ, Li B, Pierro A, Besner GE, Markel TA. Stem cell therapy in necrotizing enterocolitis: Current state and future directions. Semin Pediatr Surg 2018;27:57-64. [PMID: 29275819 DOI: 10.1053/j.sempedsurg.2017.11.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
393 Scolding NJ, Pasquini M, Reingold SC, Cohen JA; International Conference on Cell-Based Therapies for Multiple Sclerosis., International Conference on Cell-Based Therapies for Multiple Sclerosis., International Conference on Cell-Based Therapies for Multiple Sclerosis. Cell-based therapeutic strategies for multiple sclerosis. Brain 2017;140:2776-96. [PMID: 29053779 DOI: 10.1093/brain/awx154] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 17.8] [Reference Citation Analysis]
394 Barron CC, Lalu MM, Stewart DJ, Fergusson D, Yang H, Moher D, Liu P, Mazer D, Devereaux PJ, McIntyre L; Canadian Perioperative Anesthesia Clinical Trials Group. Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol. Syst Rev 2017;6:226. [PMID: 29116020 DOI: 10.1186/s13643-017-0601-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
395 Kotani T, Masutani R, Suzuka T, Oda K, Makino S, Ii M. Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia. Sci Rep 2017;7:14608. [PMID: 29097816 DOI: 10.1038/s41598-017-15022-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
396 Wagenaar N, de Theije CGM, de Vries LS, Groenendaal F, Benders MJNL, Nijboer CHA. Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells. Pediatr Res 2018;83:372-84. [DOI: 10.1038/pr.2017.243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
397 Maillacheruvu PF, Engel LM, Crum IT, Agrawal DK, Peeples ES. From cord to caudate: characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain. Pediatr Res 2018;83:205-13. [DOI: 10.1038/pr.2017.251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
398 Rocca A, Tafuri D, Paccone M, Giuliani A, Zamboli AGI, Surfaro G, Paccone A, Compagna R, Amato M, Serra R, Amato B. Cell Based Therapeutic Approach in Vascular Surgery: Application and Review. Open Med (Wars) 2017;12:308-22. [PMID: 29071303 DOI: 10.1515/med-2017-0045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
399 Cimino M, Gonçalves RM, Barrias CC, Martins MCL. Xeno-Free Strategies for Safe Human Mesenchymal Stem/Stromal Cell Expansion: Supplements and Coatings. Stem Cells Int 2017;2017:6597815. [PMID: 29158740 DOI: 10.1155/2017/6597815] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
400 Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, Goset C, Rojo P, Palma I, Lamich R, Pedreros PA, Valdivia G, Lopez VM, Nazzal C, Alcayaga-Miranda F, Cuenca J, Brobeck MJ, Patel AN, Figueroa FE, Khoury M. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]). Circ Res 2017;121:1192-204. [PMID: 28974553 DOI: 10.1161/CIRCRESAHA.117.310712] [Cited by in Crossref: 153] [Cited by in F6Publishing: 187] [Article Influence: 30.6] [Reference Citation Analysis]
401 Laroye C, Gibot S, Reppel L, Bensoussan D. Concise Review: Mesenchymal Stromal/Stem Cells: A New Treatment for Sepsis and Septic Shock? Stem Cells 2017;35:2331-9. [PMID: 28856759 DOI: 10.1002/stem.2695] [Cited by in Crossref: 35] [Cited by in F6Publishing: 48] [Article Influence: 7.0] [Reference Citation Analysis]
402 Pourjafar M, Saidijam M, Mansouri K, Malih S, Ranjbar Nejad T, Shabab N, Najafi R. Cytoprotective effects of endothelin-1 on mesenchymal stem cells: an in vitro study. Clin Exp Pharmacol Physiol 2016;43:769-76. [PMID: 27161651 DOI: 10.1111/1440-1681.12590] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
403 Fajardo-Orduña GR, Mayani H, Castro-Manrreza ME, Flores-Figueroa E, Flores-Guzmán P, Arriaga-Pizano L, Piña-Sánchez P, Hernández-Estévez E, Castell-Rodríguez AE, Chávez-Rueda AK, Legorreta-Haquet MV, Santiago-Osorio E, Montesinos JJ. Bone Marrow Mesenchymal Stromal Cells from Clinical Scale Culture: In Vitro Evaluation of Their Differentiation, Hematopoietic Support, and Immunosuppressive Capacities. Stem Cells Dev 2016;25:1299-310. [PMID: 27462977 DOI: 10.1089/scd.2016.0071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
404 Konstantinow A, Arnold A, Djabali K, Kempf W, Gutermuth J, Fischer T, Biedermann T. Therapy of ulcus cruris of venous and mixed venous arterial origin with autologous, adult, native progenitor cells from subcutaneous adipose tissue: a prospective clinical pilot study. J Eur Acad Dermatol Venereol. 2017;31:2104-2118. [PMID: 28750144 DOI: 10.1111/jdv.14489] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
405 Aithal AP, Bairy LK, Seetharam RN. Safety Assessment of Human Bone Marrow-derived Mesenchymal Stromal Cells Transplantation in Wistar Rats. J Clin Diagn Res 2017;11:FF01-3. [PMID: 29207730 DOI: 10.7860/JCDR/2017/29515.10534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
406 Brini AT, Amodeo G, Ferreira LM, Milani A, Niada S, Moschetti G, Franchi S, Borsani E, Rodella LF, Panerai AE, Sacerdote P. Therapeutic effect of human adipose-derived stem cells and their secretome in experimental diabetic pain. Sci Rep. 2017;7:9904. [PMID: 28851944 DOI: 10.1038/s41598-017-09487-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]
407 Sussman ES, Steinberg GK. A Focused Review of Clinical and Preclinical Studies of Cell-Based Therapies in Stroke. Neurosurgery 2017;64:92-6. [PMID: 28899062 DOI: 10.1093/neuros/nyx329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
408 Kiernan J, Davies JE, Stanford WL. Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. Stem Cells Transl Med 2017;6:1930-9. [PMID: 28834263 DOI: 10.1002/sctm.17-0054] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
409 Laffey JG, Matthay MA. Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. Am J Respir Crit Care Med. 2017;196:266-273. [PMID: 28306336 DOI: 10.1164/rccm.201701-0107cp] [Cited by in Crossref: 101] [Cited by in F6Publishing: 130] [Article Influence: 20.2] [Reference Citation Analysis]
410 Wagenaar N, Nijboer CH, Bel F. Repair of neonatal brain injury: bringing stem cell‐based therapy into clinical practice. Dev Med Child Neurol 2017;59:997-1003. [DOI: 10.1111/dmcn.13528] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
411 Gazdic M, Simovic Markovic B, Jovicic N, Misirkic-Marjanovic M, Djonov V, Jakovljevic V, Arsenijevic N, Lukic ML, Volarevic V. Mesenchymal Stem Cells Promote Metastasis of Lung Cancer Cells by Downregulating Systemic Antitumor Immune Response. Stem Cells Int 2017;2017:6294717. [PMID: 28798777 DOI: 10.1155/2017/6294717] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
412 Zhu Y, Xu L, Collins JJ, Vadivel A, Cyr-depauw C, Zhong S, Mense L, Möbius MA, Thébaud B. Human Umbilical Cord Mesenchymal Stromal Cells Improve Survival and Bacterial Clearance in Neonatal Sepsis in Rats. Stem Cells and Development 2017;26:1054-64. [DOI: 10.1089/scd.2016.0329] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
413 Baygan A, Aronsson-Kurttila W, Moretti G, Tibert B, Dahllöf G, Klingspor L, Gustafsson B, Khoein B, Moll G, Hausmann C, Svahn BM, Westgren M, Remberger M, Sadeghi B, Ringden O. Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis. Front Immunol 2017;8:795. [PMID: 28744284 DOI: 10.3389/fimmu.2017.00795] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
414 Kang SH, Kim MY, Baik SK. Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon. Hepatol Int 2018;12:112-21. [DOI: 10.1007/s12072-017-9806-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
415 Tsuchiya A, Kojima Y, Ikarashi S, Seino S, Watanabe Y, Kawata Y, Terai S. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regen. 2017;37:16. [PMID: 29259715 DOI: 10.1186/s41232-017-0045-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 9.8] [Reference Citation Analysis]
416 Dunavin N, Dias A, Li M, McGuirk J. Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease? Biomedicines 2017;5:E39. [PMID: 28671556 DOI: 10.3390/biomedicines5030039] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
417 Jurado M, De La Mata C, Ruiz-García A, López-Fernández E, Espinosa O, Remigia MJ, Moratalla L, Goterris R, García-Martín P, Ruiz-Cabello F, Garzón S, Pascual MJ, Espigado I, Solano C. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study. Cytotherapy 2017;19:927-36. [PMID: 28662983 DOI: 10.1016/j.jcyt.2017.05.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
418 Arzi B, Clark KC, Sundaram A, Spriet M, Verstraete FJM, Walker NJ, Loscar MR, Fazel N, Murphy WJ, Vapniarsky N, Borjesson DL. Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis. Stem Cells Transl Med 2017;6:1710-22. [PMID: 28618186 DOI: 10.1002/sctm.17-0035] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
419 Chabot D, Tremblay T, Paré I, Bazin R, Loubaki L. Transient warming events occurring after freezing impairs umbilical cord-derived mesenchymal stromal cells functionality. Cytotherapy 2017;19:978-89. [PMID: 28606762 DOI: 10.1016/j.jcyt.2017.04.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
420 Wang Y, Liu J, Jiang Q, Deng J, Xu F, Chen X, Cheng F, Zhang Y, Yao Y, Xia Z, Xu X, Su X, Huang M, Dai L, Yang Y, Zhang S, Yu D, Zhao RC, Wei Y, Deng H. Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis: hADSCs Promote Angiogenesis in Breast Cancer. Stem Cells 2017;35:2060-70. [DOI: 10.1002/stem.2643] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 10.8] [Reference Citation Analysis]
421 Plock JA, Schnider JT, Schweizer R, Zhang W, Tsuji W, Waldner M, Solari MG, Marra KG, Rubin JP, Gorantla VS. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation. Transplantation 2017;101:e1-e11. [PMID: 27893612 DOI: 10.1097/TP.0000000000001498] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
422 Makhlough A, Shekarchian S, Moghadasali R, Einollahi B, Hosseini SE, Jaroughi N, Bolurieh T, Baharvand H, Aghdami N. Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Res Ther. 2017;8:116. [PMID: 28535817 DOI: 10.1186/s13287-017-0557-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
423 Lee KS, Santagostino SF, Li D, Ramjit A, Serrano K, Ginsberg MD, Ding BS, Rafii S, Madoff DC. Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis. Radiology 2017;285:114-23. [PMID: 28498793 DOI: 10.1148/radiol.2017162617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
424 Muraca M, Piccoli M, Franzin C, Tolomeo AM, Jurga M, Pozzobon M, Perilongo G. Diverging Concepts and Novel Perspectives in Regenerative Medicine. Int J Mol Sci 2017;18:E1021. [PMID: 28486410 DOI: 10.3390/ijms18051021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
425 Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev 2016;96:1127-68. [PMID: 27335447 DOI: 10.1152/physrev.00019.2015] [Cited by in Crossref: 161] [Cited by in F6Publishing: 170] [Article Influence: 32.2] [Reference Citation Analysis]
426 Oliveira RL, Chagastelles PC, Sesterheim P, Pranke P. In Vivo Immunogenic Response to Allogeneic Mesenchymal Stem Cells and the Role of Preactivated Mesenchymal Stem Cells Cotransplanted with Allogeneic Islets. Stem Cells Int 2017;2017:9824698. [PMID: 28553360 DOI: 10.1155/2017/9824698] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
427 Conklin LS, Hanley PJ, Galipeau J, Barrett J, Bollard CM. Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience. Cytotherapy 2017;19:655-67. [PMID: 28433516 DOI: 10.1016/j.jcyt.2017.03.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
428 Chinnadurai R, Rajan D, Ng S, McCullough K, Arafat D, Waller EK, Anderson LJ, Gibson G, Galipeau J. Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming. Blood Adv 2017;1:628-43. [PMID: 28713871 DOI: 10.1182/bloodadvances.2017006205] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
429 Matsushita K, Dzau VJ. Mesenchymal stem cells in obesity: insights for translational applications. Lab Invest 2017;97:1158-66. [PMID: 28414326 DOI: 10.1038/labinvest.2017.42] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
430 Redondo-Castro E, Cunningham C, Miller J, Martuscelli L, Aoulad-Ali S, Rothwell NJ, Kielty CM, Allan SM, Pinteaux E. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res Ther 2017;8:79. [PMID: 28412968 DOI: 10.1186/s13287-017-0531-4] [Cited by in Crossref: 90] [Cited by in F6Publishing: 116] [Article Influence: 18.0] [Reference Citation Analysis]
431 Cohen JA, Imrey PB, Planchon SM, Bermel RA, Fisher E, Fox RJ, Bar-Or A, Sharp SL, Skaramagas TT, Jagodnik P, Karafa M, Morrison S, Reese Koc J, Gerson SL, Lazarus HM. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. Mult Scler. 2018;24:501-511. [PMID: 28381130 DOI: 10.1177/1352458517703802] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
432 Tatara AM, Mikos AG. Tissue Engineering in Orthopaedics. J Bone Joint Surg Am. 2016;98:1132-1139. [PMID: 27385687 DOI: 10.2106/jbjs.16.00299] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
433 Ahn SY, Chang YS, Kim JH, Sung SI, Park WS. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. J Pediatr. 2017;185:49-54.e2. [PMID: 28341525 DOI: 10.1016/j.jpeds.2017.02.061] [Cited by in Crossref: 79] [Cited by in F6Publishing: 102] [Article Influence: 15.8] [Reference Citation Analysis]
434 Nakashima M, Iohara K, Murakami M, Nakamura H, Sato Y, Ariji Y, Matsushita K. Pulp regeneration by transplantation of dental pulp stem cells in pulpitis: a pilot clinical study. Stem Cell Res Ther 2017;8:61. [PMID: 28279187 DOI: 10.1186/s13287-017-0506-5] [Cited by in Crossref: 124] [Cited by in F6Publishing: 165] [Article Influence: 24.8] [Reference Citation Analysis]
435 Detry O, Vandermeulen M, Delbouille MH, Somja J, Bletard N, Briquet A, Lechanteur C, Giet O, Baudoux E, Hannon M. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. J Hepatol. 2017;67:47-55. [PMID: 28284916 DOI: 10.1016/j.jhep.2017.03.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 73] [Article Influence: 12.0] [Reference Citation Analysis]
436 Greenough A, Papalexopoulou N. The roles of drug therapy given via the endotracheal tube to neonates. Arch Dis Child Fetal Neonatal Ed 2017;102:F277-81. [PMID: 28270430 DOI: 10.1136/archdischild-2016-311711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
437 Li X, Tan J, Xiao Z, Zhao Y, Han S, Liu D, Yin W, Li J, Li J, Wanggou S, Chen B, Ren C, Jiang X, Dai J. Transplantation of hUC-MSCs seeded collagen scaffolds reduces scar formation and promotes functional recovery in canines with chronic spinal cord injury. Sci Rep 2017;7:43559. [PMID: 28262732 DOI: 10.1038/srep43559] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 7.4] [Reference Citation Analysis]
438 Pas HI, Winters M, Haisma HJ, Koenis MJ, Tol JL, Moen MH. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med 2017;51:1125-33. [DOI: 10.1136/bjsports-2016-096793] [Cited by in Crossref: 85] [Cited by in F6Publishing: 96] [Article Influence: 17.0] [Reference Citation Analysis]
439 Kardia E, Zakaria N, Sarmiza Abdul Halim NS, Widera D, Yahaya BH. The use of mesenchymal stromal cells in treatment of lung disorders. Regenerative Medicine 2017;12:203-16. [DOI: 10.2217/rme-2016-0112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
440 Okuda A, Horii-hayashi N, Sasagawa T, Shimizu T, Shigematsu H, Iwata E, Morimoto Y, Masuda K, Koizumi M, Akahane M, Nishi M, Tanaka Y. Bone marrow stromal cell sheets may promote axonal regeneration and functional recovery with suppression of glial scar formation after spinal cord transection injury in rats. SPI 2017;26:388-95. [DOI: 10.3171/2016.8.spine16250] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
441 Moen MH, Pas HI. Stem cell treatment? Please answer these simple questions first. Br J Sports Med 2017;51:1512-3. [PMID: 28189998 DOI: 10.1136/bjsports-2016-097212] [Reference Citation Analysis]
442 Cao Y, Ding Z, Han C, Shi H, Cui L, Lin R. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis. Dig Dis Sci 2017;62:851-60. [PMID: 28168575 DOI: 10.1007/s10620-017-4453-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
443 Chambers DC, Enever D, Lawrence S, Sturm MJ, Herrmann R, Yerkovich S, Musk M, Hopkins PM. Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study. Stem Cells Transl Med 2017;6:1152-7. [PMID: 28186707 DOI: 10.1002/sctm.16-0372] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
444 Hendijani F. Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues. Cell Prolif 2017;50. [PMID: 28144997 DOI: 10.1111/cpr.12334] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 10.6] [Reference Citation Analysis]
445 Stenger EO, Chinnadurai R, Yuan S, Garcia M, Arafat D, Gibson G, Krishnamurti L, Galipeau J. Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality. Biol Blood Marrow Transplant 2017;23:736-45. [PMID: 28132869 DOI: 10.1016/j.bbmt.2017.01.081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
446 Shin TH, Kim HS, Choi SW, Kang KS. Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action. Int J Mol Sci 2017;18:E244. [PMID: 28125063 DOI: 10.3390/ijms18020244] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
447 Pas HIMFL, Moen MH, Haisma HJ, Winters M. No evidence for the use of stem cell therapy for tendon disorders: a systematic review. Br J Sports Med 2017;51:996-1002. [PMID: 28077355 DOI: 10.1136/bjsports-2016-096794] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
448 Zhang C, Yang SJ, Wen Q, Zhong JF, Chen XL, Stucky A, Press MF, Zhang X. Human-derived normal mesenchymal stem/stromal cells in anticancer therapies. J Cancer. 2017;8:85-96. [PMID: 28123601 DOI: 10.7150/jca.16792] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
449 Unsworth DJ, Mathias JL, Dorstyn DS. Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy. Regenerative Medicine 2017;12:91-108. [DOI: 10.2217/rme-2016-0082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
450 Liao L, Shi B, Chang H, Su X, Zhang L, Bi C, Shuai Y, Du X, Deng Z, Jin Y. Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy. Theranostics 2017;7:106-16. [PMID: 28042320 DOI: 10.7150/thno.16911] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 14.4] [Reference Citation Analysis]
451 Cason C, Campisciano G, Zanotta N, Valencic E, Delbue S, Bella R, Comar M. SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators. J Cell Physiol 2017;232:3060-6. [PMID: 27925194 DOI: 10.1002/jcp.25723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
452 Mueller M, Kramer BW. Stem cells and Bronchopulmonary Dysplasia - The five questions: Which cells, when, in which dose, to which patients via which route? Paediatr Respir Rev 2017;24:54-9. [PMID: 28162941 DOI: 10.1016/j.prrv.2016.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
453 Volpe G, Bernstock JD, Peruzzotti-Jametti L, Pluchino S. Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis. J Neuroimmunol 2019;331:11-27. [PMID: 28034466 DOI: 10.1016/j.jneuroim.2016.12.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
454 Han D, Wu C, Xiong Q, Zhou L, Tian Y. Anti-inflammatory Mechanism of Bone Marrow Mesenchymal Stem Cell Transplantation in Rat Model of Spinal Cord Injury. Cell Biochem Biophys 2015;71:1341-7. [PMID: 25388837 DOI: 10.1007/s12013-014-0354-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
455 Girdlestone J. Mesenchymal stromal cells with enhanced therapeutic properties. Immunotherapy 2016;8:1405-16. [DOI: 10.2217/imt-2016-0098] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
456 Grégoire C, Lechanteur C, Briquet A, Baudoux É, Baron F, Louis E, Beguin Y. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Aliment Pharmacol Ther 2017;45:205-21. [PMID: 27878827 DOI: 10.1111/apt.13864] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
457 Hadden WJ, Choi YS. The extracellular microscape governs mesenchymal stem cell fate. J Biol Eng 2016;10:16. [PMID: 27895704 DOI: 10.1186/s13036-016-0037-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
458 Moussa L, Pattappa G, Doix B, Benselama SL, Demarquay C, Benderitter M, Sémont A, Tamarat R, Guicheux J, Weiss P, Réthoré G, Mathieu N. A biomaterial-assisted mesenchymal stromal cell therapy alleviates colonic radiation-induced damage. Biomaterials 2017;115:40-52. [PMID: 27886554 DOI: 10.1016/j.biomaterials.2016.11.017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
459 Bu S, Wang Q, Zhang Q, Sun J, He B, Xiang C, Liu Z, Lai D. Human endometrial mesenchymal stem cells exhibit intrinsic anti-tumor properties on human epithelial ovarian cancer cells. Sci Rep 2016;6:37019. [PMID: 27845405 DOI: 10.1038/srep37019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
460 Reis M, Ogonek J, Qesari M, Borges NM, Nicholson L, Preußner L, Dickinson AM, Wang XN, Weissinger EM, Richter A. Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications. Front Immunol 2016;7:500. [PMID: 27895644 DOI: 10.3389/fimmu.2016.00500] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
461 Braun RK, Koch JM, Hacker TA, Pegelow D, Kim J, Raval AN, Schmuck EG, Schwahn DJ, Hei DJ, Centanni JM, Eldridge M, Hematti P. Cardiopulmonary and histological characterization of an acute rat lung injury model demonstrating safety of mesenchymal stromal cell infusion. Cytotherapy 2016;18:536-45. [PMID: 26971682 DOI: 10.1016/j.jcyt.2016.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
462 Hawkey CJ, Hommes DW. Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases? Gastroenterology 2017;152:389-397.e2. [PMID: 27845055 DOI: 10.1053/j.gastro.2016.11.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
463 Dothel G, Raschi E, Rimondini R, De Ponti F. Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology. World J Gastroenterol 2016; 22(41): 9057-9068 [PMID: 27895395 DOI: 10.3748/wjg.v22.i41.9057] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
464 Van Pham P. Stem cell drugs: the next generation of pharmaceutical products. Biomed Res Ther 2016;3. [DOI: 10.7603/s40730-016-0047-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
465 Nakamura M, Samii A, Lang JM, Götz F, Samii M, Krauss JK. De Novo Arteriovenous Malformation Growth Secondary to Implantation of Genetically Modified Allogeneic Mesenchymal Stem Cells in the Brain. Neurosurgery 2016;78:E596-600. [PMID: 26382859 DOI: 10.1227/NEU.0000000000001025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
466 Riazifar M, Pone EJ, Lötvall J, Zhao W. Stem Cell Extracellular Vesicles: Extended Messages of Regeneration. Annu Rev Pharmacol Toxicol 2017;57:125-54. [PMID: 27814025 DOI: 10.1146/annurev-pharmtox-061616-030146] [Cited by in Crossref: 133] [Cited by in F6Publishing: 158] [Article Influence: 22.2] [Reference Citation Analysis]
467 Dessels C, Potgieter M, Pepper MS. Making the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell Expansion. Front Cell Dev Biol 2016;4:115. [PMID: 27800478 DOI: 10.3389/fcell.2016.00115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
468 Mitani Y, Vagnozzi RJ, Millay DP. In vivo myomaker-mediated heterologous fusion and nuclear reprogramming. FASEB J 2017;31:400-11. [PMID: 27825107 DOI: 10.1096/fj.201600945R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
469 Heyes R, Iarocci A, Tchoukalova Y, Lott DG. Immunomodulatory Role of Mesenchymal Stem Cell Therapy in Vascularized Composite Allotransplantation. J Transplant 2016;2016:6951693. [PMID: 27822384 DOI: 10.1155/2016/6951693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
470 van Rhijn-Brouwer FC, Gremmels H, Fledderus JO, Radstake TR, Verhaar MC, van Laar JM. Cellular Therapies in Systemic Sclerosis: Recent Progress. Curr Rheumatol Rep 2016;18:12. [PMID: 26943351 DOI: 10.1007/s11926-015-0555-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
471 Doster DL, Jensen AR, Khaneki S, Markel TA. Mesenchymal stromal cell therapy for the treatment of intestinal ischemia: Defining the optimal cell isolate for maximum therapeutic benefit. Cytotherapy 2016;18:1457-70. [PMID: 27745788 DOI: 10.1016/j.jcyt.2016.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
472 Gupta PK, Krishna M, Chullikana A, Desai S, Murugesan R, Dutta S, Sarkar U, Raju R, Dhar A, Parakh R, Jeyaseelan L, Viswanathan P, Vellotare PK, Seetharam RN, Thej C, Rengasamy M, Balasubramanian S, Majumdar AS. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy. Stem Cells Transl Med 2017;6:689-99. [PMID: 28297569 DOI: 10.5966/sctm.2016-0237] [Cited by in Crossref: 31] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
473 Jolkkonen J, Mendez-Otero R, de Freitas GR, Boltze J, Rosado-de-Castro PH. The Current State of Cell Therapies for Cerebrovascular Diseases. Stem Cells Int 2016;2016:5215824. [PMID: 27672396 DOI: 10.1155/2016/5215824] [Reference Citation Analysis]
474 Kallekleiv M, Larun L, Bruserud Ø, Hatfield KJ. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis. Cytotherapy 2016;18:172-85. [PMID: 26794711 DOI: 10.1016/j.jcyt.2015.11.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
475 Urrutia M, Fernández S, González M, Vilches R, Rojas P, Vásquez M, Kurte M, Vega-Letter AM, Carrión F, Figueroa F, Rojas P, Irarrázabal C, Fuentealba RA. Overexpression of Glutamate Decarboxylase in Mesenchymal Stem Cells Enhances Their Immunosuppressive Properties and Increases GABA and Nitric Oxide Levels. PLoS One 2016;11:e0163735. [PMID: 27662193 DOI: 10.1371/journal.pone.0163735] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
476 Pierro M, Ciarmoli E, Thébaud B. Bronchopulmonary Dysplasia and Chronic Lung Disease: Stem Cell Therapy. Clin Perinatol 2015;42:889-910. [PMID: 26593085 DOI: 10.1016/j.clp.2015.08.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
477 Mangialardi G, Madeddu P. Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications. Curr Diab Rep 2016;16:43. [PMID: 27025211 DOI: 10.1007/s11892-016-0730-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
478 Marcucio RS, Nauth A, Giannoudis PV, Bahney C, Piuzzi NS, Muschler G, Miclau T 3rd. Stem Cell Therapies in Orthopaedic Trauma. J Orthop Trauma 2015;29 Suppl 12:S24-7. [PMID: 26584262 DOI: 10.1097/BOT.0000000000000459] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
479 Unsworth DJ, Mathias JL, Dorstyn DS. Safety and efficacy of cell therapies administered in the acute and subacute stages after stroke: a meta-analysis. Regen Med 2016;11:725-41. [PMID: 27580670 DOI: 10.2217/rme-2016-0063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
480 Fazeli Z, Omrani MD, Ghaderian SMH. CD29/CD184 expression analysis provides a signature for identification of neuronal like cells differentiated from PBMSCs. Neuroscience Letters 2016;630:189-93. [DOI: 10.1016/j.neulet.2016.07.056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
481 Herzig MC, Cap AP. Challenges in translating mesenchymal stem cell therapies for trauma and critical care. Transfusion 2016;56:20S-5S. [PMID: 27079318 DOI: 10.1111/trf.13566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
482 Owens SD, Kol A, Walker NJ, Borjesson DL. Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses. Stem Cells Int 2016;2016:5830103. [PMID: 27648075 DOI: 10.1155/2016/5830103] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
483 Shanbhag S, Pandis N, Mustafa K, Nyengaard JR, Stavropoulos A. Alveolar bone tissue engineering in critical-size defects of experimental animal models: a systematic review and meta-analysis. J Tissue Eng Regen Med 2017;11:2935-49. [PMID: 27524517 DOI: 10.1002/term.2198] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
484 Chao K, Zhang S, Qiu Y, Chen X, Zhang X, Cai C, Peng Y, Mao R, Pevsner-Fischer M, Ben-Horin S, Elinav E, Zeng Z, Chen B, He Y, Xiang AP, Chen M. Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5(+) B regulatory cells. Stem Cell Res Ther 2016;7:109. [PMID: 27515534 DOI: 10.1186/s13287-016-0376-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
485 Melo FR, Bressan RB, Forner S, Martini AC, Rode M, Delben PB, Rae GA, Figueiredo CP, Trentin AG. Transplantation of Human Skin-Derived Mesenchymal Stromal Cells Improves Locomotor Recovery After Spinal Cord Injury in Rats. Cell Mol Neurobiol 2017;37:941-7. [PMID: 27510317 DOI: 10.1007/s10571-016-0414-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
486 Uhrynowska-Tyszkiewicz IA, Olender E, Kaminski A. A Cell Graft or a Drug? Legal and Practical Aspects of Somatic Cells Application in Graft-Versus-Host Disease Experimental Treatment: The Polish Experience. Transplant Proc 2016;48:1402-6. [PMID: 27496415 DOI: 10.1016/j.transproceed.2016.03.027] [Reference Citation Analysis]
487 Álvarez V, Sánchez-Margallo FM, Blázquez R, Tarazona R, Casado JG. Comparison of mesenchymal stem cells and leukocytes from Large White and Göttingen Minipigs: Clues for stem cell-based immunomodulatory therapies. Vet Immunol Immunopathol 2016;179:63-9. [PMID: 27590427 DOI: 10.1016/j.vetimm.2016.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
488 Nejad-moghaddam A, Ajdary S, Tahmasbpour E, Rad FR, Panahi Y, Ghanei M. Immunomodulatory Properties of Mesenchymal Stem Cells Can Mitigate Oxidative Stress and Inflammation Process in Human Mustard Lung. Biochem Genet 2016;54:769-83. [DOI: 10.1007/s10528-016-9755-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
489 Ciccocioppo R, Corazza GR. Mesenchymal stem cells for fistulising Crohn's disease. Lancet 2016;388:1251-2. [PMID: 27477895 DOI: 10.1016/S0140-6736(16)31209-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
490 Lazarus HM, Pavletic SZ. Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for Reducing Chronic Graft-Versus-Host Disease After Haploidentical Transplantation: Just Another Labor-Intensive Strategy, or Showing the Way? J Clin Oncol 2016;34:2812-3. [PMID: 27400943 DOI: 10.1200/JCO.2016.67.7344] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
491 Chinnadurai R, Copland IB, Garcia MA, Petersen CT, Lewis CN, Waller EK, Kirk AD, Galipeau J. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing. Stem Cells 2016;34:2429-42. [PMID: 27299362 DOI: 10.1002/stem.2415] [Cited by in Crossref: 77] [Cited by in F6Publishing: 93] [Article Influence: 12.8] [Reference Citation Analysis]
492 Martínez-garza D, Cantú-rodríguez O, Jaime-pérez J, Gutiérrez-aguirre C, Góngora-rivera J, Gómez-almaguer D. Current state and perspectives of stem cell therapy for stroke. Medicina Universitaria 2016;18:169-80. [DOI: 10.1016/j.rmu.2016.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
493 Li C, Qian Y, Zhao S, Yin Y, Li J. Alginate/PEG based microcarriers with cleavable crosslinkage for expansion and non-invasive harvest of human umbilical cord blood mesenchymal stem cells. Materials Science and Engineering: C 2016;64:43-53. [DOI: 10.1016/j.msec.2016.03.089] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
494 Clé DV, Santana-Lemos B, Tellechea MF, Prata KL, Orellana MD, Covas DT, Calado RT. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia. Cytotherapy 2015;17:1696-705. [PMID: 26589752 DOI: 10.1016/j.jcyt.2015.09.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
495 Kim H, Lee JH, Roh K, Jun HJ, Kang K, Kim T. Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies: Safety and Efficacy of hUCB-MSCs in AD. Stem Cells 2017;35:248-55. [DOI: 10.1002/stem.2401] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 8.5] [Reference Citation Analysis]
496 Möbius MA, Thébaud B. Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils. Paediatr Respir Rev 2016;20:33-41. [PMID: 27425012 DOI: 10.1016/j.prrv.2016.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
497 Ezquer FE, Ezquer ME, Vicencio JM, Calligaris SD. Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity. Cell Adh Migr. 2017;11:110-119. [PMID: 27294313 DOI: 10.1080/19336918.2016.1197480] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
498 Wang D, Niu L, Feng X, Yuan X, Zhao S, Zhang H, Liang J, Zhao C, Wang H, Hua B, Sun L. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study.Clin Exp Med. 2017;17:333-340. [PMID: 27270729 DOI: 10.1007/s10238-016-0427-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
499 Álvaro-Gracia JM, Jover JA, García-Vicuña R, Carreño L, Alonso A, Marsal S, Blanco F, Martínez-Taboada VM, Taylor P, Martín-Martín C, DelaRosa O, Tagarro I, Díaz-González F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis 2017;76:196-202. [PMID: 27269294 DOI: 10.1136/annrheumdis-2015-208918] [Cited by in Crossref: 106] [Cited by in F6Publishing: 125] [Article Influence: 17.7] [Reference Citation Analysis]
500 Kingsley SM, Bhat BV. Could stem cells be the future therapy for sepsis? Blood Rev 2016;30:439-52. [PMID: 27297212 DOI: 10.1016/j.blre.2016.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
501 Freitag J, Bates D, Boyd R, Shah K, Barnard A, Huguenin L, Tenen A. Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy - a review. BMC Musculoskelet Disord. 2016;17:230. [PMID: 27229856 DOI: 10.1186/s12891-016-1085-9] [Cited by in Crossref: 137] [Cited by in F6Publishing: 147] [Article Influence: 22.8] [Reference Citation Analysis]
502 Gramlich OW, Burand AJ, Brown AJ, Deutsch RJ, Kuehn MH, Ankrum JA. Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy. Sci Rep 2016;6:26463. [PMID: 27212469 DOI: 10.1038/srep26463] [Cited by in Crossref: 36] [Cited by in F6Publishing: 48] [Article Influence: 6.0] [Reference Citation Analysis]
503 Maria ATJ, Maumus M, Le Quellec A, Jorgensen C, Noël D, Guilpain P. Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. Clinic Rev Allerg Immunol 2017;52:234-59. [DOI: 10.1007/s12016-016-8552-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 8.7] [Reference Citation Analysis]
504 Möbius MA, Rüdiger M. Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia. Mol Cell Pediatr 2016;3:18. [PMID: 27142639 DOI: 10.1186/s40348-016-0046-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
505 Sweeney NP, Regan C, Liu J, Galleu A, Dazzi F, Lindemann D, Rupar CA, McClure MO. Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector. Mol Ther 2016;24:1227-36. [PMID: 27133965 DOI: 10.1038/mt.2016.91] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
506 Ferroni L, Tocco I, De Pieri A, Menarin M, Fermi E, Piattelli A, Gardin C, Zavan B. Pulsed magnetic therapy increases osteogenic differentiation of mesenchymal stem cells only if they are pre-committed. Life Sciences 2016;152:44-51. [DOI: 10.1016/j.lfs.2016.03.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
507 Marycz K, Śmieszek A, Jeleń M, Chrząstek K, Grzesiak J, Meissner J. The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells--new opportunities in regenerative medicine. Cell Mol Biol Lett 2015;20:510-33. [PMID: 26110483 DOI: 10.1515/cmble-2015-0029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
508 Rizk M, Monaghan M, Shorr R, Kekre N, Bredeson CN, Allan DS. Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence. Biol Blood Marrow Transplant 2016;22:1416-23. [PMID: 27130504 DOI: 10.1016/j.bbmt.2016.04.010] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 8.2] [Reference Citation Analysis]
509 Hoogduijn MJ, de Witte SF, Luk F, van den Hout-van Vroonhoven MC, Ignatowicz L, Catar R, Strini T, Korevaar SS, van Ijcken WF, Betjes MG, Franquesa M, Moll G, Baan CC. Effects of Freeze–Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression. Stem Cells and Development 2016;25:586-97. [DOI: 10.1089/scd.2015.0329] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
510 Abreu SC, Weiss DJ, Rocco PR. Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases? Stem Cell Res Ther. 2016;7:53. [PMID: 27075363 DOI: 10.1186/s13287-016-0317-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 72] [Article Influence: 8.8] [Reference Citation Analysis]
511 El-sakka AI. What is the current role of intracavernosal injection in management of erectile dysfunction? Int J Impot Res 2016;28:88-95. [DOI: 10.1038/ijir.2016.14] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
512 Monsarrat P, Vergnes JN, Planat-Bénard V, Ravaud P, Kémoun P, Sensebé L, Casteilla L. An Innovative, Comprehensive Mapping and Multiscale Analysis of Registered Trials for Stem Cell-Based Regenerative Medicine. Stem Cells Transl Med 2016;5:826-35. [PMID: 27075765 DOI: 10.5966/sctm.2015-0329] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
513 Doulames VM, Plant GW. Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Int J Mol Sci 2016;17:530. [PMID: 27070598 DOI: 10.3390/ijms17040530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
514 Otero-Viñas M, Falanga V. Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy. Adv Wound Care (New Rochelle) 2016;5:149-63. [PMID: 27076993 DOI: 10.1089/wound.2015.0627] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 13.7] [Reference Citation Analysis]
515 Savukinas UB, Enes SR, Sjöland AA, Westergren-Thorsson G. Concise Review: The Bystander Effect: Mesenchymal Stem Cell-Mediated Lung Repair. Stem Cells 2016;34:1437-44. [PMID: 26991735 DOI: 10.1002/stem.2357] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
516 Ringdén O. Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome. Lancet Respir Med 2015;3:e12. [PMID: 25890656 DOI: 10.1016/S2213-2600(15)00047-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
517 Osborne H, Anderson L, Burt P, Young M, Gerrard D. Australasian College of Sports Physicians—Position Statement: The Place of Mesenchymal Stem/Stromal Cell Therapies in Sport and Exercise Medicine. Clinical Journal of Sport Medicine 2016;26:87-95. [DOI: 10.1097/jsm.0000000000000298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
518 Vijayavenkataraman S, Lu W, Fuh J. 3D bioprinting – An Ethical, Legal and Social Aspects (ELSA) framework. Bioprinting 2016;1-2:11-21. [DOI: 10.1016/j.bprint.2016.08.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
519 Shroff G. Human Embryonic Stem Cell Therapy in Crohn's Disease: A Case Report. Am J Case Rep 2016;17:124-8. [PMID: 26923312 DOI: 10.12659/ajcr.896512] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
520 Chen FM, Gao LN, Tian BM, Zhang XY, Zhang YJ, Dong GY, Lu H, Chu Q, Xu J, Yu Y, Wu RX, Yin Y, Shi S, Jin Y. Treatment of periodontal intrabony defects using autologous periodontal ligament stem cells: a randomized clinical trial. Stem Cell Res Ther. 2016;7:33. [PMID: 26895633 DOI: 10.1186/s13287-016-0288-1] [Cited by in Crossref: 123] [Cited by in F6Publishing: 144] [Article Influence: 20.5] [Reference Citation Analysis]
521 Parida SK, Madansein R, Singh N, Padayatchi N, Master I, Naidu K, Zumla A, Maeurer M. Cellular therapy in tuberculosis. Int J Infect Dis 2015;32:32-8. [PMID: 25809753 DOI: 10.1016/j.ijid.2015.01.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
522 Blázquez R, Sánchez-Margallo FM, Crisóstomo V, Báez C, Maestre J, Álvarez V, Casado JG. Intrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal Model. PLoS One 2016;11:e0149001. [PMID: 26866919 DOI: 10.1371/journal.pone.0149001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
523 Chen C, Hou J. Mesenchymal stem cell-based therapy in kidney transplantation. Stem Cell Res Ther 2016;7:16. [PMID: 26852923 DOI: 10.1186/s13287-016-0283-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
524 Escobar CH, Chaparro O. Xeno-Free Extraction, Culture, and Cryopreservation of Human Adipose-Derived Mesenchymal Stem Cells. Stem Cells Transl Med 2016;5:358-65. [PMID: 26838269 DOI: 10.5966/sctm.2015-0094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
525 Dulamea AO, Sirbu-Boeti MP, Bleotu C, Dragu D, Moldovan L, Lupescu I, Comi G. Autologous mesenchymal stem cells applied on the pressure ulcers had produced a surprising outcome in a severe case of neuromyelitis optica. Neural Regen Res 2015;10:1841-5. [PMID: 26807122 DOI: 10.4103/1673-5374.165325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
526 Mitsialis SA, Kourembanas S. Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol 2016;40:138-51. [PMID: 26778234 DOI: 10.1053/j.semperi.2015.12.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
527 de Witte SF, Franquesa M, Baan CC, Hoogduijn MJ. Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy. Front Immunol. 2015;6:648. [PMID: 26779185 DOI: 10.3389/fimmu.2015.00648] [Cited by in Crossref: 27] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
528 Wan Safwani WK, Wong CW, Yong KW, Choi JR, Mat Adenan NA, Omar SZ, Wan Abas WA, Pingguan-Murphy B. The effects of hypoxia and serum-free conditions on the stemness properties of human adipose-derived stem cells. Cytotechnology 2016;68:1859-72. [PMID: 26728363 DOI: 10.1007/s10616-015-9939-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
529 Wang F, Eid S, Dennis JE, Cooke KR, Auletta JJ, Lee Z. Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation. J Stem Cells Regen Med 2015;11:34-43. [PMID: 27330253 [PMID: 27330253 DOI: 10.46582/jsrm.1102007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
530 Yi HG, Yahng SA, Kim I, Lee JH, Min CK, Kim JH, Kim CS, Song SU. Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study. Korean J Physiol Pharmacol 2016;20:63-7. [PMID: 26807024 DOI: 10.4196/kjpp.2016.20.1.63] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
531 Osborne H, Anderson L, Burt P, Young M, Gerrard D. Australasian College of Sports Physicians—position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med 2016;50:1237-44. [DOI: 10.1136/bjsports-2015-095711] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
532 Freitag J, Ford J, Bates D, Boyd R, Hahne A, Wang Y, Cicuttini F, Huguenin L, Norsworthy C, Shah K. Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal stem cell injections. BMJ Open 2015;5:e009332. [PMID: 26685030 DOI: 10.1136/bmjopen-2015-009332] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
533 Stenger EO, Krishnamurti L, Galipeau J. Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation. BMC Immunol 2015;16:74. [PMID: 26674007 DOI: 10.1186/s12865-015-0135-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
534 Han C, Sun X, Liu L, Jiang H, Shen Y, Xu X, Li J, Zhang G, Huang J, Lin Z, Xiong N, Wang T. Exosomes and Their Therapeutic Potentials of Stem Cells. Stem Cells Int. 2016;2016:7653489. [PMID: 26770213 DOI: 10.1155/2016/7653489] [Cited by in Crossref: 72] [Cited by in F6Publishing: 93] [Article Influence: 10.3] [Reference Citation Analysis]
535 Akyurekli C, Le Y, Richardson RB, Fergusson D, Tay J, Allan DS. A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles. Stem Cell Rev Rep. 2015;11:150-160. [PMID: 25091427 DOI: 10.1007/s12015-014-9545-9] [Cited by in Crossref: 174] [Cited by in F6Publishing: 183] [Article Influence: 24.9] [Reference Citation Analysis]
536 Almubarak S, Nethercott H, Freeberg M, Beaudon C, Jha A, Jackson W, Marcucio R, Miclau T, Healy K, Bahney C. Tissue engineering strategies for promoting vascularized bone regeneration. Bone. 2016;83:197-209. [PMID: 26608518 DOI: 10.1016/j.bone.2015.11.011] [Cited by in Crossref: 99] [Cited by in F6Publishing: 111] [Article Influence: 14.1] [Reference Citation Analysis]
537 Humphreys BD, Cantaluppi V, Portilla D, Singbartl K, Yang L, Rosner MH, Kellum JA, Ronco C; Acute Dialysis Quality Initiative (ADQI) XIII Work Group. Targeting Endogenous Repair Pathways after AKI. J Am Soc Nephrol 2016;27:990-8. [PMID: 26582401 DOI: 10.1681/ASN.2015030286] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
538 Yi T, Kim SN, Lee HJ, Kim J, Cho YK, Shin DH, Tak SJ, Moon SH, Kang JE, Ji IM, Lim HJ, Lee DS, Jeon MS, Song SU. Manufacture of Clinical-Grade Human Clonal Mesenchymal Stem Cell Products from Single Colony Forming Unit-Derived Colonies Based on the Subfractionation Culturing Method. Tissue Eng Part C Methods 2015;21:1251-62. [PMID: 26421757 DOI: 10.1089/ten.TEC.2015.0017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
539 Adibi A, Sen A, Mitha AP. Cell Therapy for Intracranial Aneurysms: A Review. World Neurosurg 2016;86:390-8. [PMID: 26547001 DOI: 10.1016/j.wneu.2015.10.082] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
540 Feisst V, Meidinger S, Locke MB. From bench to bedside: use of human adipose-derived stem cells. Stem Cells Cloning. 2015;8:149-162. [PMID: 26586955 DOI: 10.2147/sccaa.s64373] [Cited by in Crossref: 16] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
541 Srour N, Thébaud B. Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review. Stem Cells Transl Med 2015;4:1500-10. [PMID: 26494779 DOI: 10.5966/sctm.2015-0121] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 9.6] [Reference Citation Analysis]
542 Paschos NK. Recent advances and future directions in the management of knee osteoarthritis: Can biological joint reconstruction replace joint arthroplasty and when? World J Orthop 2015; 6(9): 655-659 [PMID: 26495242 DOI: 10.5312/wjo.v6.i9.655] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
543 Gennai S, Monsel A, Hao Q, Liu J, Gudapati V, Barbier EL, Lee JW. Cell-based therapy for traumatic brain injury. Br J Anaesth 2015;115:203-12. [PMID: 26170348 DOI: 10.1093/bja/aev229] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
544 Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplant. 2016;25:829-848. [PMID: 26423725 DOI: 10.3727/096368915x689622] [Cited by in Crossref: 694] [Cited by in F6Publishing: 756] [Article Influence: 99.1] [Reference Citation Analysis]
545 Auletta JJ, Eid SK, Wuttisarnwattana P, Silva I, Metheny L, Keller MD, Guardia-Wolff R, Liu C, Wang F, Bowen T, Lee Z, Solchaga LA, Ganguly S, Tyler M, Wilson DL, Cooke KR. Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantation. Stem Cells 2015;33:601-14. [PMID: 25336340 DOI: 10.1002/stem.1867] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
546 Narita T, Suzuki K. Bone marrow-derived mesenchymal stem cells for the treatment of heart failure. Heart Fail Rev. 2015;20:53-68. [PMID: 24862087 DOI: 10.1007/s10741-014-9435-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
547 Castrén E, Sillat T, Oja S, Noro A, Laitinen A, Konttinen YT, Lehenkari P, Hukkanen M, Korhonen M. Osteogenic differentiation of mesenchymal stromal cells in two-dimensional and three-dimensional cultures without animal serum. Stem Cell Res Ther 2015;6:167. [PMID: 26345992 DOI: 10.1186/s13287-015-0162-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
548 Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, Wiklander OP, Nordin JZ, Skog J, Romain C, Koestler T, Hellgren-Johansson L, Schiller P, Joachimsson PO, Hägglund H, Mattsson M, Lehtiö J, Faridani OR, Sandberg R, Korsgren O, Krampera M, Weiss DJ, Grinnemo KH, Le Blanc K. In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome. Stem Cells Transl Med 2015;4:1199-213. [PMID: 26285659 DOI: 10.5966/sctm.2015-0021] [Cited by in Crossref: 75] [Cited by in F6Publishing: 92] [Article Influence: 10.7] [Reference Citation Analysis]
549 Han KH, Kim AK, Kim MH, Kim DH, Go HN, Kim DI. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia. Cell Biol Int 2016;40:27-35. [PMID: 26222206 DOI: 10.1002/cbin.10519] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
550 Martínez-Montiel MP, Casis-Herce B, Gómez-Gómez GJ, Masedo-González A, Yela-San Bernardino C, Piedracoba C, Castellano-Tortajada G. Pharmacologic therapy for inflammatory bowel disease refractory to steroids. Clin Exp Gastroenterol 2015;8:257-69. [PMID: 26316792 DOI: 10.2147/CEG.S58152] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
551 Lee SY, Kim W, Lim C, Chung SG. Treatment of Lateral Epicondylosis by Using Allogeneic Adipose-Derived Mesenchymal Stem Cells: A Pilot Study. Stem Cells. 2015;33:2995-3005. [PMID: 26202898 DOI: 10.1002/stem.2110] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
552 Chung E. Stem-cell-based therapy in the field of urology: a review of stem cell basic science, clinical applications and future directions in the treatment of various sexual and urinary conditions. Expert Opinion on Biological Therapy 2015;15:1623-32. [DOI: 10.1517/14712598.2015.1075504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
553 Levy M, Boulis N, Rao M, Svendsen CN. Regenerative cellular therapies for neurologic diseases. Brain Res 2016;1638:88-96. [PMID: 26239912 DOI: 10.1016/j.brainres.2015.06.053] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
554 Möbius MA, Thébaud B. Stem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary Dysplasia. Front Med (Lausanne) 2015;2:50. [PMID: 26284246 DOI: 10.3389/fmed.2015.00050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
555 Hua P, Liu JY, Tao J, Yang SR. Application and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic Cardiomyopathy. Biomed Res Int 2015;2015:568502. [PMID: 26295041 DOI: 10.1155/2015/568502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
556 Kim HJ, Seo SW, Chang JW, Lee JI, Kim CH, Chin J, Choi SJ, Kwon H, Yun HJ, Lee JM, Kim ST, Choe YS, Lee KH, Na DL. Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial. Alzheimers Dement (N Y). 2015;1:95-102. [PMID: 29854930 DOI: 10.1016/j.trci.2015.06.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
557 Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JA. Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects. Cryobiology. 2015;71:181-197. [PMID: 26186998 DOI: 10.1016/j.cryobiol.2015.07.003] [Cited by in Crossref: 180] [Cited by in F6Publishing: 181] [Article Influence: 25.7] [Reference Citation Analysis]
558 Algeri M, Conforti A, Pitisci A, Starc N, Tomao L, Bernardo ME, Locatelli F. Mesenchymal stromal cells and chronic inflammatory bowel disease. Immunol Lett. 2015; Jul 10. [Epub ahead of print]. [PMID: 26170204 DOI: 10.1016/j.imlet.2015.06.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
559 Szabó E, Fajka-Boja R, Kriston-Pál É, Hornung Á, Makra I, Kudlik G, Uher F, Katona RL, Monostori É, Czibula Á. Licensing by Inflammatory Cytokines Abolishes Heterogeneity of Immunosuppressive Function of Mesenchymal Stem Cell Population. Stem Cells Dev. 2015;24:2171-2180. [PMID: 26153898 DOI: 10.1089/scd.2014.0581] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
560 Batorov EV, Shevela EY, Tikhonova MA, Batorova DS, Ushakova GY, Sizikova SA, Sergeevicheva VV, Gilevich AV, Kryuchkova IV, Ostanin AA, Chernykh ER. Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas. Cell Immunol 2015;297:80-6. [PMID: 26227214 DOI: 10.1016/j.cellimm.2015.07.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
561 Moore PJ. Stem cells as a novel therapy for amyotrophic lateral sclerosis. Br J Biomed Sci 2015;72:74-5. [PMID: 26126323 DOI: 10.1080/09674845.2015.11666800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
562 Van Thi Do H, Loke WT, Kee I, Liang V, David SJ, Gan SU, Lee SS, Ng WH, Koong HN, Ong HS, Lee KO, Calne RY, Kon OL. Characterization of Insulin-Secreting Porcine Bone Marrow Stromal Cells Ex Vivo and Autologous Cell Therapy in Vivo. Cell Transplant 2015;24:1205-20. [DOI: 10.3727/096368914x679363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
563 Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, van der Woude CJ, Duijvestein M, Veenendaal RA, Zwaginga JJ, Verspaget HW, Fibbe WE, van der Meulen-de Jong AE, Hommes DW. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology. 2015;149:918-27.e6. [PMID: 26116801 DOI: 10.1053/j.gastro.2015.06.014] [Cited by in Crossref: 150] [Cited by in F6Publishing: 168] [Article Influence: 21.4] [Reference Citation Analysis]
564 Ezquer F, Gutiérrez J, Ezquer M, Caglevic C, Salgado HC, Calligaris SD. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears. Stem Cell Res Ther 2015;6:116. [PMID: 26104315 DOI: 10.1186/s13287-015-0109-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
565 Qayyum AA, Mathiasen AB, Kastrup J. Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications. Curr Diab Rep 2014;14:554. [PMID: 25344789 DOI: 10.1007/s11892-014-0554-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
566 Musialek P, Mazurek A, Jarocha D, Tekieli L, Szot W, Kostkiewicz M, Banys RP, Urbanczyk M, Kadzielski A, Trystula M, Kijowski J, Zmudka K, Podolec P, Majka M. Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. Postepy Kardiol Interwencyjnej 2015;11:100-7. [PMID: 26161101 DOI: 10.5114/pwki.2015.52282] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
567 Li T, Xia M, Gao Y, Chen Y, Xu Y. Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther. 2015;15:1293-1306. [PMID: 26067213 DOI: 10.1517/14712598.2015.1051528] [Cited by in Crossref: 65] [Cited by in F6Publishing: 85] [Article Influence: 9.3] [Reference Citation Analysis]
568 Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116:1413-1430. [PMID: 25858066 DOI: 10.1161/circresaha.116.303614] [Cited by in Crossref: 256] [Cited by in F6Publishing: 265] [Article Influence: 36.6] [Reference Citation Analysis]
569 Stabler CT, Lecht S, Lazarovici P, Lelkes PI. Mesenchymal stem cells for therapeutic applications in pulmonary medicine. Br Med Bull 2015;115:45-56. [PMID: 26063231 DOI: 10.1093/bmb/ldv026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
570 Lynch PJ, Thompson EE, Mcginnis K, Rovira Gonzalez YI, Lo Surdo J, Bauer SR, Hursh DA. Chromatin Changes at the PPAR-γ2 Promoter During Bone Marrow-Derived Multipotent Stromal Cell Culture Correlate With Loss of Gene Activation Potential: Chromatin Dynamics of BM-MSCs. Stem Cells 2015;33:2169-81. [DOI: 10.1002/stem.1967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
571 Morrison T, McAuley DF, Krasnodembskaya A. Mesenchymal stromal cells for treatment of the acute respiratory distress syndrome: The beginning of the story. J Intensive Care Soc 2015;16:320-9. [PMID: 28979439 DOI: 10.1177/1751143715586420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
572 Introna M, Rambaldi A. Mesenchymal stromal cells for prevention and treatment of graft-versus-host disease: successes and hurdles. Curr Opin Organ Transplant 2015;20:72-8. [PMID: 25563994 DOI: 10.1097/MOT.0000000000000158] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
573 Li D, Zhang M, Zhang Q, Wang Y, Song X, Zhang Q. Functional recovery after acute intravenous administration of human umbilical cord mesenchymal stem cells in rats with cerebral ischemia-reperfusion injury. Intractable Rare Dis Res 2015;4:98-104. [PMID: 25984429 DOI: 10.5582/irdr.2015.01010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
574 Agadi S, Shetty AK. Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy. Stem Cells. 2015;33:2093-2103. [PMID: 25851047 DOI: 10.1002/stem.2029] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
575 Knyazev OV, Parfenov AI, Konoplyannikov AG, Ruchkina IN, Churikova AA, Bykova SV, Albulova EA, Boldyreva ON, Fadeeva NA, Lishchinskaya AA. [Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: results of a 5-year follow-up]. Ter Arkh 2015;87:39-44. [PMID: 25864347 DOI: 10.17116/terarkh201587239-44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
576 Vertès AA. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies. Regenerative Medicine 2015;10:345-73. [DOI: 10.2217/rme.15.13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
577 Bolton EM, Bradley JA. Avoiding immunological rejection in regenerative medicine. Regenerative Medicine 2015;10:287-304. [DOI: 10.2217/rme.15.11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
578 Shabbir A, Badiavas EV. Toward an ‘off the shelf’ technology for burn victims: healing wounds with mesenchymal stem cells. Regenerative Medicine 2015;10:381-4. [DOI: 10.2217/rme.15.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
579 Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner D, McKenna DH, Rocco PR, Weiss DJ. Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice. Stem Cells Transl Med. 2015;4:615-624. [PMID: 25925837 DOI: 10.5966/sctm.2014-0268] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 7.1] [Reference Citation Analysis]
580 Barczyk M, Schmidt M, Mattoli S. Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis. Stem Cell Rev and Rep 2015;11:598-620. [DOI: 10.1007/s12015-015-9587-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
581 Blázquez R, Sánchez-Margallo FM, Crisóstomo V, Báez C, Maestre J, García-Lindo M, Usón A, Álvarez V, Casado JG. Intrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysis. PLoS One 2015;10:e0122377. [PMID: 25816232 DOI: 10.1371/journal.pone.0122377] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
582 Luk F, de Witte SF, Bramer WM, Baan CC, Hoogduijn MJ. Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review. Expert Review of Clinical Immunology 2015;11:617-36. [DOI: 10.1586/1744666x.2015.1029458] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
583 Arango-Rodriguez ML, Ezquer F, Ezquer M, Conget P. Could cancer and infection be adverse effects of mesenchymal stromal cell therapy? World J Stem Cells 2015; 7(2): 408-417 [PMID: 25815124 DOI: 10.4252/wjsc.v7.i2.408] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
584 Wang X, Liu C, Li S, Xu Y, Chen P, Liu Y, Ding Q, Wahafu W, Hong B, Yang M. Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of diabetic erectile dysfunction via augmenting angiogenesis and neuroprotection. PLoS One 2015;10:e0118951. [PMID: 25790284 DOI: 10.1371/journal.pone.0118951] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
585 Amato B, Compagna R, Amato M, Grande R, Butrico L, Rossi A, Naso A, Ruggiero M, de Franciscis S, Serra R. Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms. Stem Cells Int 2015;2015:434962. [PMID: 25866513 DOI: 10.1155/2015/434962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
586 Dulamea AO. The potential use of mesenchymal stem cells in stroke therapy--From bench to bedside. J Neurol Sci 2015;352:1-11. [PMID: 25818674 DOI: 10.1016/j.jns.2015.03.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
587 Li Z, Han S, Wang X, Han F, Zhu X, Zheng Z, Wang H, Zhou Q, Wang Y, Su L, Shi J, Tang C, Hu D. Rho kinase inhibitor Y-27632 promotes the differentiation of human bone marrow mesenchymal stem cells into keratinocyte-like cells in xeno-free conditioned medium. Stem Cell Res Ther 2015;6:17. [PMID: 25889377 DOI: 10.1186/s13287-015-0008-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
588 Hogan MV, Walker GN, Cui LR, Fu FH, Huard J. The role of stem cells and tissue engineering in orthopaedic sports medicine: current evidence and future directions. Arthroscopy 2015;31:1017-21. [PMID: 25726331 DOI: 10.1016/j.arthro.2014.11.033] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
589 Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-Art management of knee osteoarthritis. World J Clin Cases 2015; 3(2): 89-101 [PMID: 25685755 DOI: 10.12998/wjcc.v3.i2.89] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 84] [Article Influence: 13.0] [Reference Citation Analysis]
590 McLean AK, Stewart C, Kerridge I. Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia. Stem Cell Res Ther. 2015;6:33. [PMID: 25689404 DOI: 10.1186/s13287-015-0047-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
591 Papazova DA, Oosterhuis NR, Gremmels H, van Koppen A, Joles JA, Verhaar MC. Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis. Dis Model Mech. 2015;8:281-293. [PMID: 25633980 DOI: 10.1242/dmm.017699] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
592 Cui LL, Kerkelä E, Bakreen A, Nitzsche F, Andrzejewska A, Nowakowski A, Janowski M, Walczak P, Boltze J, Lukomska B, Jolkkonen J. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther 2015;6:11. [PMID: 25971703 DOI: 10.1186/scrt544] [Cited by in Crossref: 92] [Cited by in F6Publishing: 109] [Article Influence: 13.1] [Reference Citation Analysis]
593 Nagaishi K, Arimura Y, Fujimiya M. Stem cell therapy for inflammatory bowel disease. J Gastroenterol. 2015;50:280-286. [PMID: 25618180 DOI: 10.1007/s00535-015-1040-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
594 Patel SR, Copland IB, Garcia MA, Metz R, Galipeau J. Human mesenchymal stromal cells suppress T-cell proliferation independent of heme oxygenase-1. Cytotherapy 2015;17:382-91. [PMID: 25595329 DOI: 10.1016/j.jcyt.2014.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
595 Efimenko AY, Kochegura TN, Akopyan ZA, Parfyonova YV. Autologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor Cells. Biores Open Access. 2015;4:26-38. [PMID: 26309780 DOI: 10.1089/biores.2014.0042] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
596 Arzi B, Kol A, Murphy B, Walker NJ, Wood JA, Clark K, Verstraete FJ, Borjesson DL. Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development. Stem Cells Dev 2015;24:814-23. [PMID: 25404388 DOI: 10.1089/scd.2014.0317] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
597 Gesundheit B, Ashwood P, Keating A, Naor D, Melamed M, Rosenzweig JP. Therapeutic properties of mesenchymal stem cells for autism spectrum disorders. Med Hypotheses. 2015;84:169-177. [PMID: 25592283 DOI: 10.1016/j.mehy.2014.12.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
598 Lathrop MJ, Sage EK, Macura SL, Brooks EM, Cruz F, Bonenfant NR, Sokocevic D, Macpherson MB, Beuschel SL, Dunaway CW, Shukla A, Janes SM, Steele C, Mossman BT, Weiss DJ. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma. Cancer Gene Ther 2015;22:44-54. [DOI: 10.1038/cgt.2014.68] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
599 Weiss DJ. Cell therapies for ARDS: a promising start. Lancet Respir Med 2015;3:2-3. [PMID: 25529341 DOI: 10.1016/S2213-2600(14)70301-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
600 Monsel A, Zhu YG, Gennai S, Hao Q, Liu J, Lee JW. Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology 2014;121:1099-121. [PMID: 25211170 DOI: 10.1097/ALN.0000000000000446] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 10.5] [Reference Citation Analysis]
601 Chullikana A, Majumdar AS, Gottipamula S, Krishnamurthy S, Kumar AS, Prakash VS, Gupta PK. Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction. Cytotherapy 2015;17:250-61. [PMID: 25484310 DOI: 10.1016/j.jcyt.2014.10.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
602 Weiss DJ. Concise review: current status of stem cells and regenerative medicine in lung biology and diseases. Stem Cells. 2014;32:16-25. [PMID: 23959715 DOI: 10.1002/stem.1506] [Cited by in Crossref: 112] [Cited by in F6Publishing: 101] [Article Influence: 14.0] [Reference Citation Analysis]
603 Foster WS, Suen CM, Stewart DJ. Regenerative Cell and Tissue-based Therapies for Pulmonary Arterial Hypertension. Canadian Journal of Cardiology 2014;30:1350-60. [DOI: 10.1016/j.cjca.2014.08.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
604 Doeppner TR, Hermann DM. Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability. Front Cell Neurosci. 2014;8:357. [PMID: 25400548 DOI: 10.3389/fncel.2014.00357] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
605 Ikegame Y, Yamashita K, Nakashima S, Nomura Y, Yonezawa S, Asano Y, Shinoda J, Hara H, Iwama T. Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke? Front Cell Neurosci 2014;8:322. [PMID: 25374506 DOI: 10.3389/fncel.2014.00322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
606 Qiao LY, Huang FJ, Zhao M, Xie JH, Shi J, Wang J, Lin XZ, Zuo H, Wang YL, Geng TC. A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients. Cell Transplant. 2014;23 Suppl 1:S65-S72. [PMID: 25333752 DOI: 10.3727/096368914x684961] [Cited by in Crossref: 48] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
607 Gremmels H, Fledderus JO, Teraa M, Verhaar MC. Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective. Stem Cell Res Ther 2013;4:140. [PMID: 24246031 DOI: 10.1186/scrt351] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
608 Lindblad RW, Ibenana L, Wagner JE, McKenna DH Jr, Hei DJ, Hematti P, Couture LA, Silberstein LE, Armant M, Rooney CM, Gee AP, Welniak LA, Heath Mondoro T, Wood DA, Styers D. Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program. Transfusion 2015;55:674-9. [PMID: 25315143 DOI: 10.1111/trf.12881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
609 Xiao C, Zhou S, Liu Y, Hu H. Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis. Med Sci Monit 2014;20:1768-77. [PMID: 25270584 DOI: 10.12659/MSM.892047] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
610 Li X, Xiao Y, Cui Y, Tan T, Narasimhulu CA, Hao H, Liu L, Zhang J, He G, Verfaillie CM. Cell membrane damage is involved in the impaired survival of bone marrow stem cells by oxidized low-density lipoprotein. J Cell Mol Med. 2014;18:2445-2453. [PMID: 25256620 DOI: 10.1111/jcmm.12424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
611 Yang X, Li Z, Ma Y, Gao J, Liu S, Gao Y, Wang G. Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice. Cancer Cell Int 2014;14:93. [PMID: 25298750 DOI: 10.1186/s12935-014-0093-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
612 Yang X, Li Z, Ma Y, Gao J, Liu S, Gao Y, Wang G. Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice. Cancer Cell Int. 2014;14:93. [PMID: 25298750 DOI: 10.1186/s12935-014-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
613 Gotts JE, Matthay MA. Endogenous and exogenous cell-based pathways for recovery from acute respiratory distress syndrome. Clin Chest Med 2014;35:797-809. [PMID: 25453426 DOI: 10.1016/j.ccm.2014.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
614 Rolandsson S, Karlsson JC, Scheding S, Westergren-Thorsson G. Specific subsets of mesenchymal stroma cells to treat lung disorders--finding the Holy Grail. Pulm Pharmacol Ther 2014;29:93-5. [PMID: 25239767 DOI: 10.1016/j.pupt.2014.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
615 Hernanda PY, Pedroza-Gonzalez A, Sprengers D, Peppelenbosch MP, Pan Q. Multipotent mesenchymal stromal cells in liver cancer: implications for tumor biology and therapy. Biochim Biophys Acta 2014;1846:439-45. [PMID: 25204853 DOI: 10.1016/j.bbcan.2014.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
616 Abrate A, Buono R, Canu T, Esposito A, Del Maschio A, Lucianò R, Bettiga A, Colciago G, Guazzoni G, Benigni F, Hedlund P, Altaner C, Montorsi F, Cavarretta IT. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression. European Journal of Cancer 2014;50:2478-88. [DOI: 10.1016/j.ejca.2014.06.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
617 Eirin A, Riester SM, Zhu XY, Tang H, Evans JM, O'Brien D, van Wijnen AJ, Lerman LO. MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells. Gene. 2014;551:55-64. [PMID: 25158130 DOI: 10.1016/j.gene.2014.08.041] [Cited by in Crossref: 165] [Cited by in F6Publishing: 178] [Article Influence: 20.6] [Reference Citation Analysis]
618 Swart J, Wulffraat N. Mesenchymal stromal cells for treatment of arthritis. Best Practice & Research Clinical Rheumatology 2014;28:589-603. [DOI: 10.1016/j.berh.2014.10.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
619 Usunier B, Benderitter M, Tamarat R, Chapel A. Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int 2014;2014:340257. [PMID: 25132856 DOI: 10.1155/2014/340257] [Cited by in Crossref: 101] [Cited by in F6Publishing: 95] [Article Influence: 12.6] [Reference Citation Analysis]
620 Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM, Hopkins PM. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014;19:1013-1018. [PMID: 25039426 DOI: 10.1111/resp.12343] [Cited by in Crossref: 151] [Cited by in F6Publishing: 149] [Article Influence: 18.9] [Reference Citation Analysis]
621 Eirin A, Lerman LO. Mesenchymal stem cell treatment for chronic renal failure. Stem Cell Res Ther. 2014;5:83. [PMID: 25158205 DOI: 10.1186/scrt472] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
622 Choi YC, Choi JS, Woo CH, Cho YW. Stem cell delivery systems inspired by tissue-specific niches. J Control Release. 2014;193:42-50. [PMID: 24979211 DOI: 10.1016/j.jconrel.2014.06.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
623 Lachaud CC, López-Beas J, Soria B, Hmadcha A. EGF-induced adipose tissue mesothelial cells undergo functional vascular smooth muscle differentiation. Cell Death Dis 2014;5:e1304. [PMID: 24967966 DOI: 10.1038/cddis.2014.271] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
624 Weiss DJ. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc. 2013;10:S45-S97. [PMID: 23869446 DOI: 10.1513/annalsats.201304-090aw] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
625 Weiss DJ, Bates JH, Gilbert T, Liles WC, Lutzko C, Rajagopal J, Prockop D. Stem cells and cell therapies in lung biology and diseases: conference report. Ann Am Thorac Soc. 2013;10:S25-S44. [PMID: 23869447 DOI: 10.1513/annalsats.201304-089aw] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
626 Hernigou P, Flouzat Lachaniette CH, Delambre J, Chevallier N, Rouard H. Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence? Int Orthop. 2014;38:1825-1835. [PMID: 24906983 DOI: 10.1007/s00264-014-2384-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
627 Wang X, Kimbrel EA, Ijichi K, Paul D, Lazorchak AS, Chu J, Kouris NA, Yavanian GJ, Lu SJ, Pachter JS, Crocker SJ, Lanza R, Xu RH. Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports. 2014;3:115-130. [PMID: 25068126 DOI: 10.1016/j.stemcr.2014.04.020] [Cited by in Crossref: 89] [Cited by in F6Publishing: 99] [Article Influence: 11.1] [Reference Citation Analysis]
628 Pagliari S, Tirella A, Ahluwalia A, Duim S, Goumans MJ, Aoyagi T, Forte G. A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds. Front Physiol 2014;5:210. [PMID: 24917827 DOI: 10.3389/fphys.2014.00210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
629 Kusadasi N, Groeneveld AB. A perspective on mesenchymal stromal cell transplantation in the treatment of sepsis. Shock. 2013;40:352-357. [PMID: 24088992 DOI: 10.1097/shk.0000000000000039] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
630 Rosado-de-Castro PH, Pimentel-Coelho PM, Gutfilen B, Lopes de Souza SA, de Freitas GR, Mendez-Otero R, Barbosa da Fonseca LM. Radiopharmaceutical stem cell tracking for neurological diseases. Biomed Res Int 2014;2014:417091. [PMID: 24982880 DOI: 10.1155/2014/417091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
631 Zumla A, Rao M, Parida SK, Keshavjee S, Cassell G, Wallis R, Axelsson-robertsson R, Doherty M, Andersson J, Maeurer M. Inflammation and tuberculosis: host-directed therapies. J Intern Med 2015;277:373-87. [DOI: 10.1111/joim.12256] [Cited by in Crossref: 70] [Cited by in F6Publishing: 77] [Article Influence: 8.8] [Reference Citation Analysis]
632 Taylor DA, Caplan AL, Macchiarini P. Ethics of bioengineering organs and tissues. Expert Opinion on Biological Therapy 2014;14:879-82. [DOI: 10.1517/14712598.2014.915308] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
633 Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: A review. World J Stem Cells 2014; 6(2): 120-133 [PMID: 24772239 DOI: 10.4252/wjsc.v6.i2.120] [Cited by in Crossref: 132] [Cited by in F6Publishing: 114] [Article Influence: 16.5] [Reference Citation Analysis]
634 Kavanagh DPJ, Robinson J, Kalia N. Mesenchymal Stem Cell Priming: Fine-tuning Adhesion and Function. Stem Cell Rev and Rep 2014;10:587-99. [DOI: 10.1007/s12015-014-9510-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
635 Quaranta P, Antonini S, Spiga S, Mazzanti B, Curcio M, Mulas G, Diana M, Marzola P, Mosca F, Longoni B. Co-transplantation of endothelial progenitor cells and pancreatic islets to induce long-lasting normoglycemia in streptozotocin-treated diabetic rats. PLoS One. 2014;9:e94783. [PMID: 24733186 DOI: 10.1371/journal.pone.0094783] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
636 Lucarelli E, Bellotti C, Mantelli M, Avanzini MA, Maccario R, Novara F, Arrigo G, Zuffardi O, Zuntini M, Pandolfi M, Sangiorgi L, Lisini D, Donati D, Duchi S. In vitro biosafety profile evaluation of multipotent mesenchymal stem cells derived from the bone marrow of sarcoma patients. J Transl Med 2014;12:95. [PMID: 24716831 DOI: 10.1186/1479-5876-12-95] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
637 Pileggi A, Xu X, Tan J, Ricordi C. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials. Curr Opin Organ Transplant 2013;18:672-81. [PMID: 24220050 DOI: 10.1097/MOT.0000000000000029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
638 Capelli C, Pedrini O, Cassina G, Spinelli O, Salmoiraghi S, Golay J, Rambaldi A, Giussani U, Introna M. Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols. Haematologica 2014;99:e94-7. [PMID: 24682511 DOI: 10.3324/haematol.2014.104711] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
639 Ouyang B, Sun X, Han D, Chen S, Yao B, Gao Y, Bian J, Huang Y, Zhang Y, Wan Z, Yang B, Xiao H, Songyang Z, Liu G, Zhang Y, Deng C. Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model. PLoS One. 2014;9:e92825. [PMID: 24663037 DOI: 10.1371/journal.pone.0092825] [Cited by in Crossref: 68] [Cited by in F6Publishing: 78] [Article Influence: 8.5] [Reference Citation Analysis]
640 Figueroa FE, Cuenca Moreno J, La Cava A. Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors. Expert Opin Drug Discov 2014;9:555-66. [PMID: 24655067 DOI: 10.1517/17460441.2014.897692] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
641 Lee M, Jeong SY, Ha J, Kim M, Jin HJ, Kwon SJ, Chang JW, Choi SJ, Oh W, Yang YS, Kim JS, Jeon HB. Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo. Biochem Biophys Res Commun. 2014;446:983-989. [PMID: 24657442 DOI: 10.1016/j.bbrc.2014.03.051] [Cited by in Crossref: 109] [Cited by in F6Publishing: 114] [Article Influence: 13.6] [Reference Citation Analysis]
642 Hervy M, Weber JL, Pecheul M, Dolley-Sonneville P, Henry D, Zhou Y, Melkoumian Z. Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions. PLoS One 2014;9:e92120. [PMID: 24638103 DOI: 10.1371/journal.pone.0092120] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
643 Vu Q, Xie K, Eckert M, Zhao W, Cramer SC. Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke. Neurology. 2014;82:1277-1286. [PMID: 24610327 DOI: 10.1212/wnl.0000000000000278] [Cited by in Crossref: 120] [Cited by in F6Publishing: 121] [Article Influence: 15.0] [Reference Citation Analysis]
644 Thomsen GM, Gowing G, Svendsen S, Svendsen CN. The past, present and future of stem cell clinical trials for ALS. Exp Neurol. 2014;262 Pt B:127-137. [PMID: 24613827 DOI: 10.1016/j.expneurol.2014.02.021] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 11.3] [Reference Citation Analysis]
645 Bronckaers A, Hilkens P, Martens W, Gervois P, Ratajczak J, Struys T, Lambrichts I. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacol Ther. 2014;143:181-196. [PMID: 24594234 DOI: 10.1016/j.pharmthera.2014.02.013] [Cited by in Crossref: 182] [Cited by in F6Publishing: 199] [Article Influence: 22.8] [Reference Citation Analysis]
646 Hao L, Zou Z, Tian H, Zhang Y, Zhou H, Liu L. Stem cell-based therapies for ischemic stroke. Biomed Res Int. 2014;2014:468748. [PMID: 24719869 DOI: 10.1155/2014/468748] [Cited by in Crossref: 108] [Cited by in F6Publishing: 134] [Article Influence: 13.5] [Reference Citation Analysis]
647 Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 2014;32:252-60. [PMID: 24561556 DOI: 10.1038/nbt.2816] [Cited by in Crossref: 690] [Cited by in F6Publishing: 788] [Article Influence: 86.3] [Reference Citation Analysis]
648 Lalu MM, Barron CC, Stewart DJ, McIntyre LL. Adult stem cells: potential implications for perioperative medicine. Can J Anaesth 2014;61:299-305. [PMID: 24510734 DOI: 10.1007/s12630-014-0121-1] [Reference Citation Analysis]
649 François S, Usunier B, Douay L, Benderitter M, Chapel A. Long-Term Quantitative Biodistribution and Side Effects of Human Mesenchymal Stem Cells (hMSCs) Engraftment in NOD/SCID Mice following Irradiation. Stem Cells Int 2014;2014:939275. [PMID: 24672555 DOI: 10.1155/2014/939275] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
650 Martínez-Montiel Mdel P, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol 2014;20:1211-27. [PMID: 24574796 DOI: 10.3748/wjg.v20.i5.1211] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
651 van Deen WK, Oikonomopoulos A, Hommes DW. Stem cell therapy in inflammatory bowel disease: which, when and how? Curr Opin Gastroenterol. 2013;29:384-390. [PMID: 23666365 DOI: 10.1097/mog.0b013e328361f763] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
652 Liles WC, Matthay MA, dos Santos CC, Weiss DJ, Stewart DJ. Mesenchymal Stromal (Stem) Cell Therapy: An Emerging Immunomodulatory Strategy for the Adjunctive Treatment of Sepsis. Am J Respir Crit Care Med 2014;189:363-4. [DOI: 10.1164/rccm.201307-1272le] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
653 Gottipamula S, Ashwin KM, Muttigi MS, Kannan S, Kolkundkar U, Seetharam RN. Isolation, expansion and characterization of bone marrow-derived mesenchymal stromal cells in serum-free conditions. Cell Tissue Res 2014;356:123-35. [PMID: 24448665 DOI: 10.1007/s00441-013-1783-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
654 Comar M, Delbue S, Zanotta N, Valencic E, Piscianz E, Del Savio R, Tesser A, Tommasini A, Ferrante P. In vivo detection of polyomaviruses JCV and SV40 in mesenchymal stem cells from human umbilical cords. Pediatr Blood Cancer 2014;61:1347-9. [PMID: 24623583 DOI: 10.1002/pbc.24943] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
655 Dai W, Kay GL, Kloner RA. The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction. J Cardiovasc Pharmacol Ther 2014;19:350-7. [DOI: 10.1177/1074248413517746] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
656 Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A, Maeurer MJ. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Lancet Respir Med. 2014;2:108-122. [PMID: 24503266 DOI: 10.1016/s2213-2600(13)70234-0] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 9.9] [Reference Citation Analysis]
657 Ikebe C, Suzuki K. Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols. Biomed Res Int. 2014;2014:951512. [PMID: 24511552 DOI: 10.1155/2014/951512] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 14.5] [Reference Citation Analysis]
658 Gregorini M, Maccario R, Avanzini MA, Corradetti V, Moretta A, Libetta C, Esposito P, Bosio F, Dal Canton A, Rampino T. Antineutrophil cytoplasmic antibody-associated renal vasculitis treated with autologous mesenchymal stromal cells: evaluation of the contribution of immune-mediated mechanisms. Mayo Clin Proc. 2013;88:1174-1179. [PMID: 24079687 DOI: 10.1016/j.mayocp.2013.06.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
659 Introna M, Lucchini G, Dander E, Galimberti S, Rovelli A, Balduzzi A, Longoni D, Pavan F, Masciocchi F, Algarotti A. Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant. 2014;20:375-381. [PMID: 24321746 DOI: 10.1016/j.bbmt.2013.11.033] [Cited by in Crossref: 135] [Cited by in F6Publishing: 138] [Article Influence: 15.0] [Reference Citation Analysis]
660 Hsiao ST, Dilley RJ, Dusting GJ, Lim SY. Ischemic preconditioning for cell-based therapy and tissue engineering. Pharmacol Ther 2014;142:141-53. [PMID: 24321597 DOI: 10.1016/j.pharmthera.2013.12.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
661 Marquez-Curtis LA, Janowska-Wieczorek A. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. Biomed Res Int. 2013;2013:561098. [PMID: 24381939 DOI: 10.1155/2013/561098] [Cited by in Crossref: 142] [Cited by in F6Publishing: 175] [Article Influence: 15.8] [Reference Citation Analysis]
662 Watanabe S, Arimura Y, Nagaishi K, Isshiki H, Onodera K, Nasuno M, Yamashita K, Idogawa M, Naishiro Y, Murata M, Adachi Y, Fujimiya M, Imai K, Shinomura Y. Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors. J Gastroenterol. 2014;49:270-282. [PMID: 24217964 DOI: 10.1007/s00535-013-0901-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
663 Chapel A, Francois S, Douay L, Benderitter M, Voswinkel J. New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy. World J Stem Cells 2013;5:106-11. [PMID: 24179599 DOI: 10.4252/wjsc.v5.i4.106] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
664 Oliveri RS, Bello S, Biering-Sørensen F. Mesenchymal stem cells improve locomotor recovery in traumatic spinal cord injury: systematic review with meta-analyses of rat models. Neurobiol Dis 2014;62:338-53. [PMID: 24148857 DOI: 10.1016/j.nbd.2013.10.014] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 9.3] [Reference Citation Analysis]
665 Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Thébaud B, Trapnell BC, Weiss DJ, Yuan JX, Blaisdell CJ. Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. Am J Respir Crit Care Med 2013;188:370-5. [PMID: 23713908 DOI: 10.1164/rccm.201303-0522WS] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
666 Rice CM, Kemp K, Wilkins A, Scolding NJ. Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases. The Lancet 2013;382:1204-13. [DOI: 10.1016/s0140-6736(13)61810-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
667 Zurita M, Aguayo C, Bonilla C, Rodriguez A, Vaquero J. Perilesional intrathecal administration of autologous bone marrow stromal cells achieves functional improvement in pigs with chronic paraplegia. Cytotherapy 2013;15:1218-27. [DOI: 10.1016/j.jcyt.2013.05.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
668 Weiss DJ, Ortiz LA. Cell therapy trials for lung diseases: progress and cautions. Am J Respir Crit Care Med 2013;188:123-5. [PMID: 23855686 DOI: 10.1164/rccm.201302-0351ED] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
669 Linard C, Busson E, Holler V, Strup-Perrot C, Lacave-Lapalun JV, Lhomme B, Prat M, Devauchelle P, Sabourin JC, Simon JM, Bonneau M, Lataillade JJ, Benderitter M. Repeated autologous bone marrow-derived mesenchymal stem cell injections improve radiation-induced proctitis in pigs. Stem Cells Transl Med 2013;2:916-27. [PMID: 24068742 DOI: 10.5966/sctm.2013-0030] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 7.3] [Reference Citation Analysis]
670 de Girolamo L, Lucarelli E, Alessandri G, Avanzini MA, Bernardo ME, Biagi E, Brini AT, D'Amico G, Fagioli F, Ferrero I, Locatelli F, Maccario R, Marazzi M, Parolini O, Pessina A, Torre ML, Italian Mesenchymal Stem Cell Group. Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des 2013;19:2459-73. [PMID: 23278600 DOI: 10.2174/1381612811319130015] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 10.6] [Reference Citation Analysis]
671 Ennis WJ, Sui A, Bartholomew A. Stem Cells and Healing: Impact on Inflammation. Adv Wound Care (New Rochelle) 2013;2:369-78. [PMID: 24587974 DOI: 10.1089/wound.2013.0449] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
672 Liu G, Sun X, Bian J, Wu R, Guan X, Ouyang B, Huang Y, Xiao H, Luo D, Atala A, Zhang Y, Deng C. Correction of diabetic erectile dysfunction with adipose derived stem cells modified with the vascular endothelial growth factor gene in a rodent diabetic model. PLoS One 2013;8:e72790. [PMID: 24023647 DOI: 10.1371/journal.pone.0072790] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.1] [Reference Citation Analysis]
673 Griffiths S, Baraniak PR, Copland IB, Nerem RM, McDevitt TC. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. Cytotherapy 2013;15:1469-83. [PMID: 23981539 DOI: 10.1016/j.jcyt.2013.05.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
674 Brennen WN, Denmeade SR, Isaacs JT. Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment. Endocr Relat Cancer 2013;20:R269-90. [PMID: 23975882 DOI: 10.1530/ERC-13-0151] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
675 Gotts JE, Matthay MA. Cell therapy for lung disease: a step forward. Chest 2013;143:1525-7. [PMID: 23732575 DOI: 10.1378/chest.12-2993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
676 Ulrich D, Muralitharan R, Gargett CE. Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. Expert Opin Biol Ther. 2013;13:1387-1400. [PMID: 23930703 DOI: 10.1517/14712598.2013.826187] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 9.3] [Reference Citation Analysis]
677 Zheng GP, Ge MH, Shu Q, Rojas M, Xu J. Mesenchymal stem cells in the treatment of pediatric diseases. World J Pediatr 2013;9:197-211. [PMID: 23929252 DOI: 10.1007/s12519-013-0425-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
678 Bausek N. JAK-STAT signaling in stem cells and their niches in Drosophila. JAKSTAT 2013;2:e25686. [PMID: 24069566 DOI: 10.4161/jkst.25686] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
679 Pittenger MF. MSCs: science and trials. Nat Med 2013;19:811-811. [DOI: 10.1038/nm.3219] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
680 Lavoie JR, Rosu-Myles M. Uncovering the secretes of mesenchymal stem cells. Biochimie. 2013;95:2212-2221. [PMID: 23810910 DOI: 10.1016/j.biochi.2013.06.017] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 12.3] [Reference Citation Analysis]
681 Zhang J, Chopp M. Cell-based therapy for ischemic stroke. Expert Opin Biol Ther 2013;13:1229-40. [PMID: 23738646 DOI: 10.1517/14712598.2013.804507] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
682 Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD. Mesenchymal stem cell secretome and regenerative therapy after cancer. Biochimie. 2013;95:2235-2245. [PMID: 23747841 DOI: 10.1016/j.biochi.2013.05.010] [Cited by in Crossref: 113] [Cited by in F6Publishing: 114] [Article Influence: 12.6] [Reference Citation Analysis]
683 Lin CS, Xin ZC, Dai J, Lue TF. Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges. Histol Histopathol. 2013;28:1109-1116. [PMID: 23588700 DOI: 10.14670/hh-28.1109] [Cited by in F6Publishing: 79] [Reference Citation Analysis]
684 Cyranoski D. Stem cells in Texas: Cowboy culture. Nature 2013;494:166-8. [DOI: 10.1038/494166a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
685 Cohen JA. Mesenchymal stem cell transplantation in multiple sclerosis. J Neurol Sci. 2013;333:43-49. [PMID: 23294498 DOI: 10.1016/j.jns.2012.12.009] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 8.9] [Reference Citation Analysis]
686 Sipp D, Turner L. U.S. Regulation of Stem Cells as Medical Products. Science 2012;338:1296-7. [DOI: 10.1126/science.1229918] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]